id	sid	tid	token	lemma	pos
ajlm-2688	1	1	abstract	abstract	ADJ
ajlm-2688	1	2	introduction	introduction	NOUN
ajlm-2688	1	3	methods	method	NOUN
ajlm-2688	1	4	results	result	VERB
ajlm-2688	1	5	discussion	discussion	NOUN
ajlm-2688	1	6	acknowledgements	acknowledgement	NOUN
ajlm-2688	1	7	references	reference	NOUN
ajlm-2688	1	8	about	about	ADP
ajlm-2688	1	9	the	the	DET
ajlm-2688	1	10	author(s	author(s	NOUN
ajlm-2688	1	11	)	)	PUNCT
ajlm-2688	1	12	shaun	shaun	PROPN
ajlm-2688	1	13	m.	m.	PROPN
ajlm-2688	1	14	grobler	grobler	PROPN
ajlm-2688	1	15	department	department	PROPN
ajlm-2688	1	16	of	of	ADP
ajlm-2688	1	17	haematology	haematology	NOUN
ajlm-2688	1	18	and	and	CCONJ
ajlm-2688	1	19	cell	cell	NOUN
ajlm-2688	1	20	biology	biology	NOUN
ajlm-2688	1	21	,	,	PUNCT
ajlm-2688	1	22	faculty	faculty	NOUN
ajlm-2688	1	23	of	of	ADP
ajlm-2688	1	24	health	health	NOUN
ajlm-2688	1	25	sciences	sciences	PROPN
ajlm-2688	1	26	,	,	PUNCT
ajlm-2688	1	27	university	university	NOUN
ajlm-2688	1	28	of	of	ADP
ajlm-2688	1	29	the	the	DET
ajlm-2688	1	30	free	free	ADJ
ajlm-2688	1	31	state	state	PROPN
ajlm-2688	1	32	,	,	PUNCT
ajlm-2688	1	33	bloemfontein	bloemfontein	PROPN
ajlm-2688	1	34	,	,	PUNCT
ajlm-2688	1	35	south	south	PROPN
ajlm-2688	1	36	africa	africa	PROPN
ajlm-2688	1	37	department	department	PROPN
ajlm-2688	1	38	of	of	ADP
ajlm-2688	1	39	haematology	haematology	PROPN
ajlm-2688	1	40	,	,	PUNCT
ajlm-2688	1	41	national	national	PROPN
ajlm-2688	1	42	health	health	PROPN
ajlm-2688	1	43	laboratory	laboratory	PROPN
ajlm-2688	1	44	service	service	PROPN
ajlm-2688	1	45	,	,	PUNCT
ajlm-2688	1	46	bloemfontein	bloemfontein	PROPN
ajlm-2688	1	47	,	,	PUNCT
ajlm-2688	1	48	south	south	PROPN
ajlm-2688	1	49	africa	africa	PROPN
ajlm-2688	1	50	anne	anne	PROPN
ajlm-2688	1	51	-	-	PUNCT
ajlm-2688	1	52	cecilia	cecilia	PROPN
ajlm-2688	1	53	van	van	PROPN
ajlm-2688	1	54	marle	marle	PROPN
ajlm-2688	1	55	department	department	PROPN
ajlm-2688	1	56	of	of	ADP
ajlm-2688	1	57	haematology	haematology	NOUN
ajlm-2688	1	58	and	and	CCONJ
ajlm-2688	1	59	cell	cell	NOUN
ajlm-2688	1	60	biology	biology	NOUN
ajlm-2688	1	61	,	,	PUNCT
ajlm-2688	1	62	faculty	faculty	NOUN
ajlm-2688	1	63	of	of	ADP
ajlm-2688	1	64	health	health	NOUN
ajlm-2688	1	65	sciences	sciences	PROPN
ajlm-2688	1	66	,	,	PUNCT
ajlm-2688	1	67	university	university	NOUN
ajlm-2688	1	68	of	of	ADP
ajlm-2688	1	69	the	the	DET
ajlm-2688	1	70	free	free	ADJ
ajlm-2688	1	71	state	state	PROPN
ajlm-2688	1	72	,	,	PUNCT
ajlm-2688	1	73	bloemfontein	bloemfontein	PROPN
ajlm-2688	1	74	,	,	PUNCT
ajlm-2688	1	75	south	south	PROPN
ajlm-2688	1	76	africa	africa	PROPN
ajlm-2688	1	77	department	department	PROPN
ajlm-2688	1	78	of	of	ADP
ajlm-2688	1	79	haematology	haematology	PROPN
ajlm-2688	1	80	,	,	PUNCT
ajlm-2688	1	81	national	national	PROPN
ajlm-2688	1	82	health	health	PROPN
ajlm-2688	1	83	laboratory	laboratory	PROPN
ajlm-2688	1	84	service	service	PROPN
ajlm-2688	1	85	,	,	PUNCT
ajlm-2688	1	86	bloemfontein	bloemfontein	PROPN
ajlm-2688	1	87	,	,	PUNCT
ajlm-2688	1	88	south	south	PROPN
ajlm-2688	1	89	africa	africa	PROPN
ajlm-2688	1	90	citation	citation	PROPN
ajlm-2688	1	91	grobler	grobler	NOUN
ajlm-2688	1	92	sm	sm	PROPN
ajlm-2688	1	93	,	,	PUNCT
ajlm-2688	1	94	van	van	PROPN
ajlm-2688	1	95	marle	marle	PROPN
ajlm-2688	1	96	a	a	PROPN
ajlm-2688	1	97	-	-	PUNCT
ajlm-2688	1	98	c.	c.	NOUN
ajlm-2688	1	99	effects	effect	NOUN
ajlm-2688	1	100	of	of	ADP
ajlm-2688	1	101	sample	sample	NOUN
ajlm-2688	1	102	age	age	NOUN
ajlm-2688	1	103	and	and	CCONJ
ajlm-2688	1	104	storage	storage	NOUN
ajlm-2688	1	105	temperature	temperature	NOUN
ajlm-2688	1	106	on	on	ADP
ajlm-2688	1	107	the	the	DET
ajlm-2688	1	108	flow	flow	NOUN
ajlm-2688	1	109	cytometric	cytometric	ADJ
ajlm-2688	1	110	diagnosis	diagnosis	NOUN
ajlm-2688	1	111	of	of	ADP
ajlm-2688	1	112	chronic	chronic	ADJ
ajlm-2688	1	113	lymphocytic	lymphocytic	ADJ
ajlm-2688	1	114	leukaemia	leukaemia	NOUN
ajlm-2688	1	115	in	in	ADP
ajlm-2688	1	116	south	south	PROPN
ajlm-2688	1	117	africa	africa	PROPN
ajlm-2688	1	118	.	.	PUNCT
ajlm-2688	2	1	afr	afr	PROPN
ajlm-2688	2	2	j	j	PROPN
ajlm-2688	2	3	lab	lab	PROPN
ajlm-2688	2	4	med	med	PROPN
ajlm-2688	2	5	.	.	PUNCT
ajlm-2688	3	1	2025;14(1	2025;14(1	NUM
ajlm-2688	3	2	)	)	PUNCT
ajlm-2688	3	3	,	,	PUNCT
ajlm-2688	3	4	a2688	a2688	PROPN
ajlm-2688	3	5	.	.	PROPN
ajlm-2688	3	6	https://doi.org/10.4102/ajlm.v14i1.2688	https://doi.org/10.4102/ajlm.v14i1.2688	CCONJ
ajlm-2688	3	7	original	original	ADJ
ajlm-2688	3	8	research	research	NOUN
ajlm-2688	3	9	effects	effect	NOUN
ajlm-2688	3	10	of	of	ADP
ajlm-2688	3	11	sample	sample	NOUN
ajlm-2688	3	12	age	age	NOUN
ajlm-2688	3	13	and	and	CCONJ
ajlm-2688	3	14	storage	storage	NOUN
ajlm-2688	3	15	temperature	temperature	NOUN
ajlm-2688	3	16	on	on	ADP
ajlm-2688	3	17	the	the	DET
ajlm-2688	3	18	flow	flow	NOUN
ajlm-2688	3	19	cytometric	cytometric	ADJ
ajlm-2688	3	20	diagnosis	diagnosis	NOUN
ajlm-2688	3	21	of	of	ADP
ajlm-2688	3	22	chronic	chronic	ADJ
ajlm-2688	3	23	lymphocytic	lymphocytic	ADJ
ajlm-2688	3	24	leukaemia	leukaemia	NOUN
ajlm-2688	3	25	in	in	ADP
ajlm-2688	3	26	south	south	PROPN
ajlm-2688	3	27	africa	africa	PROPN
ajlm-2688	3	28	shaun	shaun	PROPN
ajlm-2688	3	29	m.	m.	PROPN
ajlm-2688	3	30	grobler	grobler	NOUN
ajlm-2688	3	31	,	,	PUNCT
ajlm-2688	3	32	anne	anne	PROPN
ajlm-2688	3	33	-	-	PUNCT
ajlm-2688	3	34	cecilia	cecilia	PROPN
ajlm-2688	3	35	van	van	PROPN
ajlm-2688	3	36	marle	marle	PROPN
ajlm-2688	3	37	received	receive	VERB
ajlm-2688	3	38	:	:	PUNCT
ajlm-2688	3	39	09	09	NUM
ajlm-2688	3	40	nov	nov	PROPN
ajlm-2688	3	41	.	.	PROPN
ajlm-2688	3	42	2024	2024	NUM
ajlm-2688	3	43	;	;	PUNCT
ajlm-2688	3	44	accepted	accept	VERB
ajlm-2688	3	45	:	:	PUNCT
ajlm-2688	3	46	28	28	NUM
ajlm-2688	3	47	feb	feb	X
ajlm-2688	3	48	.	.	PROPN
ajlm-2688	3	49	2025	2025	NUM
ajlm-2688	3	50	;	;	PUNCT
ajlm-2688	3	51	published	publish	VERB
ajlm-2688	3	52	:	:	PUNCT
ajlm-2688	3	53	31	31	NUM
ajlm-2688	3	54	may	may	AUX
ajlm-2688	3	55	2025	2025	NUM
ajlm-2688	3	56	copyright	copyright	NOUN
ajlm-2688	3	57	:	:	PUNCT
ajlm-2688	3	58	©	©	PROPN
ajlm-2688	3	59	2025	2025	NUM
ajlm-2688	3	60	.	.	PUNCT
ajlm-2688	4	1	the	the	DET
ajlm-2688	4	2	author(s	author(s	PROPN
ajlm-2688	4	3	)	)	PUNCT
ajlm-2688	4	4	.	.	PUNCT
ajlm-2688	5	1	licensee	licensee	NOUN
ajlm-2688	5	2	:	:	PUNCT
ajlm-2688	5	3	aosis	aosis	NOUN
ajlm-2688	5	4	.	.	PUNCT
ajlm-2688	6	1	this	this	PRON
ajlm-2688	6	2	is	be	AUX
ajlm-2688	6	3	an	an	DET
ajlm-2688	6	4	open	open	ADJ
ajlm-2688	6	5	access	access	NOUN
ajlm-2688	6	6	article	article	NOUN
ajlm-2688	6	7	distributed	distribute	VERB
ajlm-2688	6	8	under	under	ADP
ajlm-2688	6	9	the	the	DET
ajlm-2688	6	10	terms	term	NOUN
ajlm-2688	6	11	of	of	ADP
ajlm-2688	6	12	the	the	DET
ajlm-2688	6	13	creative	creative	ADJ
ajlm-2688	6	14	commons	common	NOUN
ajlm-2688	6	15	attribution	attribution	NOUN
ajlm-2688	6	16	license	license	NOUN
ajlm-2688	6	17	,	,	PUNCT
ajlm-2688	6	18	which	which	PRON
ajlm-2688	6	19	permits	permit	VERB
ajlm-2688	6	20	unrestricted	unrestricted	ADJ
ajlm-2688	6	21	use	use	NOUN
ajlm-2688	6	22	,	,	PUNCT
ajlm-2688	6	23	distribution	distribution	NOUN
ajlm-2688	6	24	,	,	PUNCT
ajlm-2688	6	25	and	and	CCONJ
ajlm-2688	6	26	reproduction	reproduction	NOUN
ajlm-2688	6	27	in	in	ADP
ajlm-2688	6	28	any	any	DET
ajlm-2688	6	29	medium	medium	NOUN
ajlm-2688	6	30	,	,	PUNCT
ajlm-2688	6	31	provided	provide	VERB
ajlm-2688	6	32	the	the	DET
ajlm-2688	6	33	original	original	ADJ
ajlm-2688	6	34	work	work	NOUN
ajlm-2688	6	35	is	be	AUX
ajlm-2688	6	36	properly	properly	ADV
ajlm-2688	6	37	cited	cite	VERB
ajlm-2688	6	38	.	.	PUNCT
ajlm-2688	7	1	abstract	abstract	ADJ
ajlm-2688	7	2	background	background	NOUN
ajlm-2688	7	3	:	:	PUNCT
ajlm-2688	7	4	chronic	chronic	ADJ
ajlm-2688	7	5	lymphocytic	lymphocytic	ADJ
ajlm-2688	7	6	leukaemia	leukaemia	NOUN
ajlm-2688	7	7	(	(	PUNCT
ajlm-2688	7	8	cll	cll	PROPN
ajlm-2688	7	9	)	)	PUNCT
ajlm-2688	7	10	is	be	AUX
ajlm-2688	7	11	a	a	DET
ajlm-2688	7	12	haematological	haematological	ADJ
ajlm-2688	7	13	neoplasm	neoplasm	NOUN
ajlm-2688	7	14	with	with	ADP
ajlm-2688	7	15	characteristic	characteristic	ADJ
ajlm-2688	7	16	flow	flow	NOUN
ajlm-2688	7	17	cytometric	cytometric	ADJ
ajlm-2688	7	18	immunophenotyping	immunophenotyping	NOUN
ajlm-2688	7	19	.	.	PUNCT
ajlm-2688	8	1	pre	pre	ADJ
ajlm-2688	8	2	-	-	ADJ
ajlm-2688	8	3	analytical	analytical	ADJ
ajlm-2688	8	4	variables	variable	NOUN
ajlm-2688	8	5	impact	impact	VERB
ajlm-2688	8	6	the	the	DET
ajlm-2688	8	7	quality	quality	NOUN
ajlm-2688	8	8	and	and	CCONJ
ajlm-2688	8	9	reproducibility	reproducibility	NOUN
ajlm-2688	8	10	of	of	ADP
ajlm-2688	8	11	flow	flow	NOUN
ajlm-2688	8	12	cytometric	cytometric	ADJ
ajlm-2688	8	13	data	datum	NOUN
ajlm-2688	8	14	,	,	PUNCT
ajlm-2688	8	15	which	which	PRON
ajlm-2688	8	16	could	could	AUX
ajlm-2688	8	17	alter	alter	VERB
ajlm-2688	8	18	the	the	DET
ajlm-2688	8	19	diagnosis	diagnosis	NOUN
ajlm-2688	8	20	from	from	ADP
ajlm-2688	8	21	cll	cll	PROPN
ajlm-2688	8	22	to	to	ADP
ajlm-2688	8	23	atypical	atypical	ADJ
ajlm-2688	8	24	cll	cll	PROPN
ajlm-2688	8	25	(	(	PUNCT
ajlm-2688	8	26	acll	acll	PROPN
ajlm-2688	8	27	)	)	PUNCT
ajlm-2688	8	28	.	.	PUNCT
ajlm-2688	9	1	objective	objective	NOUN
ajlm-2688	9	2	:	:	PUNCT
ajlm-2688	9	3	this	this	DET
ajlm-2688	9	4	study	study	NOUN
ajlm-2688	9	5	investigated	investigate	VERB
ajlm-2688	9	6	the	the	DET
ajlm-2688	9	7	effects	effect	NOUN
ajlm-2688	9	8	of	of	ADP
ajlm-2688	9	9	pre	pre	ADJ
ajlm-2688	9	10	-	-	ADJ
ajlm-2688	9	11	analytical	analytical	ADJ
ajlm-2688	9	12	variables	variable	NOUN
ajlm-2688	9	13	,	,	PUNCT
ajlm-2688	9	14	specifically	specifically	ADV
ajlm-2688	9	15	sample	sample	VERB
ajlm-2688	9	16	age	age	NOUN
ajlm-2688	9	17	and	and	CCONJ
ajlm-2688	9	18	storage	storage	NOUN
ajlm-2688	9	19	temperature	temperature	NOUN
ajlm-2688	9	20	,	,	PUNCT
ajlm-2688	9	21	on	on	ADP
ajlm-2688	9	22	the	the	DET
ajlm-2688	9	23	stability	stability	NOUN
ajlm-2688	9	24	of	of	ADP
ajlm-2688	9	25	key	key	ADJ
ajlm-2688	9	26	antigens	antigen	NOUN
ajlm-2688	9	27	used	use	VERB
ajlm-2688	9	28	in	in	ADP
ajlm-2688	9	29	the	the	DET
ajlm-2688	9	30	diagnosis	diagnosis	NOUN
ajlm-2688	9	31	of	of	ADP
ajlm-2688	9	32	cll	cll	PROPN
ajlm-2688	9	33	.	.	PUNCT
ajlm-2688	10	1	methods	method	NOUN
ajlm-2688	10	2	:	:	PUNCT
ajlm-2688	10	3	serial	serial	ADJ
ajlm-2688	10	4	flow	flow	NOUN
ajlm-2688	10	5	cytometric	cytometric	ADJ
ajlm-2688	10	6	analyses	analysis	NOUN
ajlm-2688	10	7	were	be	AUX
ajlm-2688	10	8	performed	perform	VERB
ajlm-2688	10	9	from	from	ADP
ajlm-2688	10	10	january	january	PROPN
ajlm-2688	10	11	2022	2022	NUM
ajlm-2688	10	12	to	to	ADP
ajlm-2688	10	13	march	march	PROPN
ajlm-2688	10	14	2023	2023	NUM
ajlm-2688	10	15	on	on	ADP
ajlm-2688	10	16	blood	blood	NOUN
ajlm-2688	10	17	samples	sample	NOUN
ajlm-2688	10	18	of	of	ADP
ajlm-2688	10	19	10	10	NUM
ajlm-2688	10	20	cll	cll	PROPN
ajlm-2688	10	21	patients	patient	NOUN
ajlm-2688	10	22	from	from	ADP
ajlm-2688	10	23	the	the	DET
ajlm-2688	10	24	universitas	universita	NOUN
ajlm-2688	10	25	academic	academic	ADJ
ajlm-2688	10	26	hospital	hospital	NOUN
ajlm-2688	10	27	haematology	haematology	PROPN
ajlm-2688	10	28	clinic	clinic	PROPN
ajlm-2688	10	29	in	in	ADP
ajlm-2688	10	30	bloemfontein	bloemfontein	PROPN
ajlm-2688	10	31	,	,	PUNCT
ajlm-2688	10	32	south	south	PROPN
ajlm-2688	10	33	africa	africa	PROPN
ajlm-2688	10	34	.	.	PUNCT
ajlm-2688	11	1	samples	sample	NOUN
ajlm-2688	11	2	were	be	AUX
ajlm-2688	11	3	stored	store	VERB
ajlm-2688	11	4	at	at	ADP
ajlm-2688	11	5	room	room	NOUN
ajlm-2688	11	6	and	and	CCONJ
ajlm-2688	11	7	refrigerator	refrigerator	NOUN
ajlm-2688	11	8	temperatures	temperature	NOUN
ajlm-2688	11	9	and	and	CCONJ
ajlm-2688	11	10	analysed	analyse	VERB
ajlm-2688	11	11	at	at	ADP
ajlm-2688	11	12	baseline	baseline	NOUN
ajlm-2688	11	13	,	,	PUNCT
ajlm-2688	11	14	24	24	NUM
ajlm-2688	11	15	h	h	NOUN
ajlm-2688	11	16	,	,	PUNCT
ajlm-2688	11	17	48	48	NUM
ajlm-2688	11	18	h	h	NOUN
ajlm-2688	11	19	,	,	PUNCT
ajlm-2688	11	20	72	72	NUM
ajlm-2688	11	21	h	h	NOUN
ajlm-2688	11	22	and	and	CCONJ
ajlm-2688	11	23	96	96	NUM
ajlm-2688	11	24	h.	h.	NOUN
ajlm-2688	12	1	we	we	PRON
ajlm-2688	12	2	recorded	record	VERB
ajlm-2688	12	3	the	the	DET
ajlm-2688	12	4	percentage	percentage	NOUN
ajlm-2688	12	5	and	and	CCONJ
ajlm-2688	12	6	intensity	intensity	NOUN
ajlm-2688	12	7	of	of	ADP
ajlm-2688	12	8	antigen	antigen	ADJ
ajlm-2688	12	9	expression	expression	NOUN
ajlm-2688	12	10	of	of	ADP
ajlm-2688	12	11	cll	cll	PROPN
ajlm-2688	12	12	makers	maker	NOUN
ajlm-2688	12	13	,	,	PUNCT
ajlm-2688	12	14	including	include	VERB
ajlm-2688	12	15	cd5	cd5	PROPN
ajlm-2688	12	16	,	,	PUNCT
ajlm-2688	12	17	cd20	cd20	PROPN
ajlm-2688	12	18	,	,	PUNCT
ajlm-2688	12	19	cd23	cd23	PROPN
ajlm-2688	12	20	,	,	PUNCT
ajlm-2688	12	21	cd79b	cd79b	ADJ
ajlm-2688	12	22	,	,	PUNCT
ajlm-2688	12	23	cd200	cd200	PROPN
ajlm-2688	12	24	and	and	CCONJ
ajlm-2688	12	25	sigm	sigm	NOUN
ajlm-2688	12	26	,	,	PUNCT
ajlm-2688	12	27	and	and	CCONJ
ajlm-2688	12	28	assessed	assess	VERB
ajlm-2688	12	29	whether	whether	SCONJ
ajlm-2688	12	30	these	these	PRON
ajlm-2688	12	31	affected	affect	VERB
ajlm-2688	12	32	the	the	DET
ajlm-2688	12	33	adapted	adapt	VERB
ajlm-2688	12	34	and	and	CCONJ
ajlm-2688	12	35	modified	modify	VERB
ajlm-2688	12	36	matutes	matute	NOUN
ajlm-2688	12	37	scores	score	NOUN
ajlm-2688	12	38	.	.	PUNCT
ajlm-2688	13	1	results	result	NOUN
ajlm-2688	13	2	:	:	PUNCT
ajlm-2688	13	3	statistically	statistically	ADV
ajlm-2688	13	4	significant	significant	ADJ
ajlm-2688	13	5	changes	change	NOUN
ajlm-2688	13	6	were	be	AUX
ajlm-2688	13	7	observed	observe	VERB
ajlm-2688	13	8	in	in	ADP
ajlm-2688	13	9	cd5	cd5	PROPN
ajlm-2688	13	10	(	(	PUNCT
ajlm-2688	13	11	p	p	X
ajlm-2688	13	12	=	=	NOUN
ajlm-2688	13	13	0.028	0.028	NUM
ajlm-2688	13	14	)	)	PUNCT
ajlm-2688	13	15	,	,	PUNCT
ajlm-2688	13	16	cd23	cd23	PROPN
ajlm-2688	13	17	(	(	PUNCT
ajlm-2688	13	18	p	p	NOUN
ajlm-2688	13	19	=	=	NOUN
ajlm-2688	13	20	0.003	0.003	NUM
ajlm-2688	13	21	)	)	PUNCT
ajlm-2688	13	22	and	and	CCONJ
ajlm-2688	13	23	cd200	cd200	PROPN
ajlm-2688	13	24	(	(	PUNCT
ajlm-2688	13	25	p	p	NOUN
ajlm-2688	13	26	=	=	NOUN
ajlm-2688	13	27	0.005	0.005	NUM
ajlm-2688	13	28	)	)	PUNCT
ajlm-2688	13	29	expression	expression	NOUN
ajlm-2688	13	30	,	,	PUNCT
ajlm-2688	13	31	with	with	ADP
ajlm-2688	13	32	better	well	ADJ
ajlm-2688	13	33	stability	stability	NOUN
ajlm-2688	13	34	at	at	ADP
ajlm-2688	13	35	refrigerator	refrigerator	NOUN
ajlm-2688	13	36	temperature	temperature	NOUN
ajlm-2688	13	37	.	.	PUNCT
ajlm-2688	14	1	two	two	NUM
ajlm-2688	14	2	samples	sample	NOUN
ajlm-2688	14	3	showed	show	VERB
ajlm-2688	14	4	changes	change	NOUN
ajlm-2688	14	5	in	in	ADP
ajlm-2688	14	6	both	both	DET
ajlm-2688	14	7	matutes	matute	NOUN
ajlm-2688	14	8	scores	score	NOUN
ajlm-2688	14	9	by	by	ADP
ajlm-2688	14	10	24	24	NUM
ajlm-2688	14	11	h	h	NOUN
ajlm-2688	14	12	,	,	PUNCT
ajlm-2688	14	13	irrespective	irrespective	ADV
ajlm-2688	14	14	of	of	ADP
ajlm-2688	14	15	storage	storage	NOUN
ajlm-2688	14	16	temperature	temperature	NOUN
ajlm-2688	14	17	.	.	PUNCT
ajlm-2688	15	1	by	by	ADP
ajlm-2688	15	2	48	48	NUM
ajlm-2688	15	3	h	h	NOUN
ajlm-2688	15	4	,	,	PUNCT
ajlm-2688	15	5	scores	score	NOUN
ajlm-2688	15	6	changed	change	VERB
ajlm-2688	15	7	to	to	ADP
ajlm-2688	15	8	acll	acll	NOUN
ajlm-2688	15	9	in	in	ADP
ajlm-2688	15	10	six	six	NUM
ajlm-2688	15	11	room	room	NOUN
ajlm-2688	15	12	-	-	PUNCT
ajlm-2688	15	13	temperature	temperature	NOUN
ajlm-2688	15	14	and	and	CCONJ
ajlm-2688	15	15	four	four	NUM
ajlm-2688	15	16	refrigerated	refrigerated	ADJ
ajlm-2688	15	17	samples	sample	NOUN
ajlm-2688	15	18	.	.	PUNCT
ajlm-2688	16	1	a	a	DET
ajlm-2688	16	2	majority	majority	NOUN
ajlm-2688	16	3	shift	shift	NOUN
ajlm-2688	16	4	in	in	ADP
ajlm-2688	16	5	diagnosis	diagnosis	NOUN
ajlm-2688	16	6	to	to	ADP
ajlm-2688	16	7	acll	acll	PROPN
ajlm-2688	16	8	(	(	PUNCT
ajlm-2688	16	9	modified	modify	VERB
ajlm-2688	16	10	matutes	matute	NOUN
ajlm-2688	16	11	:	:	PUNCT
ajlm-2688	16	12	n	n	PROPN
ajlm-2688	16	13	=	=	SYM
ajlm-2688	16	14	8/10	8/10	NUM
ajlm-2688	16	15	;	;	PUNCT
ajlm-2688	16	16	adapted	adapt	VERB
ajlm-2688	16	17	matutes	matute	NOUN
ajlm-2688	16	18	:	:	PUNCT
ajlm-2688	16	19	n	n	PROPN
ajlm-2688	16	20	=	=	SYM
ajlm-2688	16	21	7/10	7/10	NUM
ajlm-2688	16	22	)	)	PUNCT
ajlm-2688	16	23	was	be	AUX
ajlm-2688	16	24	observed	observe	VERB
ajlm-2688	16	25	at	at	ADP
ajlm-2688	16	26	96	96	NUM
ajlm-2688	16	27	h	h	NOUN
ajlm-2688	16	28	for	for	ADP
ajlm-2688	16	29	refrigerated	refrigerated	ADJ
ajlm-2688	16	30	samples	sample	NOUN
ajlm-2688	16	31	.	.	PUNCT
ajlm-2688	17	1	conclusion	conclusion	NOUN
ajlm-2688	17	2	:	:	PUNCT
ajlm-2688	17	3	these	these	DET
ajlm-2688	17	4	findings	finding	NOUN
ajlm-2688	17	5	indicate	indicate	VERB
ajlm-2688	17	6	that	that	SCONJ
ajlm-2688	17	7	pre	pre	ADJ
ajlm-2688	17	8	-	-	ADJ
ajlm-2688	17	9	analytical	analytical	ADJ
ajlm-2688	17	10	variables	variable	NOUN
ajlm-2688	17	11	influence	influence	VERB
ajlm-2688	17	12	antigen	antigen	ADP
ajlm-2688	17	13	stability	stability	NOUN
ajlm-2688	17	14	in	in	ADP
ajlm-2688	17	15	cll	cll	PROPN
ajlm-2688	17	16	samples	sample	NOUN
ajlm-2688	17	17	,	,	PUNCT
ajlm-2688	17	18	with	with	ADP
ajlm-2688	17	19	better	well	ADJ
ajlm-2688	17	20	preservation	preservation	NOUN
ajlm-2688	17	21	at	at	ADP
ajlm-2688	17	22	refrigerator	refrigerator	NOUN
ajlm-2688	17	23	temperature	temperature	NOUN
ajlm-2688	17	24	,	,	PUNCT
ajlm-2688	17	25	recommending	recommend	VERB
ajlm-2688	17	26	analysis	analysis	NOUN
ajlm-2688	17	27	within	within	ADP
ajlm-2688	17	28	48	48	NUM
ajlm-2688	17	29	h	h	NOUN
ajlm-2688	17	30	of	of	ADP
ajlm-2688	17	31	collection	collection	NOUN
ajlm-2688	17	32	.	.	PUNCT
ajlm-2688	18	1	what	what	PRON
ajlm-2688	18	2	this	this	DET
ajlm-2688	18	3	study	study	NOUN
ajlm-2688	18	4	adds	add	VERB
ajlm-2688	18	5	:	:	PUNCT
ajlm-2688	18	6	this	this	DET
ajlm-2688	18	7	study	study	NOUN
ajlm-2688	18	8	highlights	highlight	VERB
ajlm-2688	18	9	the	the	DET
ajlm-2688	18	10	impact	impact	NOUN
ajlm-2688	18	11	of	of	ADP
ajlm-2688	18	12	pre	pre	ADJ
ajlm-2688	18	13	-	-	ADJ
ajlm-2688	18	14	analytical	analytical	ADJ
ajlm-2688	18	15	variables	variable	NOUN
ajlm-2688	18	16	on	on	ADP
ajlm-2688	18	17	the	the	DET
ajlm-2688	18	18	flow	flow	NOUN
ajlm-2688	18	19	cytometric	cytometric	ADJ
ajlm-2688	18	20	diagnosis	diagnosis	NOUN
ajlm-2688	18	21	of	of	ADP
ajlm-2688	18	22	cll	cll	PROPN
ajlm-2688	18	23	.	.	PROPN
ajlm-2688	18	24	extended	extended	ADJ
ajlm-2688	18	25	room	room	NOUN
ajlm-2688	18	26	temperature	temperature	NOUN
ajlm-2688	18	27	storage	storage	NOUN
ajlm-2688	18	28	alters	alter	VERB
ajlm-2688	18	29	antigen	antigen	ADJ
ajlm-2688	18	30	expression	expression	NOUN
ajlm-2688	18	31	,	,	PUNCT
ajlm-2688	18	32	shifting	shift	VERB
ajlm-2688	18	33	matutes	matute	NOUN
ajlm-2688	18	34	scores	score	NOUN
ajlm-2688	18	35	and	and	CCONJ
ajlm-2688	18	36	potentially	potentially	ADV
ajlm-2688	18	37	affecting	affect	VERB
ajlm-2688	18	38	the	the	DET
ajlm-2688	18	39	final	final	ADJ
ajlm-2688	18	40	diagnosis	diagnosis	NOUN
ajlm-2688	18	41	.	.	PUNCT
ajlm-2688	19	1	the	the	DET
ajlm-2688	19	2	findings	finding	NOUN
ajlm-2688	19	3	emphasise	emphasise	VERB
ajlm-2688	19	4	optimised	optimise	VERB
ajlm-2688	19	5	sample	sample	NOUN
ajlm-2688	19	6	handling	handling	NOUN
ajlm-2688	19	7	,	,	PUNCT
ajlm-2688	19	8	for	for	ADP
ajlm-2688	19	9	improved	improved	ADJ
ajlm-2688	19	10	diagnostic	diagnostic	ADJ
ajlm-2688	19	11	accuracy	accuracy	NOUN
ajlm-2688	19	12	in	in	ADP
ajlm-2688	19	13	laboratory	laboratory	NOUN
ajlm-2688	19	14	medicine	medicine	NOUN
ajlm-2688	19	15	.	.	PUNCT
ajlm-2688	20	1	keywords	keyword	NOUN
ajlm-2688	20	2	:	:	PUNCT
ajlm-2688	20	3	chronic	chronic	ADJ
ajlm-2688	20	4	lymphocytic	lymphocytic	ADJ
ajlm-2688	20	5	leukaemia	leukaemia	NOUN
ajlm-2688	20	6	;	;	PUNCT
ajlm-2688	20	7	atypical	atypical	ADJ
ajlm-2688	20	8	chronic	chronic	ADJ
ajlm-2688	20	9	lymphocytic	lymphocytic	ADJ
ajlm-2688	20	10	leukaemia	leukaemia	NOUN
ajlm-2688	20	11	;	;	PUNCT
ajlm-2688	20	12	flow	flow	NOUN
ajlm-2688	20	13	cytometry	cytometry	NOUN
ajlm-2688	20	14	;	;	PUNCT
ajlm-2688	20	15	matutes	matute	NOUN
ajlm-2688	20	16	score	score	NOUN
ajlm-2688	20	17	;	;	PUNCT
ajlm-2688	20	18	pre	pre	ADJ
ajlm-2688	20	19	-	-	ADJ
ajlm-2688	20	20	analytical	analytical	ADJ
ajlm-2688	20	21	variables	variable	NOUN
ajlm-2688	20	22	;	;	PUNCT
ajlm-2688	20	23	storage	storage	NOUN
ajlm-2688	20	24	time	time	NOUN
ajlm-2688	20	25	;	;	PUNCT
ajlm-2688	20	26	storage	storage	NOUN
ajlm-2688	20	27	temperature	temperature	NOUN
ajlm-2688	20	28	.	.	PUNCT
ajlm-2688	21	1	introduction	introduction	NOUN
ajlm-2688	21	2	chronic	chronic	ADJ
ajlm-2688	21	3	lymphocytic	lymphocytic	ADJ
ajlm-2688	21	4	leukaemia	leukaemia	NOUN
ajlm-2688	21	5	(	(	PUNCT
ajlm-2688	21	6	cll	cll	PROPN
ajlm-2688	21	7	)	)	PUNCT
ajlm-2688	21	8	is	be	AUX
ajlm-2688	21	9	a	a	DET
ajlm-2688	21	10	clonal	clonal	ADJ
ajlm-2688	21	11	haematological	haematological	ADJ
ajlm-2688	21	12	disorder	disorder	NOUN
ajlm-2688	21	13	consisting	consist	VERB
ajlm-2688	21	14	of	of	ADP
ajlm-2688	21	15	immunologically	immunologically	ADV
ajlm-2688	21	16	inept	inept	ADJ
ajlm-2688	21	17	,	,	PUNCT
ajlm-2688	21	18	small	small	ADJ
ajlm-2688	21	19	,	,	PUNCT
ajlm-2688	21	20	monomorphous	monomorphous	ADJ
ajlm-2688	21	21	and	and	CCONJ
ajlm-2688	21	22	well	well	ADV
ajlm-2688	21	23	-	-	PUNCT
ajlm-2688	21	24	differentiated	differentiate	VERB
ajlm-2688	21	25	b	b	NOUN
ajlm-2688	21	26	-	-	PUNCT
ajlm-2688	21	27	lymphocytes	lymphocytes	ADJ
ajlm-2688	21	28	that	that	SCONJ
ajlm-2688	21	29	aberrantly	aberrantly	ADV
ajlm-2688	21	30	express	express	VERB
ajlm-2688	21	31	the	the	DET
ajlm-2688	21	32	antigens	antigen	NOUN
ajlm-2688	21	33	cd5	cd5	PROPN
ajlm-2688	21	34	and	and	CCONJ
ajlm-2688	21	35	cd23	cd23	PROPN
ajlm-2688	21	36	on	on	ADP
ajlm-2688	21	37	their	their	PRON
ajlm-2688	21	38	surfaces.1	surfaces.1	NOUN
ajlm-2688	21	39	a	a	DET
ajlm-2688	21	40	sustained	sustain	VERB
ajlm-2688	21	41	(	(	PUNCT
ajlm-2688	21	42	≥	≥	NUM
ajlm-2688	21	43	3	3	NUM
ajlm-2688	21	44	months	month	NOUN
ajlm-2688	21	45	)	)	PUNCT
ajlm-2688	21	46	monoclonal	monoclonal	NOUN
ajlm-2688	21	47	b	b	NOUN
ajlm-2688	21	48	-	-	PUNCT
ajlm-2688	21	49	lymphocytosis	lymphocytosis	NOUN
ajlm-2688	21	50	of	of	ADP
ajlm-2688	21	51	≥	≥	NUM
ajlm-2688	21	52	5	5	NUM
ajlm-2688	21	53	×	×	NOUN
ajlm-2688	21	54	109	109	NUM
ajlm-2688	21	55	/	/	SYM
ajlm-2688	21	56	l	l	NOUN
ajlm-2688	21	57	in	in	ADP
ajlm-2688	21	58	the	the	DET
ajlm-2688	21	59	peripheral	peripheral	ADJ
ajlm-2688	21	60	blood	blood	NOUN
ajlm-2688	21	61	,	,	PUNCT
ajlm-2688	21	62	with	with	ADP
ajlm-2688	21	63	characteristic	characteristic	ADJ
ajlm-2688	21	64	morphological	morphological	ADJ
ajlm-2688	21	65	and	and	CCONJ
ajlm-2688	21	66	immunophenotypic	immunophenotypic	ADJ
ajlm-2688	21	67	features	feature	NOUN
ajlm-2688	21	68	,	,	PUNCT
ajlm-2688	21	69	is	be	AUX
ajlm-2688	21	70	required	require	VERB
ajlm-2688	21	71	to	to	PART
ajlm-2688	21	72	establish	establish	VERB
ajlm-2688	21	73	the	the	DET
ajlm-2688	21	74	diagnosis	diagnosis	NOUN
ajlm-2688	21	75	of	of	ADP
ajlm-2688	21	76	cll.2	cll.2	PROPN
ajlm-2688	21	77	immunophenotyping	immunophenotype	VERB
ajlm-2688	21	78	not	not	PART
ajlm-2688	21	79	only	only	ADV
ajlm-2688	21	80	confirms	confirm	VERB
ajlm-2688	21	81	the	the	DET
ajlm-2688	21	82	diagnosis	diagnosis	NOUN
ajlm-2688	21	83	of	of	ADP
ajlm-2688	21	84	a	a	DET
ajlm-2688	21	85	mature	mature	ADJ
ajlm-2688	21	86	,	,	PUNCT
ajlm-2688	21	87	clonal	clonal	ADJ
ajlm-2688	21	88	b	b	NOUN
ajlm-2688	21	89	-	-	PUNCT
ajlm-2688	21	90	cell	cell	NOUN
ajlm-2688	21	91	neoplasm	neoplasm	NOUN
ajlm-2688	21	92	but	but	CCONJ
ajlm-2688	21	93	also	also	ADV
ajlm-2688	21	94	helps	help	VERB
ajlm-2688	21	95	to	to	PART
ajlm-2688	21	96	differentiate	differentiate	VERB
ajlm-2688	21	97	cll	cll	PROPN
ajlm-2688	21	98	from	from	ADP
ajlm-2688	21	99	other	other	ADJ
ajlm-2688	21	100	b	b	NOUN
ajlm-2688	21	101	-	-	PUNCT
ajlm-2688	21	102	cell	cell	NOUN
ajlm-2688	21	103	lymphoproliferative	lymphoproliferative	ADJ
ajlm-2688	21	104	disorders	disorder	NOUN
ajlm-2688	21	105	(	(	PUNCT
ajlm-2688	21	106	b	b	X
ajlm-2688	21	107	-	-	PUNCT
ajlm-2688	21	108	lpds	lpds	NOUN
ajlm-2688	21	109	)	)	PUNCT
ajlm-2688	21	110	.	.	PUNCT
ajlm-2688	22	1	notwithstanding	notwithstanding	ADP
ajlm-2688	22	2	substantial	substantial	ADJ
ajlm-2688	22	3	advances	advance	NOUN
ajlm-2688	22	4	in	in	ADP
ajlm-2688	22	5	cytogenetics	cytogenetic	NOUN
ajlm-2688	22	6	and	and	CCONJ
ajlm-2688	22	7	molecular	molecular	ADJ
ajlm-2688	22	8	biology	biology	NOUN
ajlm-2688	22	9	,	,	PUNCT
ajlm-2688	22	10	morphology	morphology	NOUN
ajlm-2688	22	11	and	and	CCONJ
ajlm-2688	22	12	immunophenotyping	immunophenotyping	NOUN
ajlm-2688	22	13	remain	remain	VERB
ajlm-2688	22	14	the	the	DET
ajlm-2688	22	15	benchmark	benchmark	NOUN
ajlm-2688	22	16	for	for	ADP
ajlm-2688	22	17	diagnosing	diagnose	VERB
ajlm-2688	22	18	mature	mature	ADJ
ajlm-2688	22	19	b	b	NOUN
ajlm-2688	22	20	-	-	PUNCT
ajlm-2688	22	21	lpds.3	lpds.3	VERB
ajlm-2688	22	22	the	the	DET
ajlm-2688	22	23	matutes	matute	NOUN
ajlm-2688	22	24	score	score	NOUN
ajlm-2688	22	25	,	,	PUNCT
ajlm-2688	22	26	developed	develop	VERB
ajlm-2688	22	27	in	in	ADP
ajlm-2688	22	28	1994	1994	NUM
ajlm-2688	22	29	,	,	PUNCT
ajlm-2688	22	30	uses	use	VERB
ajlm-2688	22	31	five	five	NUM
ajlm-2688	22	32	surface	surface	NOUN
ajlm-2688	22	33	markers	marker	NOUN
ajlm-2688	22	34	(	(	PUNCT
ajlm-2688	22	35	cd23	cd23	PROPN
ajlm-2688	22	36	,	,	PUNCT
ajlm-2688	22	37	cd5	cd5	PROPN
ajlm-2688	22	38	,	,	PUNCT
ajlm-2688	22	39	fmc7	fmc7	PROPN
ajlm-2688	22	40	,	,	PUNCT
ajlm-2688	22	41	surface	surface	NOUN
ajlm-2688	22	42	immunoglobulin	immunoglobulin	NOUN
ajlm-2688	23	1	[	[	X
ajlm-2688	23	2	sig	sig	X
ajlm-2688	23	3	]	]	X
ajlm-2688	23	4	,	,	PUNCT
ajlm-2688	23	5	and	and	CCONJ
ajlm-2688	23	6	cd22	cd22	PROPN
ajlm-2688	23	7	)	)	PUNCT
ajlm-2688	23	8	to	to	PART
ajlm-2688	23	9	diagnose	diagnose	VERB
ajlm-2688	23	10	cll	cll	PROPN
ajlm-2688	23	11	,	,	PUNCT
ajlm-2688	23	12	with	with	ADP
ajlm-2688	23	13	scores	score	NOUN
ajlm-2688	23	14	of	of	ADP
ajlm-2688	23	15	4	4	NUM
ajlm-2688	23	16	or	or	CCONJ
ajlm-2688	23	17	5	5	NUM
ajlm-2688	23	18	indicating	indicate	VERB
ajlm-2688	23	19	cll	cll	PROPN
ajlm-2688	23	20	,	,	PUNCT
ajlm-2688	23	21	and	and	CCONJ
ajlm-2688	23	22	scores	score	NOUN
ajlm-2688	23	23	below	below	ADP
ajlm-2688	23	24	4	4	NUM
ajlm-2688	23	25	suggesting	suggest	VERB
ajlm-2688	23	26	non	non	NOUN
ajlm-2688	23	27	-	-	NOUN
ajlm-2688	23	28	cll	cll	NOUN
ajlm-2688	23	29	;	;	PUNCT
ajlm-2688	23	30	a	a	DET
ajlm-2688	23	31	score	score	NOUN
ajlm-2688	23	32	of	of	ADP
ajlm-2688	23	33	3	3	NUM
ajlm-2688	23	34	implies	imply	VERB
ajlm-2688	23	35	atypical	atypical	ADJ
ajlm-2688	23	36	cll	cll	PROPN
ajlm-2688	23	37	(	(	PUNCT
ajlm-2688	23	38	acll).4,5,6	acll).4,5,6	NOUN
ajlm-2688	23	39	in	in	ADP
ajlm-2688	23	40	1997	1997	NUM
ajlm-2688	23	41	,	,	PUNCT
ajlm-2688	23	42	a	a	DET
ajlm-2688	23	43	modification	modification	NOUN
ajlm-2688	23	44	known	know	VERB
ajlm-2688	23	45	as	as	ADP
ajlm-2688	23	46	the	the	DET
ajlm-2688	23	47	moreau	moreau	PROPN
ajlm-2688	23	48	score	score	NOUN
ajlm-2688	23	49	replaced	replace	VERB
ajlm-2688	23	50	cd22	cd22	PROPN
ajlm-2688	23	51	with	with	ADP
ajlm-2688	23	52	cd79b	cd79b	NOUN
ajlm-2688	23	53	to	to	PART
ajlm-2688	23	54	better	well	ADV
ajlm-2688	23	55	distinguish	distinguish	VERB
ajlm-2688	23	56	cll	cll	PROPN
ajlm-2688	23	57	from	from	ADP
ajlm-2688	23	58	other	other	ADJ
ajlm-2688	23	59	b	b	PROPN
ajlm-2688	23	60	-	-	PUNCT
ajlm-2688	23	61	lpds.4,5,6	lpds.4,5,6	NOUN
ajlm-2688	23	62	cooperative	cooperative	ADJ
ajlm-2688	23	63	groups	group	NOUN
ajlm-2688	23	64	,	,	PUNCT
ajlm-2688	23	65	including	include	VERB
ajlm-2688	23	66	the	the	DET
ajlm-2688	23	67	euroflow	euroflow	NOUN
ajlm-2688	23	68	consortium	consortium	NOUN
ajlm-2688	23	69	,	,	PUNCT
ajlm-2688	23	70	now	now	ADV
ajlm-2688	23	71	omit	omit	VERB
ajlm-2688	23	72	fmc7	fmc7	PROPN
ajlm-2688	23	73	and	and	CCONJ
ajlm-2688	23	74	use	use	VERB
ajlm-2688	23	75	cd20	cd20	PROPN
ajlm-2688	23	76	to	to	PART
ajlm-2688	23	77	streamline	streamline	VERB
ajlm-2688	23	78	testing	testing	NOUN
ajlm-2688	23	79	without	without	ADP
ajlm-2688	23	80	compromising	compromise	VERB
ajlm-2688	23	81	diagnostic	diagnostic	ADJ
ajlm-2688	23	82	accuracy.5,7,8	accuracy.5,7,8	X
ajlm-2688	23	83	cd200	cd200	PROPN
ajlm-2688	23	84	,	,	PUNCT
ajlm-2688	23	85	identified	identify	VERB
ajlm-2688	23	86	in	in	ADP
ajlm-2688	23	87	2009	2009	NUM
ajlm-2688	23	88	,	,	PUNCT
ajlm-2688	23	89	further	far	ADV
ajlm-2688	23	90	improved	improve	VERB
ajlm-2688	23	91	the	the	DET
ajlm-2688	23	92	score	score	NOUN
ajlm-2688	23	93	’s	’s	PART
ajlm-2688	23	94	accuracy	accuracy	NOUN
ajlm-2688	23	95	,	,	PUNCT
ajlm-2688	23	96	distinguishing	distinguish	VERB
ajlm-2688	23	97	cll	cll	PROPN
ajlm-2688	23	98	from	from	ADP
ajlm-2688	23	99	mantle	mantle	ADJ
ajlm-2688	23	100	cell	cell	NOUN
ajlm-2688	23	101	lymphoma.9	lymphoma.9	PROPN
ajlm-2688	23	102	an	an	DET
ajlm-2688	23	103	adapted	adapt	VERB
ajlm-2688	23	104	matutes	matute	NOUN
ajlm-2688	23	105	score	score	NOUN
ajlm-2688	23	106	that	that	PRON
ajlm-2688	23	107	includes	include	VERB
ajlm-2688	23	108	cd200	cd200	PROPN
ajlm-2688	23	109	has	have	AUX
ajlm-2688	23	110	been	be	AUX
ajlm-2688	23	111	shown	show	VERB
ajlm-2688	23	112	to	to	PART
ajlm-2688	23	113	achieve	achieve	VERB
ajlm-2688	23	114	nearly	nearly	ADV
ajlm-2688	23	115	100	100	NUM
ajlm-2688	23	116	%	%	NOUN
ajlm-2688	23	117	diagnostic	diagnostic	ADJ
ajlm-2688	23	118	accuracy	accuracy	NOUN
ajlm-2688	23	119	for	for	ADP
ajlm-2688	23	120	cll	cll	PROPN
ajlm-2688	23	121	,	,	PUNCT
ajlm-2688	23	122	underscoring	underscore	VERB
ajlm-2688	23	123	the	the	DET
ajlm-2688	23	124	value	value	NOUN
ajlm-2688	23	125	of	of	ADP
ajlm-2688	23	126	these	these	DET
ajlm-2688	23	127	refinements.10	refinements.10	NOUN
ajlm-2688	23	128	the	the	DET
ajlm-2688	23	129	concept	concept	NOUN
ajlm-2688	23	130	of	of	ADP
ajlm-2688	23	131	acll	acll	PROPN
ajlm-2688	23	132	,	,	PUNCT
ajlm-2688	23	133	initially	initially	ADV
ajlm-2688	23	134	described	describe	VERB
ajlm-2688	23	135	by	by	ADP
ajlm-2688	23	136	criel	criel	PROPN
ajlm-2688	23	137	et	et	PROPN
ajlm-2688	23	138	al	al	PROPN
ajlm-2688	23	139	.	.	PROPN
ajlm-2688	23	140	,11	,11	PUNCT
ajlm-2688	23	141	refers	refer	VERB
ajlm-2688	23	142	to	to	ADP
ajlm-2688	23	143	a	a	DET
ajlm-2688	23	144	b	b	PROPN
ajlm-2688	23	145	-	-	PUNCT
ajlm-2688	23	146	lpd	lpd	PROPN
ajlm-2688	23	147	with	with	ADP
ajlm-2688	23	148	atypical	atypical	ADJ
ajlm-2688	23	149	morphology	morphology	NOUN
ajlm-2688	23	150	,	,	PUNCT
ajlm-2688	23	151	including	include	VERB
ajlm-2688	23	152	larger	large	ADJ
ajlm-2688	23	153	cll	cll	PROPN
ajlm-2688	23	154	cells	cell	NOUN
ajlm-2688	23	155	with	with	ADP
ajlm-2688	23	156	pleomorphic	pleomorphic	ADJ
ajlm-2688	23	157	nuclear	nuclear	ADJ
ajlm-2688	23	158	contours	contours	NOUN
ajlm-2688	23	159	.	.	PUNCT
ajlm-2688	24	1	the	the	DET
ajlm-2688	24	2	revised	revised	ADJ
ajlm-2688	24	3	4th	4th	ADJ
ajlm-2688	24	4	edition	edition	NOUN
ajlm-2688	24	5	of	of	ADP
ajlm-2688	24	6	the	the	DET
ajlm-2688	24	7	world	world	PROPN
ajlm-2688	24	8	health	health	PROPN
ajlm-2688	24	9	organization	organization	PROPN
ajlm-2688	24	10	classification	classification	NOUN
ajlm-2688	24	11	of	of	ADP
ajlm-2688	24	12	tumours	tumour	NOUN
ajlm-2688	24	13	of	of	ADP
ajlm-2688	24	14	hematopoietic	hematopoietic	ADJ
ajlm-2688	24	15	and	and	CCONJ
ajlm-2688	24	16	lymphoid	lymphoid	ADJ
ajlm-2688	24	17	tissues	tissue	NOUN
ajlm-2688	24	18	describes	describe	VERB
ajlm-2688	24	19	acll	acll	NOUN
ajlm-2688	24	20	as	as	ADP
ajlm-2688	24	21	having	have	VERB
ajlm-2688	24	22	at	at	ADV
ajlm-2688	24	23	least	least	ADV
ajlm-2688	24	24	10	10	NUM
ajlm-2688	24	25	%	%	NOUN
ajlm-2688	24	26	circulating	circulate	VERB
ajlm-2688	24	27	‘	'	PUNCT
ajlm-2688	24	28	cll	cll	PROPN
ajlm-2688	24	29	cells	cell	NOUN
ajlm-2688	24	30	’	'	PUNCT
ajlm-2688	24	31	with	with	ADP
ajlm-2688	24	32	prominent	prominent	ADJ
ajlm-2688	24	33	nuclear	nuclear	ADJ
ajlm-2688	24	34	clefts	cleft	NOUN
ajlm-2688	24	35	and	and	CCONJ
ajlm-2688	24	36	folds.12	folds.12	DET
ajlm-2688	24	37	the	the	DET
ajlm-2688	24	38	incidence	incidence	NOUN
ajlm-2688	24	39	of	of	ADP
ajlm-2688	24	40	acll	acll	NOUN
ajlm-2688	24	41	is	be	AUX
ajlm-2688	24	42	reported	report	VERB
ajlm-2688	24	43	to	to	PART
ajlm-2688	24	44	be	be	AUX
ajlm-2688	24	45	7	7	NUM
ajlm-2688	24	46	%	%	NOUN
ajlm-2688	24	47	among	among	ADP
ajlm-2688	24	48	all	all	DET
ajlm-2688	24	49	b	b	NOUN
ajlm-2688	24	50	-	-	PUNCT
ajlm-2688	24	51	lpds	lpds	NOUN
ajlm-2688	24	52	diagnosed	diagnose	VERB
ajlm-2688	24	53	by	by	ADP
ajlm-2688	24	54	flow	flow	NOUN
ajlm-2688	24	55	cytometry.13	cytometry.13	PROPN
ajlm-2688	24	56	atypical	atypical	PROPN
ajlm-2688	24	57	cll	cll	PROPN
ajlm-2688	24	58	is	be	AUX
ajlm-2688	24	59	described	describe	VERB
ajlm-2688	24	60	as	as	ADP
ajlm-2688	24	61	having	have	VERB
ajlm-2688	24	62	a	a	DET
ajlm-2688	24	63	lower	low	ADJ
ajlm-2688	24	64	matutes	matute	NOUN
ajlm-2688	24	65	score	score	NOUN
ajlm-2688	24	66	owing	owe	VERB
ajlm-2688	24	67	to	to	ADP
ajlm-2688	24	68	the	the	DET
ajlm-2688	24	69	unusually	unusually	ADV
ajlm-2688	24	70	brighter	bright	ADJ
ajlm-2688	24	71	expression	expression	NOUN
ajlm-2688	24	72	of	of	ADP
ajlm-2688	24	73	sig	sig	NOUN
ajlm-2688	24	74	or	or	CCONJ
ajlm-2688	24	75	cd79b	cd79b	ADJ
ajlm-2688	24	76	,	,	PUNCT
ajlm-2688	24	77	lack	lack	NOUN
ajlm-2688	24	78	of	of	ADP
ajlm-2688	24	79	cd5	cd5	PROPN
ajlm-2688	24	80	or	or	CCONJ
ajlm-2688	24	81	cd23	cd23	PROPN
ajlm-2688	24	82	,	,	PUNCT
ajlm-2688	24	83	or	or	CCONJ
ajlm-2688	24	84	positivity	positivity	NOUN
ajlm-2688	24	85	for	for	ADP
ajlm-2688	24	86	fmc7	fmc7	PROPN
ajlm-2688	24	87	/	/	SYM
ajlm-2688	24	88	cd20.11,13,14	cd20.11,13,14	ADV
ajlm-2688	24	89	these	these	DET
ajlm-2688	24	90	immunophenotypic	immunophenotypic	ADJ
ajlm-2688	24	91	changes	change	NOUN
ajlm-2688	24	92	may	may	AUX
ajlm-2688	24	93	,	,	PUNCT
ajlm-2688	24	94	however	however	ADV
ajlm-2688	24	95	,	,	PUNCT
ajlm-2688	24	96	be	be	AUX
ajlm-2688	24	97	secondary	secondary	ADJ
ajlm-2688	24	98	to	to	ADP
ajlm-2688	24	99	trisomy	trisomy	NOUN
ajlm-2688	24	100	12	12	NUM
ajlm-2688	24	101	,	,	PUNCT
ajlm-2688	24	102	acting	act	VERB
ajlm-2688	24	103	as	as	ADP
ajlm-2688	24	104	a	a	DET
ajlm-2688	24	105	confounding	confound	VERB
ajlm-2688	24	106	variable.11,14	variable.11,14	ADV
ajlm-2688	24	107	whether	whether	SCONJ
ajlm-2688	24	108	the	the	DET
ajlm-2688	24	109	distinction	distinction	NOUN
ajlm-2688	24	110	between	between	ADP
ajlm-2688	24	111	cll	cll	PROPN
ajlm-2688	24	112	and	and	CCONJ
ajlm-2688	24	113	acll	acll	PROPN
ajlm-2688	24	114	is	be	AUX
ajlm-2688	24	115	clinically	clinically	ADV
ajlm-2688	24	116	significant	significant	ADJ
ajlm-2688	24	117	remains	remain	VERB
ajlm-2688	24	118	controversial	controversial	ADJ
ajlm-2688	24	119	,	,	PUNCT
ajlm-2688	24	120	although	although	SCONJ
ajlm-2688	24	121	acll	acll	NOUN
ajlm-2688	24	122	has	have	AUX
ajlm-2688	24	123	been	be	AUX
ajlm-2688	24	124	associated	associate	VERB
ajlm-2688	24	125	with	with	ADP
ajlm-2688	24	126	a	a	DET
ajlm-2688	24	127	more	more	ADV
ajlm-2688	24	128	aggressive	aggressive	ADJ
ajlm-2688	24	129	clinical	clinical	ADJ
ajlm-2688	24	130	course	course	NOUN
ajlm-2688	24	131	and	and	CCONJ
ajlm-2688	24	132	a	a	DET
ajlm-2688	24	133	higher	high	ADJ
ajlm-2688	24	134	probability	probability	NOUN
ajlm-2688	24	135	of	of	ADP
ajlm-2688	24	136	disease	disease	NOUN
ajlm-2688	24	137	progression.14	progression.14	PROPN
ajlm-2688	24	138	owing	owe	VERB
ajlm-2688	24	139	to	to	ADP
ajlm-2688	24	140	the	the	DET
ajlm-2688	24	141	lack	lack	NOUN
ajlm-2688	24	142	of	of	ADP
ajlm-2688	24	143	a	a	DET
ajlm-2688	24	144	concrete	concrete	ADJ
ajlm-2688	24	145	standardised	standardised	ADJ
ajlm-2688	24	146	concept	concept	NOUN
ajlm-2688	24	147	of	of	ADP
ajlm-2688	24	148	acll,15	acll,15	ADJ
ajlm-2688	24	149	and	and	CCONJ
ajlm-2688	24	150	ambiguous	ambiguous	ADJ
ajlm-2688	24	151	definitions	definition	NOUN
ajlm-2688	24	152	in	in	ADP
ajlm-2688	24	153	the	the	DET
ajlm-2688	24	154	successive	successive	ADJ
ajlm-2688	24	155	world	world	NOUN
ajlm-2688	24	156	health	health	NOUN
ajlm-2688	24	157	organization	organization	NOUN
ajlm-2688	24	158	classifications,3,16	classifications,3,16	PROPN
ajlm-2688	24	159	acll	acll	PROPN
ajlm-2688	24	160	is	be	AUX
ajlm-2688	24	161	now	now	ADV
ajlm-2688	24	162	used	use	VERB
ajlm-2688	24	163	more	more	ADV
ajlm-2688	24	164	generically	generically	ADV
ajlm-2688	24	165	to	to	PART
ajlm-2688	24	166	denote	denote	VERB
ajlm-2688	24	167	forms	form	NOUN
ajlm-2688	24	168	with	with	ADP
ajlm-2688	24	169	an	an	DET
ajlm-2688	24	170	unusual	unusual	ADJ
ajlm-2688	24	171	immunophenotype	immunophenotype	NOUN
ajlm-2688	24	172	,	,	PUNCT
ajlm-2688	24	173	regardless	regardless	ADV
ajlm-2688	24	174	of	of	ADP
ajlm-2688	24	175	blood	blood	NOUN
ajlm-2688	24	176	smear	smear	NOUN
ajlm-2688	24	177	findings.16	findings.16	NOUN
ajlm-2688	24	178	the	the	DET
ajlm-2688	24	179	impact	impact	NOUN
ajlm-2688	24	180	of	of	ADP
ajlm-2688	24	181	pre	pre	ADJ
ajlm-2688	24	182	-	-	ADJ
ajlm-2688	24	183	analytical	analytical	ADJ
ajlm-2688	24	184	variables	variable	NOUN
ajlm-2688	24	185	on	on	ADP
ajlm-2688	24	186	the	the	DET
ajlm-2688	24	187	quality	quality	NOUN
ajlm-2688	24	188	and	and	CCONJ
ajlm-2688	24	189	reproducibility	reproducibility	NOUN
ajlm-2688	24	190	of	of	ADP
ajlm-2688	24	191	flow	flow	NOUN
ajlm-2688	24	192	cytometry	cytometry	NOUN
ajlm-2688	24	193	data	datum	NOUN
ajlm-2688	24	194	is	be	AUX
ajlm-2688	24	195	well	well	ADV
ajlm-2688	24	196	described.17,18,19,20	described.17,18,19,20	ADJ
ajlm-2688	24	197	parameters	parameter	NOUN
ajlm-2688	24	198	such	such	ADJ
ajlm-2688	24	199	as	as	ADP
ajlm-2688	24	200	the	the	DET
ajlm-2688	24	201	type	type	NOUN
ajlm-2688	24	202	of	of	ADP
ajlm-2688	24	203	anticoagulant	anticoagulant	NOUN
ajlm-2688	24	204	in	in	ADP
ajlm-2688	24	205	which	which	PRON
ajlm-2688	24	206	samples	sample	NOUN
ajlm-2688	24	207	are	be	AUX
ajlm-2688	24	208	collected	collect	VERB
ajlm-2688	24	209	,	,	PUNCT
ajlm-2688	24	210	the	the	DET
ajlm-2688	24	211	storage	storage	NOUN
ajlm-2688	24	212	time	time	NOUN
ajlm-2688	24	213	and	and	CCONJ
ajlm-2688	24	214	the	the	DET
ajlm-2688	24	215	storage	storage	NOUN
ajlm-2688	24	216	temperature	temperature	NOUN
ajlm-2688	24	217	of	of	ADP
ajlm-2688	24	218	samples	sample	NOUN
ajlm-2688	24	219	before	before	ADP
ajlm-2688	24	220	analysis	analysis	NOUN
ajlm-2688	24	221	,	,	PUNCT
ajlm-2688	24	222	were	be	AUX
ajlm-2688	24	223	found	find	VERB
ajlm-2688	24	224	to	to	PART
ajlm-2688	24	225	affect	affect	VERB
ajlm-2688	24	226	absolute	absolute	ADJ
ajlm-2688	24	227	cell	cell	NOUN
ajlm-2688	24	228	counts	count	NOUN
ajlm-2688	24	229	and	and	CCONJ
ajlm-2688	24	230	antigen	antigen	ADJ
ajlm-2688	24	231	expression	expression	NOUN
ajlm-2688	24	232	.	.	PUNCT
ajlm-2688	25	1	however	however	ADV
ajlm-2688	25	2	,	,	PUNCT
ajlm-2688	25	3	these	these	DET
ajlm-2688	25	4	effects	effect	NOUN
ajlm-2688	25	5	have	have	AUX
ajlm-2688	25	6	primarily	primarily	ADV
ajlm-2688	25	7	been	be	AUX
ajlm-2688	25	8	assessed	assess	VERB
ajlm-2688	25	9	on	on	ADP
ajlm-2688	25	10	healthy	healthy	ADJ
ajlm-2688	25	11	subjects	subject	NOUN
ajlm-2688	25	12	’	'	PUNCT
ajlm-2688	25	13	blood	blood	NOUN
ajlm-2688	25	14	samples	sample	NOUN
ajlm-2688	25	15	.	.	PUNCT
ajlm-2688	26	1	extensive	extensive	ADJ
ajlm-2688	26	2	comparative	comparative	ADJ
ajlm-2688	26	3	studies	study	NOUN
ajlm-2688	26	4	to	to	PART
ajlm-2688	26	5	determine	determine	VERB
ajlm-2688	26	6	the	the	DET
ajlm-2688	26	7	optimal	optimal	ADJ
ajlm-2688	26	8	pre	pre	ADJ
ajlm-2688	26	9	-	-	ADJ
ajlm-2688	26	10	analytical	analytical	ADJ
ajlm-2688	26	11	flow	flow	NOUN
ajlm-2688	26	12	conditions	condition	NOUN
ajlm-2688	26	13	for	for	ADP
ajlm-2688	26	14	b	b	PROPN
ajlm-2688	26	15	-	-	PUNCT
ajlm-2688	26	16	lpd	lpd	PROPN
ajlm-2688	26	17	samples	sample	NOUN
ajlm-2688	26	18	are	be	AUX
ajlm-2688	26	19	lacking.17,19,20	lacking.17,19,20	DET
ajlm-2688	26	20	universitas	universitas	NOUN
ajlm-2688	26	21	academic	academic	ADJ
ajlm-2688	26	22	hospital	hospital	PROPN
ajlm-2688	26	23	national	national	PROPN
ajlm-2688	26	24	health	health	PROPN
ajlm-2688	26	25	laboratory	laboratory	PROPN
ajlm-2688	26	26	service	service	NOUN
ajlm-2688	26	27	(	(	PUNCT
ajlm-2688	26	28	nhls	nhls	PROPN
ajlm-2688	26	29	)	)	PUNCT
ajlm-2688	26	30	is	be	AUX
ajlm-2688	26	31	in	in	ADP
ajlm-2688	26	32	the	the	DET
ajlm-2688	26	33	city	city	NOUN
ajlm-2688	26	34	of	of	ADP
ajlm-2688	26	35	bloemfontein	bloemfontein	PROPN
ajlm-2688	26	36	in	in	ADP
ajlm-2688	26	37	the	the	DET
ajlm-2688	26	38	free	free	ADJ
ajlm-2688	26	39	state	state	NOUN
ajlm-2688	26	40	province	province	NOUN
ajlm-2688	26	41	of	of	ADP
ajlm-2688	26	42	central	central	PROPN
ajlm-2688	26	43	south	south	PROPN
ajlm-2688	26	44	africa	africa	PROPN
ajlm-2688	26	45	.	.	PUNCT
ajlm-2688	27	1	universitas	universitas	PROPN
ajlm-2688	27	2	academic	academic	ADJ
ajlm-2688	27	3	hospital	hospital	NOUN
ajlm-2688	27	4	nhls	nhls	PROPN
ajlm-2688	27	5	serves	serve	VERB
ajlm-2688	27	6	as	as	ADP
ajlm-2688	27	7	the	the	DET
ajlm-2688	27	8	referral	referral	ADJ
ajlm-2688	27	9	laboratory	laboratory	NOUN
ajlm-2688	27	10	for	for	ADP
ajlm-2688	27	11	the	the	DET
ajlm-2688	27	12	free	free	ADJ
ajlm-2688	27	13	state	state	NOUN
ajlm-2688	27	14	,	,	PUNCT
ajlm-2688	27	15	northern	northern	ADJ
ajlm-2688	27	16	cape	cape	NOUN
ajlm-2688	27	17	and	and	CCONJ
ajlm-2688	27	18	north	north	NOUN
ajlm-2688	27	19	west	west	PROPN
ajlm-2688	27	20	provinces	province	NOUN
ajlm-2688	27	21	,	,	PUNCT
ajlm-2688	27	22	and	and	CCONJ
ajlm-2688	27	23	provides	provide	VERB
ajlm-2688	27	24	diagnostic	diagnostic	ADJ
ajlm-2688	27	25	and	and	CCONJ
ajlm-2688	27	26	laboratory	laboratory	NOUN
ajlm-2688	27	27	services	service	NOUN
ajlm-2688	27	28	for	for	ADP
ajlm-2688	27	29	a	a	DET
ajlm-2688	27	30	population	population	NOUN
ajlm-2688	27	31	of	of	ADP
ajlm-2688	27	32	8.41	8.41	NUM
ajlm-2688	27	33	million	million	NUM
ajlm-2688	27	34	people	people	NOUN
ajlm-2688	27	35	,	,	PUNCT
ajlm-2688	27	36	occupying	occupy	VERB
ajlm-2688	27	37	a	a	DET
ajlm-2688	27	38	total	total	ADJ
ajlm-2688	27	39	geographic	geographic	ADJ
ajlm-2688	27	40	surface	surface	NOUN
ajlm-2688	27	41	area	area	NOUN
ajlm-2688	27	42	of	of	ADP
ajlm-2688	27	43	607	607	NUM
ajlm-2688	27	44	596	596	NUM
ajlm-2688	27	45	km2.21	km2.21	PROPN
ajlm-2688	27	46	universitas	universita	NOUN
ajlm-2688	27	47	academic	academic	ADJ
ajlm-2688	27	48	hospital	hospital	NOUN
ajlm-2688	27	49	nhls	nhls	PROPN
ajlm-2688	27	50	often	often	ADV
ajlm-2688	27	51	receives	receive	VERB
ajlm-2688	27	52	blood	blood	NOUN
ajlm-2688	27	53	samples	sample	NOUN
ajlm-2688	27	54	requiring	require	VERB
ajlm-2688	27	55	immunophenotyping	immunophenotype	VERB
ajlm-2688	27	56	from	from	ADP
ajlm-2688	27	57	distant	distant	ADJ
ajlm-2688	27	58	peripheral	peripheral	ADJ
ajlm-2688	27	59	clinics	clinic	NOUN
ajlm-2688	27	60	,	,	PUNCT
ajlm-2688	27	61	which	which	PRON
ajlm-2688	27	62	only	only	ADV
ajlm-2688	27	63	reach	reach	VERB
ajlm-2688	27	64	the	the	DET
ajlm-2688	27	65	laboratory	laboratory	NOUN
ajlm-2688	27	66	3–5	3–5	PRON
ajlm-2688	27	67	days	day	NOUN
ajlm-2688	27	68	after	after	ADP
ajlm-2688	27	69	collection	collection	NOUN
ajlm-2688	27	70	.	.	PUNCT
ajlm-2688	28	1	consequently	consequently	ADV
ajlm-2688	28	2	,	,	PUNCT
ajlm-2688	28	3	universitas	universita	NOUN
ajlm-2688	28	4	academic	academic	ADJ
ajlm-2688	28	5	hospital	hospital	NOUN
ajlm-2688	28	6	nhls	nhls	PROPN
ajlm-2688	28	7	frequently	frequently	ADV
ajlm-2688	28	8	diagnoses	diagnose	VERB
ajlm-2688	28	9	immunophenotypically	immunophenotypically	ADV
ajlm-2688	28	10	‘	'	PUNCT
ajlm-2688	28	11	atypical	atypical	ADJ
ajlm-2688	28	12	cll	cll	NOUN
ajlm-2688	28	13	’	'	PUNCT
ajlm-2688	28	14	cases	case	NOUN
ajlm-2688	28	15	,	,	PUNCT
ajlm-2688	28	16	where	where	SCONJ
ajlm-2688	28	17	the	the	DET
ajlm-2688	28	18	morphological	morphological	ADJ
ajlm-2688	28	19	assessment	assessment	NOUN
ajlm-2688	28	20	of	of	ADP
ajlm-2688	28	21	these	these	DET
ajlm-2688	28	22	blood	blood	NOUN
ajlm-2688	28	23	samples	sample	NOUN
ajlm-2688	28	24	supports	support	VERB
ajlm-2688	28	25	‘	'	PUNCT
ajlm-2688	28	26	typical	typical	ADJ
ajlm-2688	28	27	’	'	PUNCT
ajlm-2688	28	28	cll	cll	PROPN
ajlm-2688	28	29	.	.	PUNCT
ajlm-2688	29	1	this	this	PRON
ajlm-2688	29	2	raises	raise	VERB
ajlm-2688	29	3	the	the	DET
ajlm-2688	29	4	question	question	NOUN
ajlm-2688	29	5	of	of	ADP
ajlm-2688	29	6	whether	whether	SCONJ
ajlm-2688	29	7	we	we	PRON
ajlm-2688	29	8	truly	truly	ADV
ajlm-2688	29	9	see	see	VERB
ajlm-2688	29	10	more	more	ADJ
ajlm-2688	29	11	atypical	atypical	ADJ
ajlm-2688	29	12	cases	case	NOUN
ajlm-2688	29	13	or	or	CCONJ
ajlm-2688	29	14	whether	whether	SCONJ
ajlm-2688	29	15	the	the	DET
ajlm-2688	29	16	sample	sample	NOUN
ajlm-2688	29	17	age	age	NOUN
ajlm-2688	29	18	and	and	CCONJ
ajlm-2688	29	19	storage	storage	NOUN
ajlm-2688	29	20	conditions	condition	NOUN
ajlm-2688	29	21	significantly	significantly	ADV
ajlm-2688	29	22	affect	affect	VERB
ajlm-2688	29	23	the	the	DET
ajlm-2688	29	24	percentage	percentage	NOUN
ajlm-2688	29	25	antigen	antigen	NOUN
ajlm-2688	29	26	expression	expression	NOUN
ajlm-2688	29	27	and	and	CCONJ
ajlm-2688	29	28	intensity	intensity	NOUN
ajlm-2688	29	29	of	of	ADP
ajlm-2688	29	30	expression	expression	NOUN
ajlm-2688	29	31	on	on	ADP
ajlm-2688	29	32	lymphoid	lymphoid	ADJ
ajlm-2688	29	33	cells	cell	NOUN
ajlm-2688	29	34	in	in	ADP
ajlm-2688	29	35	haematological	haematological	ADJ
ajlm-2688	29	36	malignancies	malignancy	NOUN
ajlm-2688	29	37	.	.	PUNCT
ajlm-2688	30	1	the	the	DET
ajlm-2688	30	2	aim	aim	NOUN
ajlm-2688	30	3	of	of	ADP
ajlm-2688	30	4	our	our	PRON
ajlm-2688	30	5	study	study	NOUN
ajlm-2688	30	6	was	be	AUX
ajlm-2688	30	7	to	to	PART
ajlm-2688	30	8	measure	measure	VERB
ajlm-2688	30	9	objectively	objectively	ADV
ajlm-2688	30	10	the	the	DET
ajlm-2688	30	11	effects	effect	NOUN
ajlm-2688	30	12	of	of	ADP
ajlm-2688	30	13	sample	sample	NOUN
ajlm-2688	30	14	age	age	NOUN
ajlm-2688	30	15	(	(	PUNCT
ajlm-2688	30	16	from	from	ADP
ajlm-2688	30	17	time	time	NOUN
ajlm-2688	30	18	of	of	ADP
ajlm-2688	30	19	collection	collection	NOUN
ajlm-2688	30	20	to	to	ADP
ajlm-2688	30	21	time	time	NOUN
ajlm-2688	30	22	of	of	ADP
ajlm-2688	30	23	analysis	analysis	NOUN
ajlm-2688	30	24	)	)	PUNCT
ajlm-2688	30	25	and	and	CCONJ
ajlm-2688	30	26	storage	storage	NOUN
ajlm-2688	30	27	conditions	condition	NOUN
ajlm-2688	30	28	(	(	PUNCT
ajlm-2688	30	29	room	room	NOUN
ajlm-2688	30	30	versus	versus	ADP
ajlm-2688	30	31	refrigerator	refrigerator	NOUN
ajlm-2688	30	32	temperature	temperature	NOUN
ajlm-2688	30	33	)	)	PUNCT
ajlm-2688	30	34	on	on	ADP
ajlm-2688	30	35	the	the	DET
ajlm-2688	30	36	percentage	percentage	NOUN
ajlm-2688	30	37	antigen	antigen	NOUN
ajlm-2688	30	38	expression	expression	NOUN
ajlm-2688	30	39	and	and	CCONJ
ajlm-2688	30	40	the	the	DET
ajlm-2688	30	41	intensity	intensity	NOUN
ajlm-2688	30	42	of	of	ADP
ajlm-2688	30	43	expression	expression	NOUN
ajlm-2688	30	44	of	of	ADP
ajlm-2688	30	45	surface	surface	NOUN
ajlm-2688	30	46	antigens	antigen	NOUN
ajlm-2688	30	47	in	in	ADP
ajlm-2688	30	48	cll	cll	PROPN
ajlm-2688	30	49	.	.	PUNCT
ajlm-2688	31	1	we	we	PRON
ajlm-2688	31	2	wanted	want	VERB
ajlm-2688	31	3	to	to	PART
ajlm-2688	31	4	determine	determine	VERB
ajlm-2688	31	5	the	the	DET
ajlm-2688	31	6	optimal	optimal	ADJ
ajlm-2688	31	7	storage	storage	NOUN
ajlm-2688	31	8	conditions	condition	NOUN
ajlm-2688	31	9	to	to	PART
ajlm-2688	31	10	produce	produce	VERB
ajlm-2688	31	11	quality	quality	NOUN
ajlm-2688	31	12	results	result	NOUN
ajlm-2688	31	13	and	and	CCONJ
ajlm-2688	31	14	establish	establish	VERB
ajlm-2688	31	15	a	a	DET
ajlm-2688	31	16	cut	cut	VERB
ajlm-2688	31	17	-	-	PUNCT
ajlm-2688	31	18	off	off	ADP
ajlm-2688	31	19	time	time	NOUN
ajlm-2688	31	20	after	after	ADP
ajlm-2688	31	21	which	which	PRON
ajlm-2688	31	22	samples	sample	NOUN
ajlm-2688	31	23	are	be	AUX
ajlm-2688	31	24	considered	consider	VERB
ajlm-2688	31	25	unsuitable	unsuitable	ADJ
ajlm-2688	31	26	for	for	ADP
ajlm-2688	31	27	reliable	reliable	ADJ
ajlm-2688	31	28	diagnoses	diagnosis	NOUN
ajlm-2688	31	29	.	.	PUNCT
ajlm-2688	32	1	methods	method	NOUN
ajlm-2688	32	2	ethical	ethical	ADJ
ajlm-2688	32	3	considerations	consideration	NOUN
ajlm-2688	32	4	the	the	DET
ajlm-2688	32	5	study	study	NOUN
ajlm-2688	32	6	was	be	AUX
ajlm-2688	32	7	conducted	conduct	VERB
ajlm-2688	32	8	in	in	ADP
ajlm-2688	32	9	accordance	accordance	NOUN
ajlm-2688	32	10	with	with	ADP
ajlm-2688	32	11	the	the	DET
ajlm-2688	32	12	declaration	declaration	NOUN
ajlm-2688	32	13	of	of	ADP
ajlm-2688	32	14	helsinki	helsinki	PROPN
ajlm-2688	32	15	and	and	CCONJ
ajlm-2688	32	16	approved	approve	VERB
ajlm-2688	32	17	by	by	ADP
ajlm-2688	32	18	the	the	DET
ajlm-2688	32	19	health	health	PROPN
ajlm-2688	32	20	sciences	sciences	PROPN
ajlm-2688	32	21	research	research	PROPN
ajlm-2688	32	22	ethics	ethic	NOUN
ajlm-2688	32	23	committee	committee	PROPN
ajlm-2688	32	24	of	of	ADP
ajlm-2688	32	25	the	the	DET
ajlm-2688	32	26	university	university	NOUN
ajlm-2688	32	27	of	of	ADP
ajlm-2688	32	28	the	the	DET
ajlm-2688	32	29	free	free	ADJ
ajlm-2688	32	30	state	state	NOUN
ajlm-2688	32	31	(	(	PUNCT
ajlm-2688	32	32	reference	reference	NOUN
ajlm-2688	32	33	number	number	NOUN
ajlm-2688	32	34	ufs	ufs	NOUN
ajlm-2688	32	35	-	-	PROPN
ajlm-2688	32	36	hsd2021/1257/3011	hsd2021/1257/3011	NOUN
ajlm-2688	32	37	)	)	PUNCT
ajlm-2688	32	38	,	,	PUNCT
ajlm-2688	32	39	free	free	ADJ
ajlm-2688	32	40	state	state	PROPN
ajlm-2688	32	41	department	department	PROPN
ajlm-2688	32	42	of	of	ADP
ajlm-2688	32	43	health	health	PROPN
ajlm-2688	32	44	and	and	CCONJ
ajlm-2688	32	45	the	the	DET
ajlm-2688	32	46	national	national	PROPN
ajlm-2688	32	47	health	health	PROPN
ajlm-2688	32	48	laboratory	laboratory	PROPN
ajlm-2688	32	49	service	service	NOUN
ajlm-2688	32	50	.	.	PUNCT
ajlm-2688	33	1	as	as	ADP
ajlm-2688	33	2	per	per	ADP
ajlm-2688	33	3	the	the	DET
ajlm-2688	33	4	institutional	institutional	ADJ
ajlm-2688	33	5	review	review	PROPN
ajlm-2688	33	6	board	board	NOUN
ajlm-2688	33	7	,	,	PUNCT
ajlm-2688	33	8	no	no	DET
ajlm-2688	33	9	informed	informed	ADJ
ajlm-2688	33	10	consent	consent	NOUN
ajlm-2688	33	11	was	be	AUX
ajlm-2688	33	12	required	require	VERB
ajlm-2688	33	13	as	as	SCONJ
ajlm-2688	33	14	there	there	PRON
ajlm-2688	33	15	was	be	VERB
ajlm-2688	33	16	no	no	DET
ajlm-2688	33	17	interaction	interaction	NOUN
ajlm-2688	33	18	between	between	ADP
ajlm-2688	33	19	the	the	DET
ajlm-2688	33	20	principal	principal	ADJ
ajlm-2688	33	21	investigator	investigator	NOUN
ajlm-2688	33	22	and	and	CCONJ
ajlm-2688	33	23	the	the	DET
ajlm-2688	33	24	patients	patient	NOUN
ajlm-2688	33	25	,	,	PUNCT
ajlm-2688	33	26	nor	nor	CCONJ
ajlm-2688	33	27	did	do	AUX
ajlm-2688	33	28	the	the	DET
ajlm-2688	33	29	study	study	NOUN
ajlm-2688	33	30	’s	’s	PART
ajlm-2688	33	31	outcome	outcome	NOUN
ajlm-2688	33	32	affect	affect	VERB
ajlm-2688	33	33	patients	patient	NOUN
ajlm-2688	33	34	’	'	PUNCT
ajlm-2688	33	35	well	well	ADV
ajlm-2688	33	36	-	-	PUNCT
ajlm-2688	33	37	being	being	NOUN
ajlm-2688	33	38	or	or	CCONJ
ajlm-2688	33	39	medical	medical	ADJ
ajlm-2688	33	40	care	care	NOUN
ajlm-2688	33	41	.	.	PUNCT
ajlm-2688	34	1	the	the	DET
ajlm-2688	34	2	blood	blood	NOUN
ajlm-2688	34	3	samples	sample	NOUN
ajlm-2688	34	4	used	use	VERB
ajlm-2688	34	5	in	in	ADP
ajlm-2688	34	6	this	this	DET
ajlm-2688	34	7	study	study	NOUN
ajlm-2688	34	8	were	be	AUX
ajlm-2688	34	9	the	the	DET
ajlm-2688	34	10	surplus	surplus	ADJ
ajlm-2688	34	11	blood	blood	NOUN
ajlm-2688	34	12	of	of	ADP
ajlm-2688	34	13	routine	routine	ADJ
ajlm-2688	34	14	samples	sample	NOUN
ajlm-2688	34	15	collected	collect	VERB
ajlm-2688	34	16	by	by	ADP
ajlm-2688	34	17	trained	train	VERB
ajlm-2688	34	18	nursing	nursing	NOUN
ajlm-2688	34	19	staff	staff	NOUN
ajlm-2688	34	20	during	during	ADP
ajlm-2688	34	21	the	the	DET
ajlm-2688	34	22	patient	patient	NOUN
ajlm-2688	34	23	’s	’s	PART
ajlm-2688	34	24	scheduled	schedule	VERB
ajlm-2688	34	25	haematology	haematology	NOUN
ajlm-2688	34	26	clinic	clinic	NOUN
ajlm-2688	34	27	visits	visit	NOUN
ajlm-2688	34	28	,	,	PUNCT
ajlm-2688	34	29	independent	independent	ADJ
ajlm-2688	34	30	of	of	ADP
ajlm-2688	34	31	our	our	PRON
ajlm-2688	34	32	research	research	NOUN
ajlm-2688	34	33	.	.	PUNCT
ajlm-2688	35	1	the	the	DET
ajlm-2688	35	2	researchers	researcher	NOUN
ajlm-2688	35	3	did	do	AUX
ajlm-2688	35	4	not	not	PART
ajlm-2688	35	5	have	have	VERB
ajlm-2688	35	6	access	access	NOUN
ajlm-2688	35	7	to	to	ADP
ajlm-2688	35	8	patient	patient	VERB
ajlm-2688	35	9	sociodemographic	sociodemographic	ADJ
ajlm-2688	35	10	or	or	CCONJ
ajlm-2688	35	11	clinical	clinical	ADJ
ajlm-2688	35	12	details	detail	NOUN
ajlm-2688	35	13	.	.	PUNCT
ajlm-2688	36	1	study	study	NOUN
ajlm-2688	36	2	design	design	NOUN
ajlm-2688	36	3	and	and	CCONJ
ajlm-2688	36	4	patient	patient	ADJ
ajlm-2688	36	5	selection	selection	NOUN
ajlm-2688	36	6	whole	whole	ADJ
ajlm-2688	36	7	blood	blood	NOUN
ajlm-2688	36	8	samples	sample	NOUN
ajlm-2688	36	9	in	in	ADP
ajlm-2688	36	10	vacutainers	vacutainer	NOUN
ajlm-2688	36	11	containing	contain	VERB
ajlm-2688	36	12	ethylenediamine	ethylenediamine	NOUN
ajlm-2688	36	13	tetra	tetra	NOUN
ajlm-2688	36	14	-	-	PUNCT
ajlm-2688	36	15	acetic	acetic	ADJ
ajlm-2688	36	16	acid	acid	NOUN
ajlm-2688	36	17	(	(	PUNCT
ajlm-2688	36	18	edta	edta	NOUN
ajlm-2688	36	19	)	)	PUNCT
ajlm-2688	36	20	(	(	PUNCT
ajlm-2688	36	21	becton	becton	PROPN
ajlm-2688	36	22	dickinson	dickinson	PROPN
ajlm-2688	37	1	[	[	X
ajlm-2688	37	2	bd	bd	X
ajlm-2688	37	3	]	]	X
ajlm-2688	37	4	,	,	PUNCT
ajlm-2688	37	5	san	san	PROPN
ajlm-2688	37	6	jose	jose	PROPN
ajlm-2688	37	7	,	,	PUNCT
ajlm-2688	37	8	california	california	PROPN
ajlm-2688	37	9	,	,	PUNCT
ajlm-2688	37	10	united	united	PROPN
ajlm-2688	37	11	states	states	PROPN
ajlm-2688	37	12	)	)	PUNCT
ajlm-2688	37	13	were	be	AUX
ajlm-2688	37	14	obtained	obtain	VERB
ajlm-2688	37	15	by	by	ADP
ajlm-2688	37	16	designated	designate	VERB
ajlm-2688	37	17	clinic	clinic	NOUN
ajlm-2688	37	18	personnel	personnel	NOUN
ajlm-2688	37	19	from	from	ADP
ajlm-2688	37	20	patients	patient	NOUN
ajlm-2688	37	21	with	with	ADP
ajlm-2688	37	22	confirmed	confirm	VERB
ajlm-2688	37	23	diagnoses	diagnosis	NOUN
ajlm-2688	37	24	of	of	ADP
ajlm-2688	37	25	cll	cll	PROPN
ajlm-2688	37	26	attending	attend	VERB
ajlm-2688	37	27	the	the	DET
ajlm-2688	37	28	universitas	universita	NOUN
ajlm-2688	37	29	academic	academic	ADJ
ajlm-2688	37	30	hospital	hospital	NOUN
ajlm-2688	37	31	haematology	haematology	PROPN
ajlm-2688	37	32	clinic	clinic	PROPN
ajlm-2688	37	33	,	,	PUNCT
ajlm-2688	37	34	bloemfontein	bloemfontein	PROPN
ajlm-2688	37	35	,	,	PUNCT
ajlm-2688	37	36	south	south	PROPN
ajlm-2688	37	37	africa	africa	PROPN
ajlm-2688	37	38	,	,	PUNCT
ajlm-2688	37	39	between	between	ADP
ajlm-2688	37	40	january	january	PROPN
ajlm-2688	37	41	2022	2022	NUM
ajlm-2688	37	42	and	and	CCONJ
ajlm-2688	37	43	march	march	PROPN
ajlm-2688	37	44	2023	2023	NUM
ajlm-2688	37	45	.	.	PUNCT
ajlm-2688	38	1	the	the	DET
ajlm-2688	38	2	blood	blood	NOUN
ajlm-2688	38	3	samples	sample	NOUN
ajlm-2688	38	4	used	use	VERB
ajlm-2688	38	5	in	in	ADP
ajlm-2688	38	6	this	this	DET
ajlm-2688	38	7	study	study	NOUN
ajlm-2688	38	8	were	be	AUX
ajlm-2688	38	9	the	the	DET
ajlm-2688	38	10	surplus	surplus	ADJ
ajlm-2688	38	11	blood	blood	NOUN
ajlm-2688	38	12	of	of	ADP
ajlm-2688	38	13	the	the	DET
ajlm-2688	38	14	routine	routine	ADJ
ajlm-2688	38	15	blood	blood	NOUN
ajlm-2688	38	16	samples	sample	NOUN
ajlm-2688	38	17	collected	collect	VERB
ajlm-2688	38	18	by	by	ADP
ajlm-2688	38	19	trained	train	VERB
ajlm-2688	38	20	nursing	nursing	NOUN
ajlm-2688	38	21	personnel	personnel	NOUN
ajlm-2688	38	22	during	during	ADP
ajlm-2688	38	23	the	the	DET
ajlm-2688	38	24	patients	patient	NOUN
ajlm-2688	38	25	’	'	PUNCT
ajlm-2688	38	26	haematology	haematology	NOUN
ajlm-2688	38	27	clinic	clinic	NOUN
ajlm-2688	38	28	visit	visit	NOUN
ajlm-2688	38	29	,	,	PUNCT
ajlm-2688	38	30	independent	independent	ADJ
ajlm-2688	38	31	of	of	ADP
ajlm-2688	38	32	our	our	PRON
ajlm-2688	38	33	research	research	NOUN
ajlm-2688	38	34	.	.	PUNCT
ajlm-2688	39	1	full	full	ADJ
ajlm-2688	39	2	blood	blood	NOUN
ajlm-2688	39	3	count	count	NOUN
ajlm-2688	39	4	and	and	CCONJ
ajlm-2688	39	5	peripheral	peripheral	ADJ
ajlm-2688	39	6	blood	blood	NOUN
ajlm-2688	39	7	smear	smear	NOUN
ajlm-2688	39	8	results	result	NOUN
ajlm-2688	39	9	were	be	AUX
ajlm-2688	39	10	screened	screen	VERB
ajlm-2688	39	11	to	to	PART
ajlm-2688	39	12	identify	identify	VERB
ajlm-2688	39	13	eligible	eligible	ADJ
ajlm-2688	39	14	samples	sample	NOUN
ajlm-2688	39	15	.	.	PUNCT
ajlm-2688	40	1	these	these	PRON
ajlm-2688	40	2	included	include	VERB
ajlm-2688	40	3	samples	sample	NOUN
ajlm-2688	40	4	with	with	ADP
ajlm-2688	40	5	morphologically	morphologically	ADV
ajlm-2688	40	6	detectable	detectable	ADJ
ajlm-2688	40	7	disease	disease	NOUN
ajlm-2688	40	8	,	,	PUNCT
ajlm-2688	40	9	regardless	regardless	ADV
ajlm-2688	40	10	of	of	ADP
ajlm-2688	40	11	whether	whether	SCONJ
ajlm-2688	40	12	the	the	DET
ajlm-2688	40	13	patients	patient	NOUN
ajlm-2688	40	14	were	be	AUX
ajlm-2688	40	15	newly	newly	ADV
ajlm-2688	40	16	diagnosed	diagnose	VERB
ajlm-2688	40	17	or	or	CCONJ
ajlm-2688	40	18	receiving	receive	VERB
ajlm-2688	40	19	treatment	treatment	NOUN
ajlm-2688	40	20	.	.	PUNCT
ajlm-2688	41	1	the	the	DET
ajlm-2688	41	2	edta	edta	NOUN
ajlm-2688	41	3	samples	sample	NOUN
ajlm-2688	41	4	were	be	AUX
ajlm-2688	41	5	immediately	immediately	ADV
ajlm-2688	41	6	de	de	VERB
ajlm-2688	41	7	-	-	VERB
ajlm-2688	41	8	identified	identify	VERB
ajlm-2688	41	9	and	and	CCONJ
ajlm-2688	41	10	assigned	assign	VERB
ajlm-2688	41	11	study	study	NOUN
ajlm-2688	41	12	numbers	number	NOUN
ajlm-2688	41	13	to	to	PART
ajlm-2688	41	14	ensure	ensure	VERB
ajlm-2688	41	15	patient	patient	ADJ
ajlm-2688	41	16	confidentiality	confidentiality	NOUN
ajlm-2688	41	17	,	,	PUNCT
ajlm-2688	41	18	after	after	ADP
ajlm-2688	41	19	which	which	DET
ajlm-2688	41	20	baseline	baseline	VERB
ajlm-2688	41	21	(	(	PUNCT
ajlm-2688	41	22	within	within	ADP
ajlm-2688	41	23	12	12	NUM
ajlm-2688	41	24	h	h	NOUN
ajlm-2688	41	25	of	of	ADP
ajlm-2688	41	26	collection	collection	NOUN
ajlm-2688	41	27	)	)	PUNCT
ajlm-2688	41	28	flow	flow	NOUN
ajlm-2688	41	29	cytometric	cytometric	ADJ
ajlm-2688	41	30	analysis	analysis	NOUN
ajlm-2688	41	31	was	be	AUX
ajlm-2688	41	32	performed	perform	VERB
ajlm-2688	41	33	.	.	PUNCT
ajlm-2688	42	1	only	only	ADV
ajlm-2688	42	2	samples	sample	NOUN
ajlm-2688	42	3	with	with	ADP
ajlm-2688	42	4	a	a	DET
ajlm-2688	42	5	baseline	baseline	ADJ
ajlm-2688	42	6	immunophenotype	immunophenotype	NOUN
ajlm-2688	42	7	of	of	ADP
ajlm-2688	42	8	typical	typical	ADJ
ajlm-2688	42	9	cll	cll	PROPN
ajlm-2688	42	10	were	be	AUX
ajlm-2688	42	11	included	include	VERB
ajlm-2688	42	12	in	in	ADP
ajlm-2688	42	13	the	the	DET
ajlm-2688	42	14	study	study	NOUN
ajlm-2688	42	15	.	.	PUNCT
ajlm-2688	43	1	following	follow	VERB
ajlm-2688	43	2	baseline	baseline	NOUN
ajlm-2688	43	3	flow	flow	NOUN
ajlm-2688	43	4	cytometry	cytometry	NOUN
ajlm-2688	43	5	,	,	PUNCT
ajlm-2688	43	6	each	each	DET
ajlm-2688	43	7	sample	sample	NOUN
ajlm-2688	43	8	was	be	AUX
ajlm-2688	43	9	then	then	ADV
ajlm-2688	43	10	divided	divide	VERB
ajlm-2688	43	11	into	into	ADP
ajlm-2688	43	12	two	two	NUM
ajlm-2688	43	13	separate	separate	ADJ
ajlm-2688	43	14	specimen	speciman	NOUN
ajlm-2688	43	15	tubes	tube	NOUN
ajlm-2688	43	16	:	:	PUNCT
ajlm-2688	43	17	one	one	NUM
ajlm-2688	43	18	stored	store	VERB
ajlm-2688	43	19	at	at	ADP
ajlm-2688	43	20	refrigerator	refrigerator	NOUN
ajlm-2688	43	21	temperature	temperature	NOUN
ajlm-2688	43	22	(	(	PUNCT
ajlm-2688	43	23	4	4	NUM
ajlm-2688	43	24	°	°	NOUN
ajlm-2688	43	25	c	c	NOUN
ajlm-2688	43	26	)	)	PUNCT
ajlm-2688	43	27	and	and	CCONJ
ajlm-2688	43	28	the	the	DET
ajlm-2688	43	29	other	other	ADJ
ajlm-2688	43	30	at	at	ADP
ajlm-2688	43	31	room	room	NOUN
ajlm-2688	43	32	temperature	temperature	NOUN
ajlm-2688	43	33	(	(	PUNCT
ajlm-2688	43	34	rt	rt	PROPN
ajlm-2688	43	35	)	)	PUNCT
ajlm-2688	43	36	,	,	PUNCT
ajlm-2688	43	37	defined	define	VERB
ajlm-2688	43	38	as	as	ADP
ajlm-2688	43	39	23	23	NUM
ajlm-2688	43	40	°	°	NOUN
ajlm-2688	43	41	c	c	PROPN
ajlm-2688	43	42	in	in	ADP
ajlm-2688	43	43	nhls	nhls	PROPN
ajlm-2688	43	44	laboratories.22,23	laboratories.22,23	NOUN
ajlm-2688	43	45	these	these	DET
ajlm-2688	43	46	two	two	NUM
ajlm-2688	43	47	aliquots	aliquot	NOUN
ajlm-2688	43	48	per	per	ADP
ajlm-2688	43	49	sample	sample	NOUN
ajlm-2688	43	50	were	be	AUX
ajlm-2688	43	51	then	then	ADV
ajlm-2688	43	52	analysed	analyse	VERB
ajlm-2688	43	53	after	after	ADP
ajlm-2688	43	54	24	24	NUM
ajlm-2688	43	55	h	h	NOUN
ajlm-2688	43	56	,	,	PUNCT
ajlm-2688	43	57	48	48	NUM
ajlm-2688	43	58	h	h	NOUN
ajlm-2688	43	59	,	,	PUNCT
ajlm-2688	43	60	72	72	NUM
ajlm-2688	43	61	h	h	NOUN
ajlm-2688	43	62	and	and	CCONJ
ajlm-2688	43	63	96	96	NUM
ajlm-2688	43	64	h	h	NOUN
ajlm-2688	43	65	of	of	ADP
ajlm-2688	43	66	storage	storage	NOUN
ajlm-2688	43	67	at	at	ADP
ajlm-2688	43	68	the	the	DET
ajlm-2688	43	69	respective	respective	ADJ
ajlm-2688	43	70	temperatures	temperature	NOUN
ajlm-2688	43	71	.	.	PUNCT
ajlm-2688	44	1	all	all	DET
ajlm-2688	44	2	flow	flow	VERB
ajlm-2688	44	3	cytometric	cytometric	ADJ
ajlm-2688	44	4	analyses	analysis	NOUN
ajlm-2688	44	5	were	be	AUX
ajlm-2688	44	6	performed	perform	VERB
ajlm-2688	44	7	on	on	ADP
ajlm-2688	44	8	the	the	DET
ajlm-2688	44	9	facscanto	facscanto	NOUN
ajlm-2688	44	10	™	™	PROPN
ajlm-2688	44	11	ii	ii	PROPN
ajlm-2688	44	12	(	(	PUNCT
ajlm-2688	44	13	bd	bd	PROPN
ajlm-2688	44	14	,	,	PUNCT
ajlm-2688	44	15	san	san	PROPN
ajlm-2688	44	16	jose	jose	PROPN
ajlm-2688	44	17	,	,	PUNCT
ajlm-2688	44	18	california	california	PROPN
ajlm-2688	44	19	,	,	PUNCT
ajlm-2688	44	20	united	united	PROPN
ajlm-2688	44	21	states	states	PROPN
ajlm-2688	44	22	)	)	PUNCT
ajlm-2688	44	23	.	.	PUNCT
ajlm-2688	45	1	the	the	DET
ajlm-2688	45	2	percentage	percentage	NOUN
ajlm-2688	45	3	antigen	antigen	NOUN
ajlm-2688	45	4	expression	expression	NOUN
ajlm-2688	45	5	,	,	PUNCT
ajlm-2688	45	6	median	median	ADJ
ajlm-2688	45	7	fluorescence	fluorescence	NOUN
ajlm-2688	45	8	intensity	intensity	NOUN
ajlm-2688	45	9	(	(	PUNCT
ajlm-2688	45	10	mfi	mfi	PROPN
ajlm-2688	45	11	)	)	PUNCT
ajlm-2688	45	12	and	and	CCONJ
ajlm-2688	45	13	difference	difference	NOUN
ajlm-2688	45	14	in	in	ADP
ajlm-2688	45	15	mfi	mfi	PROPN
ajlm-2688	45	16	for	for	ADP
ajlm-2688	45	17	each	each	DET
ajlm-2688	45	18	marker	marker	NOUN
ajlm-2688	45	19	were	be	AUX
ajlm-2688	45	20	recorded	record	VERB
ajlm-2688	45	21	,	,	PUNCT
ajlm-2688	45	22	as	as	SCONJ
ajlm-2688	45	23	shown	show	VERB
ajlm-2688	45	24	in	in	ADP
ajlm-2688	45	25	figure	figure	NOUN
ajlm-2688	45	26	1	1	NUM
ajlm-2688	45	27	,	,	PUNCT
ajlm-2688	45	28	which	which	PRON
ajlm-2688	45	29	illustrates	illustrate	VERB
ajlm-2688	45	30	the	the	DET
ajlm-2688	45	31	study	study	NOUN
ajlm-2688	45	32	design	design	NOUN
ajlm-2688	45	33	.	.	PUNCT
ajlm-2688	46	1	figure	figure	NOUN
ajlm-2688	46	2	1	1	NUM
ajlm-2688	46	3	:	:	PUNCT
ajlm-2688	46	4	schematic	schematic	ADJ
ajlm-2688	46	5	representation	representation	NOUN
ajlm-2688	46	6	of	of	ADP
ajlm-2688	46	7	the	the	DET
ajlm-2688	46	8	study	study	NOUN
ajlm-2688	46	9	design	design	NOUN
ajlm-2688	46	10	,	,	PUNCT
ajlm-2688	46	11	universitas	universita	NOUN
ajlm-2688	46	12	academic	academic	ADJ
ajlm-2688	46	13	hospital	hospital	NOUN
ajlm-2688	46	14	,	,	PUNCT
ajlm-2688	46	15	bloemfontein	bloemfontein	PROPN
ajlm-2688	46	16	,	,	PUNCT
ajlm-2688	46	17	south	south	PROPN
ajlm-2688	46	18	africa	africa	PROPN
ajlm-2688	46	19	,	,	PUNCT
ajlm-2688	46	20	january	january	PROPN
ajlm-2688	46	21	2022	2022	NUM
ajlm-2688	46	22	to	to	ADP
ajlm-2688	46	23	march	march	PROPN
ajlm-2688	46	24	2023	2023	NUM
ajlm-2688	46	25	.	.	PUNCT
ajlm-2688	47	1	sample	sample	NOUN
ajlm-2688	47	2	processing	processing	NOUN
ajlm-2688	47	3	sample	sample	NOUN
ajlm-2688	47	4	preparation	preparation	NOUN
ajlm-2688	47	5	was	be	AUX
ajlm-2688	47	6	done	do	VERB
ajlm-2688	47	7	according	accord	VERB
ajlm-2688	47	8	to	to	ADP
ajlm-2688	47	9	the	the	DET
ajlm-2688	47	10	euroflow	euroflow	NOUN
ajlm-2688	47	11	protocols.22	protocols.22	NOUN
ajlm-2688	47	12	because	because	SCONJ
ajlm-2688	47	13	of	of	ADP
ajlm-2688	47	14	the	the	DET
ajlm-2688	47	15	inclusion	inclusion	NOUN
ajlm-2688	47	16	of	of	ADP
ajlm-2688	47	17	surface	surface	NOUN
ajlm-2688	47	18	membrane	membrane	NOUN
ajlm-2688	47	19	immunoglobulins	immunoglobulin	NOUN
ajlm-2688	47	20	(	(	PUNCT
ajlm-2688	47	21	sigm	sigm	NOUN
ajlm-2688	47	22	,	,	PUNCT
ajlm-2688	47	23	skappa	skappa	ADJ
ajlm-2688	47	24	,	,	PUNCT
ajlm-2688	47	25	slambda	slambda	ADJ
ajlm-2688	47	26	)	)	PUNCT
ajlm-2688	47	27	,	,	PUNCT
ajlm-2688	47	28	a	a	DET
ajlm-2688	47	29	wash	wash	NOUN
ajlm-2688	47	30	-	-	PUNCT
ajlm-2688	47	31	stain	stain	NOUN
ajlm-2688	47	32	-	-	PUNCT
ajlm-2688	47	33	lyse	lyse	NOUN
ajlm-2688	47	34	approach	approach	NOUN
ajlm-2688	47	35	was	be	AUX
ajlm-2688	47	36	followed	follow	VERB
ajlm-2688	47	37	.	.	PUNCT
ajlm-2688	48	1	in	in	ADP
ajlm-2688	48	2	brief	brief	ADJ
ajlm-2688	48	3	,	,	PUNCT
ajlm-2688	48	4	3000	3000	NUM
ajlm-2688	48	5	µl	µl	NOUN
ajlm-2688	48	6	of	of	ADP
ajlm-2688	48	7	phosphate	phosphate	NOUN
ajlm-2688	48	8	-	-	PUNCT
ajlm-2688	48	9	buffered	buffer	VERB
ajlm-2688	48	10	saline	saline	NOUN
ajlm-2688	48	11	was	be	AUX
ajlm-2688	48	12	mixed	mix	VERB
ajlm-2688	48	13	with	with	ADP
ajlm-2688	48	14	300	300	NUM
ajlm-2688	48	15	µl	µl	NOUN
ajlm-2688	48	16	of	of	ADP
ajlm-2688	48	17	edta	edta	NOUN
ajlm-2688	48	18	whole	whole	ADJ
ajlm-2688	48	19	blood	blood	NOUN
ajlm-2688	48	20	,	,	PUNCT
ajlm-2688	48	21	followed	follow	VERB
ajlm-2688	48	22	by	by	ADP
ajlm-2688	48	23	centrifugation	centrifugation	NOUN
ajlm-2688	48	24	at	at	ADP
ajlm-2688	48	25	540	540	NUM
ajlm-2688	48	26	g	g	NOUN
ajlm-2688	48	27	for	for	ADP
ajlm-2688	48	28	5	5	NUM
ajlm-2688	48	29	min	min	NOUN
ajlm-2688	48	30	in	in	ADP
ajlm-2688	48	31	a	a	DET
ajlm-2688	48	32	heraeus	heraeus	NOUN
ajlm-2688	48	33	megafuge	megafuge	NOUN
ajlm-2688	48	34	8	8	NUM
ajlm-2688	48	35	centrifuge	centrifuge	NOUN
ajlm-2688	48	36	(	(	PUNCT
ajlm-2688	48	37	thermo	thermo	PROPN
ajlm-2688	48	38	scientific	scientific	PROPN
ajlm-2688	48	39	inc	inc	PROPN
ajlm-2688	48	40	.	.	PROPN
ajlm-2688	48	41	,	,	PUNCT
ajlm-2688	48	42	waltham	waltham	PROPN
ajlm-2688	48	43	,	,	PUNCT
ajlm-2688	48	44	massachusetts	massachusetts	PROPN
ajlm-2688	48	45	,	,	PUNCT
ajlm-2688	48	46	united	united	PROPN
ajlm-2688	48	47	states	states	PROPN
ajlm-2688	48	48	)	)	PUNCT
ajlm-2688	48	49	.	.	PUNCT
ajlm-2688	49	1	thereafter	thereafter	ADV
ajlm-2688	49	2	,	,	PUNCT
ajlm-2688	49	3	the	the	DET
ajlm-2688	49	4	supernatant	supernatant	NOUN
ajlm-2688	49	5	was	be	AUX
ajlm-2688	49	6	discarded	discard	VERB
ajlm-2688	49	7	and	and	CCONJ
ajlm-2688	49	8	these	these	DET
ajlm-2688	49	9	steps	step	NOUN
ajlm-2688	49	10	repeated	repeat	VERB
ajlm-2688	49	11	once	once	ADV
ajlm-2688	49	12	more	more	ADJ
ajlm-2688	49	13	.	.	PUNCT
ajlm-2688	50	1	the	the	DET
ajlm-2688	50	2	cell	cell	NOUN
ajlm-2688	50	3	pellet	pellet	NOUN
ajlm-2688	50	4	was	be	AUX
ajlm-2688	50	5	then	then	ADV
ajlm-2688	50	6	resuspended	resuspend	VERB
ajlm-2688	50	7	in	in	ADP
ajlm-2688	50	8	300	300	NUM
ajlm-2688	50	9	µl	µl	NOUN
ajlm-2688	50	10	of	of	ADP
ajlm-2688	50	11	phosphate	phosphate	NOUN
ajlm-2688	50	12	-	-	PUNCT
ajlm-2688	50	13	buffered	buffer	VERB
ajlm-2688	50	14	saline	saline	NOUN
ajlm-2688	50	15	.	.	PUNCT
ajlm-2688	51	1	the	the	DET
ajlm-2688	51	2	correct	correct	ADJ
ajlm-2688	51	3	volume	volume	NOUN
ajlm-2688	51	4	of	of	ADP
ajlm-2688	51	5	cells	cell	NOUN
ajlm-2688	51	6	required	require	VERB
ajlm-2688	51	7	per	per	ADP
ajlm-2688	51	8	tube	tube	NOUN
ajlm-2688	51	9	was	be	AUX
ajlm-2688	51	10	calculated	calculate	VERB
ajlm-2688	51	11	using	use	VERB
ajlm-2688	51	12	equation	equation	NOUN
ajlm-2688	51	13	1	1	NUM
ajlm-2688	51	14	:	:	PUNCT
ajlm-2688	51	15	this	this	DET
ajlm-2688	51	16	calculated	calculate	VERB
ajlm-2688	51	17	volume	volume	NOUN
ajlm-2688	51	18	was	be	AUX
ajlm-2688	51	19	incubated	incubate	VERB
ajlm-2688	51	20	for	for	ADP
ajlm-2688	51	21	15	15	NUM
ajlm-2688	51	22	min	min	NOUN
ajlm-2688	51	23	at	at	ADP
ajlm-2688	51	24	rt	rt	PROPN
ajlm-2688	51	25	in	in	ADP
ajlm-2688	51	26	the	the	DET
ajlm-2688	51	27	dark	dark	NOUN
ajlm-2688	51	28	with	with	ADP
ajlm-2688	51	29	10	10	NUM
ajlm-2688	51	30	µl	µl	NOUN
ajlm-2688	51	31	of	of	ADP
ajlm-2688	51	32	each	each	PRON
ajlm-2688	51	33	of	of	ADP
ajlm-2688	51	34	the	the	DET
ajlm-2688	51	35	following	follow	VERB
ajlm-2688	51	36	monoclonal	monoclonal	NOUN
ajlm-2688	51	37	antibodies	antibodie	VERB
ajlm-2688	51	38	:	:	PUNCT
ajlm-2688	51	39	cd5	cd5	PROPN
ajlm-2688	51	40	,	,	PUNCT
ajlm-2688	51	41	cd19	cd19	PROPN
ajlm-2688	51	42	,	,	PUNCT
ajlm-2688	51	43	cd20	cd20	PROPN
ajlm-2688	51	44	,	,	PUNCT
ajlm-2688	51	45	cd23	cd23	PROPN
ajlm-2688	51	46	,	,	PUNCT
ajlm-2688	51	47	cd43	cd43	PROPN
ajlm-2688	51	48	,	,	PUNCT
ajlm-2688	51	49	cd45	cd45	PROPN
ajlm-2688	51	50	,	,	PUNCT
ajlm-2688	51	51	cd79b	cd79b	ADJ
ajlm-2688	51	52	,	,	PUNCT
ajlm-2688	51	53	cd200	cd200	PROPN
ajlm-2688	51	54	,	,	PUNCT
ajlm-2688	51	55	sigm	sigm	NOUN
ajlm-2688	51	56	,	,	PUNCT
ajlm-2688	51	57	skappa	skappa	ADJ
ajlm-2688	51	58	,	,	PUNCT
ajlm-2688	51	59	and	and	CCONJ
ajlm-2688	51	60	slambda	slambda	NOUN
ajlm-2688	51	61	.	.	PUNCT
ajlm-2688	52	1	the	the	DET
ajlm-2688	52	2	chosen	choose	VERB
ajlm-2688	52	3	antibody	antibody	NOUN
ajlm-2688	52	4	panel	panel	NOUN
ajlm-2688	52	5	(	(	PUNCT
ajlm-2688	52	6	table	table	NOUN
ajlm-2688	52	7	1	1	NUM
ajlm-2688	52	8	)	)	PUNCT
ajlm-2688	52	9	was	be	AUX
ajlm-2688	52	10	adapted	adapt	VERB
ajlm-2688	52	11	from	from	ADP
ajlm-2688	52	12	the	the	DET
ajlm-2688	52	13	euroflow	euroflow	ADJ
ajlm-2688	52	14	lymphoid	lymphoid	NOUN
ajlm-2688	52	15	screening	screen	VERB
ajlm-2688	52	16	tube	tube	NOUN
ajlm-2688	52	17	and	and	CCONJ
ajlm-2688	52	18	b	b	PROPN
ajlm-2688	52	19	-	-	PUNCT
ajlm-2688	52	20	lpd	lpd	PROPN
ajlm-2688	52	21	panels	panel	NOUN
ajlm-2688	52	22	including	include	VERB
ajlm-2688	52	23	those	those	DET
ajlm-2688	52	24	markers	marker	NOUN
ajlm-2688	52	25	considered	consider	VERB
ajlm-2688	52	26	crucial	crucial	ADJ
ajlm-2688	52	27	in	in	ADP
ajlm-2688	52	28	the	the	DET
ajlm-2688	52	29	diagnosis	diagnosis	NOUN
ajlm-2688	52	30	of	of	ADP
ajlm-2688	52	31	cll.1,5,7	cll.1,5,7	NOUN
ajlm-2688	52	32	table	table	NOUN
ajlm-2688	52	33	1	1	NUM
ajlm-2688	52	34	:	:	PUNCT
ajlm-2688	52	35	 	 	SPACE
ajlm-2688	52	36	antibody	antibody	NOUN
ajlm-2688	52	37	panel	panel	NOUN
ajlm-2688	52	38	design	design	NOUN
ajlm-2688	52	39	for	for	ADP
ajlm-2688	52	40	flow	flow	NOUN
ajlm-2688	52	41	cytometric	cytometric	ADJ
ajlm-2688	52	42	analysis	analysis	NOUN
ajlm-2688	52	43	of	of	ADP
ajlm-2688	52	44	patients	patient	NOUN
ajlm-2688	52	45	attending	attend	VERB
ajlm-2688	52	46	the	the	DET
ajlm-2688	52	47	universitas	universita	NOUN
ajlm-2688	52	48	academic	academic	ADJ
ajlm-2688	52	49	hospital	hospital	NOUN
ajlm-2688	52	50	haematology	haematology	PROPN
ajlm-2688	52	51	clinic	clinic	PROPN
ajlm-2688	52	52	,	,	PUNCT
ajlm-2688	52	53	bloemfontein	bloemfontein	PROPN
ajlm-2688	52	54	,	,	PUNCT
ajlm-2688	52	55	south	south	PROPN
ajlm-2688	52	56	africa	africa	PROPN
ajlm-2688	52	57	,	,	PUNCT
ajlm-2688	52	58	january	january	PROPN
ajlm-2688	52	59	2022	2022	NUM
ajlm-2688	52	60	to	to	ADP
ajlm-2688	52	61	march	march	PROPN
ajlm-2688	52	62	2023	2023	NUM
ajlm-2688	52	63	.	.	PUNCT
ajlm-2688	53	1	the	the	DET
ajlm-2688	53	2	cells	cell	NOUN
ajlm-2688	53	3	were	be	AUX
ajlm-2688	53	4	then	then	ADV
ajlm-2688	53	5	lysed	lyse	VERB
ajlm-2688	53	6	with	with	ADP
ajlm-2688	53	7	2000	2000	NUM
ajlm-2688	53	8	µl	µl	ADP
ajlm-2688	53	9	of	of	ADP
ajlm-2688	53	10	diluted	diluted	ADJ
ajlm-2688	53	11	bd	bd	PROPN
ajlm-2688	53	12	facs	fac	NOUN
ajlm-2688	53	13	™	™	ADJ
ajlm-2688	53	14	lysing	lysing	NOUN
ajlm-2688	53	15	solution	solution	NOUN
ajlm-2688	53	16	(	(	PUNCT
ajlm-2688	53	17	bd	bd	PROPN
ajlm-2688	53	18	biosciences	bioscience	NOUN
ajlm-2688	53	19	,	,	PUNCT
ajlm-2688	53	20	san	san	PROPN
ajlm-2688	53	21	jose	jose	PROPN
ajlm-2688	53	22	,	,	PUNCT
ajlm-2688	53	23	california	california	PROPN
ajlm-2688	53	24	,	,	PUNCT
ajlm-2688	53	25	united	united	PROPN
ajlm-2688	53	26	states	states	PROPN
ajlm-2688	53	27	)	)	PUNCT
ajlm-2688	53	28	and	and	CCONJ
ajlm-2688	53	29	incubated	incubate	VERB
ajlm-2688	53	30	at	at	ADP
ajlm-2688	53	31	rt	rt	PROPN
ajlm-2688	53	32	in	in	ADP
ajlm-2688	53	33	the	the	DET
ajlm-2688	53	34	dark	dark	NOUN
ajlm-2688	53	35	for	for	ADP
ajlm-2688	53	36	another	another	DET
ajlm-2688	53	37	15	15	NUM
ajlm-2688	53	38	min	min	NOUN
ajlm-2688	53	39	.	.	PROPN
ajlm-2688	53	40	following	follow	VERB
ajlm-2688	53	41	centrifugation	centrifugation	NOUN
ajlm-2688	53	42	at	at	ADP
ajlm-2688	53	43	540	540	NUM
ajlm-2688	53	44	g	g	NOUN
ajlm-2688	53	45	for	for	ADP
ajlm-2688	53	46	5	5	NUM
ajlm-2688	53	47	min	min	NOUN
ajlm-2688	53	48	,	,	PUNCT
ajlm-2688	53	49	the	the	DET
ajlm-2688	53	50	supernatant	supernatant	NOUN
ajlm-2688	53	51	was	be	AUX
ajlm-2688	53	52	discarded	discard	VERB
ajlm-2688	53	53	,	,	PUNCT
ajlm-2688	53	54	and	and	CCONJ
ajlm-2688	53	55	the	the	DET
ajlm-2688	53	56	cell	cell	NOUN
ajlm-2688	53	57	pellet	pellet	NOUN
ajlm-2688	53	58	finally	finally	ADV
ajlm-2688	53	59	resuspended	resuspend	VERB
ajlm-2688	53	60	in	in	ADP
ajlm-2688	53	61	500	500	NUM
ajlm-2688	53	62	µl	µl	NOUN
ajlm-2688	53	63	of	of	ADP
ajlm-2688	53	64	phosphate	phosphate	NOUN
ajlm-2688	53	65	-	-	PUNCT
ajlm-2688	53	66	buffered	buffer	VERB
ajlm-2688	53	67	saline	saline	NOUN
ajlm-2688	53	68	for	for	ADP
ajlm-2688	53	69	analysis	analysis	NOUN
ajlm-2688	53	70	on	on	ADP
ajlm-2688	53	71	the	the	DET
ajlm-2688	53	72	facscanto	facscanto	NOUN
ajlm-2688	53	73	™	™	PROPN
ajlm-2688	53	74	ii	ii	PROPN
ajlm-2688	53	75	(	(	PUNCT
ajlm-2688	53	76	bd	bd	PROPN
ajlm-2688	53	77	,	,	PUNCT
ajlm-2688	53	78	san	san	PROPN
ajlm-2688	53	79	jose	jose	PROPN
ajlm-2688	53	80	,	,	PUNCT
ajlm-2688	53	81	california	california	PROPN
ajlm-2688	53	82	,	,	PUNCT
ajlm-2688	53	83	united	united	PROPN
ajlm-2688	53	84	states	states	PROPN
ajlm-2688	53	85	)	)	PUNCT
ajlm-2688	53	86	.	.	PUNCT
ajlm-2688	54	1	sample	sample	NOUN
ajlm-2688	54	2	analysis	analysis	NOUN
ajlm-2688	54	3	and	and	CCONJ
ajlm-2688	54	4	interpretation	interpretation	NOUN
ajlm-2688	54	5	analysis	analysis	NOUN
ajlm-2688	54	6	was	be	AUX
ajlm-2688	54	7	conducted	conduct	VERB
ajlm-2688	54	8	using	use	VERB
ajlm-2688	54	9	the	the	DET
ajlm-2688	54	10	bd	bd	PROPN
ajlm-2688	54	11	facsdiva	facsdiva	NOUN
ajlm-2688	54	12	™	™	ADJ
ajlm-2688	54	13	version	version	NOUN
ajlm-2688	54	14	8	8	NUM
ajlm-2688	54	15	(	(	PUNCT
ajlm-2688	54	16	bd	bd	PROPN
ajlm-2688	54	17	,	,	PUNCT
ajlm-2688	54	18	san	san	PROPN
ajlm-2688	54	19	jose	jose	PROPN
ajlm-2688	54	20	,	,	PUNCT
ajlm-2688	54	21	california	california	PROPN
ajlm-2688	54	22	,	,	PUNCT
ajlm-2688	54	23	united	united	PROPN
ajlm-2688	54	24	states	states	PROPN
ajlm-2688	54	25	)	)	PUNCT
ajlm-2688	54	26	and	and	CCONJ
ajlm-2688	54	27	infinicyt	infinicyt	VERB
ajlm-2688	54	28	™	™	ADJ
ajlm-2688	54	29	version	version	NOUN
ajlm-2688	54	30	2.0	2.0	NUM
ajlm-2688	54	31	(	(	PUNCT
ajlm-2688	54	32	cytognos	cytogno	NOUN
ajlm-2688	54	33	,	,	PUNCT
ajlm-2688	54	34	santa	santa	PROPN
ajlm-2688	54	35	marta	marta	PROPN
ajlm-2688	54	36	de	de	PROPN
ajlm-2688	54	37	tormes	tormes	PROPN
ajlm-2688	54	38	,	,	PUNCT
ajlm-2688	54	39	salamanca	salamanca	PROPN
ajlm-2688	54	40	,	,	PUNCT
ajlm-2688	54	41	spain	spain	PROPN
ajlm-2688	54	42	)	)	PUNCT
ajlm-2688	54	43	software	software	NOUN
ajlm-2688	54	44	.	.	PUNCT
ajlm-2688	55	1	the	the	DET
ajlm-2688	55	2	lymphocyte	lymphocyte	PROPN
ajlm-2688	55	3	gate	gate	NOUN
ajlm-2688	55	4	(	(	PUNCT
ajlm-2688	55	5	forward	forward	ADV
ajlm-2688	55	6	versus	versus	ADP
ajlm-2688	55	7	side	side	ADJ
ajlm-2688	55	8	light	light	NOUN
ajlm-2688	55	9	scatter	scatter	NOUN
ajlm-2688	55	10	)	)	PUNCT
ajlm-2688	55	11	,	,	PUNCT
ajlm-2688	55	12	cd45	cd45	PROPN
ajlm-2688	55	13	and	and	CCONJ
ajlm-2688	55	14	cd19	cd19	PROPN
ajlm-2688	55	15	against	against	ADP
ajlm-2688	55	16	side	side	NOUN
ajlm-2688	55	17	scatter	scatter	NOUN
ajlm-2688	55	18	were	be	AUX
ajlm-2688	55	19	employed	employ	VERB
ajlm-2688	55	20	for	for	ADP
ajlm-2688	55	21	gating	gate	VERB
ajlm-2688	55	22	.	.	PUNCT
ajlm-2688	56	1	normal	normal	ADJ
ajlm-2688	56	2	t	t	PROPN
ajlm-2688	56	3	-	-	PUNCT
ajlm-2688	56	4	lymphocytes	lymphocyte	NOUN
ajlm-2688	56	5	were	be	AUX
ajlm-2688	56	6	used	use	VERB
ajlm-2688	56	7	as	as	ADP
ajlm-2688	56	8	internal	internal	ADJ
ajlm-2688	56	9	negative	negative	ADJ
ajlm-2688	56	10	reference	reference	NOUN
ajlm-2688	56	11	populations	population	NOUN
ajlm-2688	56	12	(	(	PUNCT
ajlm-2688	56	13	nrp	nrp	NOUN
ajlm-2688	56	14	)	)	PUNCT
ajlm-2688	56	15	,	,	PUNCT
ajlm-2688	56	16	and	and	CCONJ
ajlm-2688	56	17	,	,	PUNCT
ajlm-2688	56	18	where	where	SCONJ
ajlm-2688	56	19	necessary	necessary	ADJ
ajlm-2688	56	20	,	,	PUNCT
ajlm-2688	56	21	with	with	ADP
ajlm-2688	56	22	markers	marker	NOUN
ajlm-2688	56	23	such	such	ADJ
ajlm-2688	56	24	as	as	ADP
ajlm-2688	56	25	cd5	cd5	PROPN
ajlm-2688	56	26	,	,	PUNCT
ajlm-2688	56	27	typically	typically	ADV
ajlm-2688	56	28	expressed	express	VERB
ajlm-2688	56	29	by	by	ADP
ajlm-2688	56	30	t	t	PROPN
ajlm-2688	56	31	-	-	PUNCT
ajlm-2688	56	32	cells	cell	NOUN
ajlm-2688	56	33	,	,	PUNCT
ajlm-2688	56	34	neutrophils	neutrophil	NOUN
ajlm-2688	56	35	were	be	AUX
ajlm-2688	56	36	employed	employ	VERB
ajlm-2688	56	37	as	as	ADP
ajlm-2688	56	38	the	the	DET
ajlm-2688	56	39	nrp	nrp	NOUN
ajlm-2688	56	40	.	.	PUNCT
ajlm-2688	57	1	positive	positive	ADJ
ajlm-2688	57	2	designation	designation	NOUN
ajlm-2688	57	3	for	for	ADP
ajlm-2688	57	4	markers	marker	NOUN
ajlm-2688	57	5	were	be	AUX
ajlm-2688	57	6	assigned	assign	VERB
ajlm-2688	57	7	if	if	SCONJ
ajlm-2688	57	8	expression	expression	NOUN
ajlm-2688	57	9	was	be	AUX
ajlm-2688	57	10	present	present	ADJ
ajlm-2688	57	11	in	in	ADP
ajlm-2688	57	12	>	>	X
ajlm-2688	57	13	20	20	NUM
ajlm-2688	57	14	%	%	NOUN
ajlm-2688	57	15	of	of	ADP
ajlm-2688	57	16	monotypic	monotypic	NOUN
ajlm-2688	57	17	b	b	NOUN
ajlm-2688	57	18	cells24,25,26	cells24,25,26	NOUN
ajlm-2688	57	19	or	or	CCONJ
ajlm-2688	57	20	when	when	SCONJ
ajlm-2688	57	21	the	the	DET
ajlm-2688	57	22	fluorescent	fluorescent	NOUN
ajlm-2688	57	23	signal	signal	NOUN
ajlm-2688	57	24	for	for	ADP
ajlm-2688	57	25	a	a	DET
ajlm-2688	57	26	particular	particular	ADJ
ajlm-2688	57	27	marker	marker	NOUN
ajlm-2688	57	28	was	be	AUX
ajlm-2688	57	29	greater	great	ADJ
ajlm-2688	57	30	than	than	ADP
ajlm-2688	57	31	that	that	PRON
ajlm-2688	57	32	of	of	ADP
ajlm-2688	57	33	the	the	DET
ajlm-2688	57	34	internal	internal	PROPN
ajlm-2688	57	35	nrp	nrp	PROPN
ajlm-2688	57	36	.	.	PUNCT
ajlm-2688	58	1	negative	negative	ADJ
ajlm-2688	58	2	staining	stain	VERB
ajlm-2688	58	3	was	be	AUX
ajlm-2688	58	4	assigned	assign	VERB
ajlm-2688	58	5	when	when	SCONJ
ajlm-2688	58	6	the	the	DET
ajlm-2688	58	7	fluorescence	fluorescence	NOUN
ajlm-2688	58	8	of	of	ADP
ajlm-2688	58	9	any	any	DET
ajlm-2688	58	10	given	give	VERB
ajlm-2688	58	11	marker	marker	NOUN
ajlm-2688	58	12	was	be	AUX
ajlm-2688	58	13	similar	similar	ADJ
ajlm-2688	58	14	to	to	ADP
ajlm-2688	58	15	that	that	PRON
ajlm-2688	58	16	of	of	ADP
ajlm-2688	58	17	the	the	DET
ajlm-2688	58	18	nrp	nrp	NOUN
ajlm-2688	58	19	(	(	PUNCT
ajlm-2688	58	20	qualitative	qualitative	VERB
ajlm-2688	58	21	assessment).22,26	assessment).22,26	PROPN
ajlm-2688	58	22	median	median	ADJ
ajlm-2688	58	23	fluorescence	fluorescence	NOUN
ajlm-2688	58	24	intensity	intensity	NOUN
ajlm-2688	58	25	,	,	PUNCT
ajlm-2688	58	26	and	and	CCONJ
ajlm-2688	58	27	specifically	specifically	ADV
ajlm-2688	58	28	mfi	mfi	PROPN
ajlm-2688	58	29	difference	difference	NOUN
ajlm-2688	58	30	,	,	PUNCT
ajlm-2688	58	31	that	that	ADV
ajlm-2688	58	32	is	is	ADV
ajlm-2688	58	33	,	,	PUNCT
ajlm-2688	58	34	the	the	DET
ajlm-2688	58	35	intensity	intensity	NOUN
ajlm-2688	58	36	of	of	ADP
ajlm-2688	58	37	expression	expression	NOUN
ajlm-2688	58	38	in	in	ADP
ajlm-2688	58	39	monotypic	monotypic	ADJ
ajlm-2688	58	40	b	b	PROPN
ajlm-2688	58	41	cells	cell	NOUN
ajlm-2688	58	42	compared	compare	VERB
ajlm-2688	58	43	to	to	ADP
ajlm-2688	58	44	that	that	PRON
ajlm-2688	58	45	of	of	ADP
ajlm-2688	58	46	the	the	DET
ajlm-2688	58	47	internal	internal	ADJ
ajlm-2688	58	48	reference	reference	NOUN
ajlm-2688	58	49	populations	population	NOUN
ajlm-2688	58	50	in	in	ADP
ajlm-2688	58	51	arbitrary	arbitrary	ADJ
ajlm-2688	58	52	units	unit	NOUN
ajlm-2688	58	53	provided	provide	VERB
ajlm-2688	58	54	by	by	ADP
ajlm-2688	58	55	the	the	DET
ajlm-2688	58	56	analysis	analysis	NOUN
ajlm-2688	58	57	software	software	NOUN
ajlm-2688	58	58	,	,	PUNCT
ajlm-2688	58	59	and	and	CCONJ
ajlm-2688	58	60	converted	convert	VERB
ajlm-2688	58	61	to	to	ADP
ajlm-2688	58	62	logarithms	logarithm	NOUN
ajlm-2688	58	63	,	,	PUNCT
ajlm-2688	58	64	was	be	AUX
ajlm-2688	58	65	used	use	VERB
ajlm-2688	58	66	for	for	ADP
ajlm-2688	58	67	quantitative	quantitative	ADJ
ajlm-2688	58	68	assessment	assessment	NOUN
ajlm-2688	58	69	.	.	PUNCT
ajlm-2688	59	1	table	table	NOUN
ajlm-2688	59	2	2	2	NUM
ajlm-2688	59	3	and	and	CCONJ
ajlm-2688	59	4	figure	figure	NOUN
ajlm-2688	59	5	2	2	NUM
ajlm-2688	59	6	represent	represent	VERB
ajlm-2688	59	7	an	an	DET
ajlm-2688	59	8	example	example	NOUN
ajlm-2688	59	9	of	of	ADP
ajlm-2688	59	10	the	the	DET
ajlm-2688	59	11	mfi	mfi	PROPN
ajlm-2688	59	12	measurements	measurement	NOUN
ajlm-2688	59	13	for	for	ADP
ajlm-2688	59	14	the	the	DET
ajlm-2688	59	15	different	different	ADJ
ajlm-2688	59	16	markers	marker	NOUN
ajlm-2688	59	17	in	in	ADP
ajlm-2688	59	18	one	one	NUM
ajlm-2688	59	19	cll	cll	PROPN
ajlm-2688	59	20	sample	sample	NOUN
ajlm-2688	59	21	.	.	PUNCT
ajlm-2688	60	1	table	table	NOUN
ajlm-2688	60	2	2	2	NUM
ajlm-2688	60	3	:	:	PUNCT
ajlm-2688	60	4	 	 	SPACE
ajlm-2688	60	5	an	an	DET
ajlm-2688	60	6	example	example	NOUN
ajlm-2688	60	7	of	of	ADP
ajlm-2688	60	8	the	the	DET
ajlm-2688	60	9	median	median	ADJ
ajlm-2688	60	10	fluorescence	fluorescence	NOUN
ajlm-2688	60	11	intensity	intensity	NOUN
ajlm-2688	60	12	measurements	measurement	NOUN
ajlm-2688	60	13	for	for	ADP
ajlm-2688	60	14	the	the	DET
ajlm-2688	60	15	different	different	ADJ
ajlm-2688	60	16	markers	marker	NOUN
ajlm-2688	60	17	in	in	ADP
ajlm-2688	60	18	one	one	NUM
ajlm-2688	60	19	sample	sample	NOUN
ajlm-2688	60	20	of	of	ADP
ajlm-2688	60	21	a	a	DET
ajlm-2688	60	22	patient	patient	NOUN
ajlm-2688	60	23	with	with	ADP
ajlm-2688	60	24	chronic	chronic	ADJ
ajlm-2688	60	25	lymphocytic	lymphocytic	ADJ
ajlm-2688	60	26	leukaemia	leukaemia	NOUN
ajlm-2688	60	27	at	at	ADP
ajlm-2688	60	28	universitas	universita	NOUN
ajlm-2688	60	29	academic	academic	ADJ
ajlm-2688	60	30	hospital	hospital	NOUN
ajlm-2688	60	31	,	,	PUNCT
ajlm-2688	60	32	bloemfontein	bloemfontein	PROPN
ajlm-2688	60	33	,	,	PUNCT
ajlm-2688	60	34	south	south	PROPN
ajlm-2688	60	35	africa	africa	PROPN
ajlm-2688	60	36	,	,	PUNCT
ajlm-2688	60	37	january	january	PROPN
ajlm-2688	60	38	2022	2022	NUM
ajlm-2688	60	39	to	to	ADP
ajlm-2688	60	40	march	march	PROPN
ajlm-2688	60	41	2023	2023	NUM
ajlm-2688	60	42	.	.	PUNCT
ajlm-2688	61	1	figure	figure	NOUN
ajlm-2688	61	2	2	2	NUM
ajlm-2688	61	3	:	:	PUNCT
ajlm-2688	61	4	example	example	NOUN
ajlm-2688	61	5	of	of	ADP
ajlm-2688	61	6	change	change	NOUN
ajlm-2688	61	7	in	in	ADP
ajlm-2688	61	8	median	median	ADJ
ajlm-2688	61	9	fluorescence	fluorescence	NOUN
ajlm-2688	61	10	intensity	intensity	NOUN
ajlm-2688	61	11	of	of	ADP
ajlm-2688	61	12	one	one	NUM
ajlm-2688	61	13	subject	subject	NOUN
ajlm-2688	61	14	from	from	ADP
ajlm-2688	61	15	baseline	baseline	PROPN
ajlm-2688	61	16	(	(	PUNCT
ajlm-2688	61	17	dotted	dotted	ADJ
ajlm-2688	61	18	histogram	histogram	NOUN
ajlm-2688	61	19	)	)	PUNCT
ajlm-2688	61	20	compared	compare	VERB
ajlm-2688	61	21	to	to	ADP
ajlm-2688	61	22	96	96	NUM
ajlm-2688	61	23	h	h	NOUN
ajlm-2688	61	24	(	(	PUNCT
ajlm-2688	61	25	solid	solid	ADJ
ajlm-2688	61	26	histogram	histogram	NOUN
ajlm-2688	61	27	)	)	PUNCT
ajlm-2688	61	28	at	at	ADP
ajlm-2688	61	29	universitas	universitas	PROPN
ajlm-2688	61	30	academic	academic	ADJ
ajlm-2688	61	31	hospital	hospital	NOUN
ajlm-2688	61	32	,	,	PUNCT
ajlm-2688	61	33	bloemfontein	bloemfontein	PROPN
ajlm-2688	61	34	,	,	PUNCT
ajlm-2688	61	35	south	south	PROPN
ajlm-2688	61	36	africa	africa	PROPN
ajlm-2688	61	37	,	,	PUNCT
ajlm-2688	61	38	january	january	PROPN
ajlm-2688	61	39	2022	2022	NUM
ajlm-2688	61	40	to	to	ADP
ajlm-2688	61	41	march	march	PROPN
ajlm-2688	61	42	2023	2023	NUM
ajlm-2688	61	43	.	.	PUNCT
ajlm-2688	62	1	in	in	ADP
ajlm-2688	62	2	addition	addition	NOUN
ajlm-2688	62	3	to	to	ADP
ajlm-2688	62	4	the	the	DET
ajlm-2688	62	5	positive	positive	ADJ
ajlm-2688	62	6	or	or	CCONJ
ajlm-2688	62	7	negative	negative	ADJ
ajlm-2688	62	8	designation	designation	NOUN
ajlm-2688	62	9	,	,	PUNCT
ajlm-2688	62	10	markers	marker	NOUN
ajlm-2688	62	11	were	be	AUX
ajlm-2688	62	12	further	far	ADV
ajlm-2688	62	13	described	describe	VERB
ajlm-2688	62	14	according	accord	VERB
ajlm-2688	62	15	to	to	ADP
ajlm-2688	62	16	the	the	DET
ajlm-2688	62	17	intensity	intensity	NOUN
ajlm-2688	62	18	of	of	ADP
ajlm-2688	62	19	the	the	DET
ajlm-2688	62	20	positive	positive	ADJ
ajlm-2688	62	21	signal	signal	NOUN
ajlm-2688	62	22	as	as	ADP
ajlm-2688	62	23	either	either	CCONJ
ajlm-2688	62	24	dim	dim	ADJ
ajlm-2688	62	25	,	,	PUNCT
ajlm-2688	62	26	moderate	moderate	ADJ
ajlm-2688	62	27	,	,	PUNCT
ajlm-2688	62	28	bright	bright	ADJ
ajlm-2688	62	29	or	or	CCONJ
ajlm-2688	62	30	variable	variable	ADJ
ajlm-2688	62	31	by	by	ADP
ajlm-2688	62	32	comparing	compare	VERB
ajlm-2688	62	33	the	the	DET
ajlm-2688	62	34	fluorescent	fluorescent	NOUN
ajlm-2688	62	35	signal	signal	NOUN
ajlm-2688	62	36	,	,	PUNCT
ajlm-2688	62	37	expressed	express	VERB
ajlm-2688	62	38	in	in	ADP
ajlm-2688	62	39	logarithms	logarithm	NOUN
ajlm-2688	62	40	,	,	PUNCT
ajlm-2688	62	41	of	of	ADP
ajlm-2688	62	42	each	each	DET
ajlm-2688	62	43	marker	marker	NOUN
ajlm-2688	62	44	to	to	ADP
ajlm-2688	62	45	the	the	DET
ajlm-2688	62	46	nrp	nrp	NOUN
ajlm-2688	62	47	.	.	PUNCT
ajlm-2688	63	1	dim	dim	ADJ
ajlm-2688	63	2	staining	stain	VERB
ajlm-2688	63	3	was	be	AUX
ajlm-2688	63	4	defined	define	VERB
ajlm-2688	63	5	as	as	ADP
ajlm-2688	63	6	mildly	mildly	ADV
ajlm-2688	63	7	increased	increase	VERB
ajlm-2688	63	8	when	when	SCONJ
ajlm-2688	63	9	compared	compare	VERB
ajlm-2688	63	10	to	to	ADP
ajlm-2688	63	11	the	the	DET
ajlm-2688	63	12	nrp	nrp	NOUN
ajlm-2688	63	13	(	(	PUNCT
ajlm-2688	63	14	less	less	ADJ
ajlm-2688	63	15	than	than	ADP
ajlm-2688	63	16	one	one	NUM
ajlm-2688	63	17	logarithm	logarithm	NOUN
ajlm-2688	63	18	brighter	bright	ADJ
ajlm-2688	63	19	than	than	ADP
ajlm-2688	63	20	the	the	DET
ajlm-2688	63	21	nrp	nrp	NOUN
ajlm-2688	63	22	)	)	PUNCT
ajlm-2688	63	23	.	.	PUNCT
ajlm-2688	64	1	moderate	moderate	ADJ
ajlm-2688	64	2	staining	stain	VERB
ajlm-2688	64	3	was	be	AUX
ajlm-2688	64	4	at	at	ADP
ajlm-2688	64	5	least	least	ADJ
ajlm-2688	64	6	one	one	NUM
ajlm-2688	64	7	logarithm	logarithm	NOUN
ajlm-2688	64	8	brighter	bright	ADJ
ajlm-2688	64	9	than	than	ADP
ajlm-2688	64	10	the	the	DET
ajlm-2688	64	11	nrp	nrp	NOUN
ajlm-2688	64	12	,	,	PUNCT
ajlm-2688	64	13	and	and	CCONJ
ajlm-2688	64	14	bright	bright	ADJ
ajlm-2688	64	15	staining	stain	VERB
ajlm-2688	64	16	was	be	AUX
ajlm-2688	64	17	defined	define	VERB
ajlm-2688	64	18	as	as	ADP
ajlm-2688	64	19	at	at	ADV
ajlm-2688	64	20	least	least	ADV
ajlm-2688	64	21	two	two	NUM
ajlm-2688	64	22	logarithms	logarithm	NOUN
ajlm-2688	64	23	brighter	bright	ADJ
ajlm-2688	64	24	than	than	ADP
ajlm-2688	64	25	the	the	DET
ajlm-2688	64	26	nrp	nrp	NOUN
ajlm-2688	64	27	(	(	PUNCT
ajlm-2688	64	28	table	table	NOUN
ajlm-2688	64	29	2).26	2).26	NUM
ajlm-2688	64	30	two	two	NUM
ajlm-2688	64	31	cll	cll	PROPN
ajlm-2688	64	32	scoring	scoring	NOUN
ajlm-2688	64	33	systems	system	NOUN
ajlm-2688	64	34	,	,	PUNCT
ajlm-2688	64	35	the	the	DET
ajlm-2688	64	36	moreau	moreau	PROPN
ajlm-2688	64	37	score	score	NOUN
ajlm-2688	64	38	and	and	CCONJ
ajlm-2688	64	39	the	the	DET
ajlm-2688	64	40	adapted	adapt	VERB
ajlm-2688	64	41	matutes	matute	NOUN
ajlm-2688	64	42	score	score	NOUN
ajlm-2688	64	43	,	,	PUNCT
ajlm-2688	64	44	were	be	AUX
ajlm-2688	64	45	applied	apply	VERB
ajlm-2688	64	46	to	to	ADP
ajlm-2688	64	47	the	the	DET
ajlm-2688	64	48	flow	flow	NOUN
ajlm-2688	64	49	cytometric	cytometric	ADJ
ajlm-2688	64	50	data	datum	NOUN
ajlm-2688	64	51	for	for	ADP
ajlm-2688	64	52	the	the	DET
ajlm-2688	64	53	various	various	ADJ
ajlm-2688	64	54	intervals	interval	NOUN
ajlm-2688	64	55	and	and	CCONJ
ajlm-2688	64	56	temperatures	temperature	NOUN
ajlm-2688	64	57	to	to	PART
ajlm-2688	64	58	determine	determine	VERB
ajlm-2688	64	59	a	a	DET
ajlm-2688	64	60	change	change	NOUN
ajlm-2688	64	61	in	in	ADP
ajlm-2688	64	62	the	the	DET
ajlm-2688	64	63	diagnosis	diagnosis	NOUN
ajlm-2688	64	64	from	from	ADP
ajlm-2688	64	65	cll	cll	PROPN
ajlm-2688	64	66	(	(	PUNCT
ajlm-2688	64	67	table	table	NOUN
ajlm-2688	64	68	3).1,4,6,10	3).1,4,6,10	NUM
ajlm-2688	64	69	the	the	DET
ajlm-2688	64	70	diagnosis	diagnosis	NOUN
ajlm-2688	64	71	of	of	ADP
ajlm-2688	64	72	cll	cll	PROPN
ajlm-2688	64	73	,	,	PUNCT
ajlm-2688	64	74	employing	employ	VERB
ajlm-2688	64	75	the	the	DET
ajlm-2688	64	76	moreau	moreau	PROPN
ajlm-2688	64	77	and	and	CCONJ
ajlm-2688	64	78	the	the	DET
ajlm-2688	64	79	adapted	adapt	VERB
ajlm-2688	64	80	matutes	matute	NOUN
ajlm-2688	64	81	scores	score	NOUN
ajlm-2688	64	82	,	,	PUNCT
ajlm-2688	64	83	necessitates	necessitate	VERB
ajlm-2688	64	84	the	the	DET
ajlm-2688	64	85	observation	observation	NOUN
ajlm-2688	64	86	of	of	ADP
ajlm-2688	64	87	dim	dim	ADJ
ajlm-2688	64	88	(	(	PUNCT
ajlm-2688	64	89	1	1	NUM
ajlm-2688	64	90	point	point	NOUN
ajlm-2688	64	91	)	)	PUNCT
ajlm-2688	64	92	or	or	CCONJ
ajlm-2688	64	93	bright	bright	ADJ
ajlm-2688	64	94	(	(	PUNCT
ajlm-2688	64	95	0	0	NUM
ajlm-2688	64	96	points	point	NOUN
ajlm-2688	64	97	)	)	PUNCT
ajlm-2688	64	98	expression	expression	NOUN
ajlm-2688	64	99	of	of	ADP
ajlm-2688	64	100	certain	certain	ADJ
ajlm-2688	64	101	markers	marker	NOUN
ajlm-2688	64	102	(	(	PUNCT
ajlm-2688	64	103	sig	sig	NOUN
ajlm-2688	64	104	and	and	CCONJ
ajlm-2688	64	105	cd79b	cd79b	ADJ
ajlm-2688	64	106	)	)	PUNCT
ajlm-2688	64	107	.	.	PUNCT
ajlm-2688	65	1	consequently	consequently	ADV
ajlm-2688	65	2	,	,	PUNCT
ajlm-2688	65	3	instances	instance	NOUN
ajlm-2688	65	4	of	of	ADP
ajlm-2688	65	5	transition	transition	NOUN
ajlm-2688	65	6	to	to	ADP
ajlm-2688	65	7	moderate	moderate	ADJ
ajlm-2688	65	8	expression	expression	NOUN
ajlm-2688	65	9	did	do	AUX
ajlm-2688	65	10	not	not	PART
ajlm-2688	65	11	result	result	VERB
ajlm-2688	65	12	in	in	ADP
ajlm-2688	65	13	point	point	NOUN
ajlm-2688	65	14	deduction	deduction	NOUN
ajlm-2688	65	15	within	within	ADP
ajlm-2688	65	16	the	the	DET
ajlm-2688	65	17	scoring	scoring	NOUN
ajlm-2688	65	18	framework	framework	NOUN
ajlm-2688	65	19	.	.	PUNCT
ajlm-2688	66	1	table	table	NOUN
ajlm-2688	66	2	3	3	NUM
ajlm-2688	66	3	:	:	PUNCT
ajlm-2688	66	4	 	 	SPACE
ajlm-2688	66	5	modified	modify	VERB
ajlm-2688	66	6	matutes	matute	NOUN
ajlm-2688	66	7	/	/	SYM
ajlm-2688	66	8	moreau	moreau	PROPN
ajlm-2688	66	9	and	and	CCONJ
ajlm-2688	66	10	adapted	adapt	VERB
ajlm-2688	66	11	matutes	matute	NOUN
ajlm-2688	66	12	scores	score	NOUN
ajlm-2688	66	13	for	for	ADP
ajlm-2688	66	14	the	the	DET
ajlm-2688	66	15	diagnosis	diagnosis	NOUN
ajlm-2688	66	16	of	of	ADP
ajlm-2688	66	17	chronic	chronic	ADJ
ajlm-2688	66	18	lymphocytic	lymphocytic	ADJ
ajlm-2688	66	19	leukemia	leukemia	NOUN
ajlm-2688	66	20	at	at	ADP
ajlm-2688	66	21	universitas	universita	NOUN
ajlm-2688	66	22	academic	academic	ADJ
ajlm-2688	66	23	hospital	hospital	NOUN
ajlm-2688	66	24	,	,	PUNCT
ajlm-2688	66	25	bloemfontein	bloemfontein	PROPN
ajlm-2688	66	26	,	,	PUNCT
ajlm-2688	66	27	south	south	PROPN
ajlm-2688	66	28	africa	africa	PROPN
ajlm-2688	66	29	,	,	PUNCT
ajlm-2688	66	30	january	january	PROPN
ajlm-2688	66	31	2022	2022	NUM
ajlm-2688	66	32	to	to	ADP
ajlm-2688	66	33	march	march	PROPN
ajlm-2688	66	34	2023	2023	NUM
ajlm-2688	66	35	.	.	PUNCT
ajlm-2688	67	1	data	datum	NOUN
ajlm-2688	67	2	analysis	analysis	NOUN
ajlm-2688	67	3	to	to	PART
ajlm-2688	67	4	assess	assess	VERB
ajlm-2688	67	5	whether	whether	SCONJ
ajlm-2688	67	6	the	the	DET
ajlm-2688	67	7	mfi	mfi	PROPN
ajlm-2688	67	8	difference	difference	NOUN
ajlm-2688	67	9	observed	observe	VERB
ajlm-2688	67	10	at	at	ADP
ajlm-2688	67	11	24	24	NUM
ajlm-2688	67	12	h	h	NOUN
ajlm-2688	67	13	,	,	PUNCT
ajlm-2688	67	14	48	48	NUM
ajlm-2688	67	15	h	h	NOUN
ajlm-2688	67	16	,	,	PUNCT
ajlm-2688	67	17	72	72	NUM
ajlm-2688	67	18	h	h	NOUN
ajlm-2688	67	19	or	or	CCONJ
ajlm-2688	67	20	96	96	NUM
ajlm-2688	67	21	h	h	NOUN
ajlm-2688	67	22	during	during	ADP
ajlm-2688	67	23	storage	storage	NOUN
ajlm-2688	67	24	of	of	ADP
ajlm-2688	67	25	the	the	DET
ajlm-2688	67	26	blood	blood	NOUN
ajlm-2688	67	27	samples	sample	NOUN
ajlm-2688	67	28	at	at	ADP
ajlm-2688	67	29	rt	rt	PROPN
ajlm-2688	67	30	or	or	CCONJ
ajlm-2688	67	31	4	4	NUM
ajlm-2688	67	32	°	°	NOUN
ajlm-2688	67	33	c	c	NOUN
ajlm-2688	67	34	were	be	AUX
ajlm-2688	67	35	different	different	ADJ
ajlm-2688	67	36	from	from	ADP
ajlm-2688	67	37	their	their	PRON
ajlm-2688	67	38	initial	initial	ADJ
ajlm-2688	67	39	baseline	baseline	NOUN
ajlm-2688	67	40	values	value	NOUN
ajlm-2688	67	41	(	(	PUNCT
ajlm-2688	67	42	at	at	ADP
ajlm-2688	67	43	<	<	X
ajlm-2688	67	44	12	12	NUM
ajlm-2688	67	45	h	h	NOUN
ajlm-2688	67	46	,	,	PUNCT
ajlm-2688	67	47	rt	rt	PROPN
ajlm-2688	67	48	)	)	PUNCT
ajlm-2688	67	49	,	,	PUNCT
ajlm-2688	67	50	a	a	DET
ajlm-2688	67	51	two	two	NUM
ajlm-2688	67	52	-	-	PUNCT
ajlm-2688	67	53	factor	factor	NOUN
ajlm-2688	67	54	analysis	analysis	NOUN
ajlm-2688	67	55	of	of	ADP
ajlm-2688	67	56	variance	variance	NOUN
ajlm-2688	67	57	was	be	AUX
ajlm-2688	67	58	used	use	VERB
ajlm-2688	67	59	.	.	PUNCT
ajlm-2688	68	1	when	when	SCONJ
ajlm-2688	68	2	the	the	DET
ajlm-2688	68	3	two	two	NUM
ajlm-2688	68	4	-	-	PUNCT
ajlm-2688	68	5	factor	factor	NOUN
ajlm-2688	68	6	analysis	analysis	NOUN
ajlm-2688	68	7	of	of	ADP
ajlm-2688	68	8	variance	variance	NOUN
ajlm-2688	68	9	test	test	NOUN
ajlm-2688	68	10	showed	show	VERB
ajlm-2688	68	11	significant	significant	ADJ
ajlm-2688	68	12	changes	change	NOUN
ajlm-2688	68	13	,	,	PUNCT
ajlm-2688	68	14	a	a	DET
ajlm-2688	68	15	post	post	ADJ
ajlm-2688	68	16	-	-	ADJ
ajlm-2688	68	17	hoc	hoc	ADJ
ajlm-2688	68	18	two	two	NUM
ajlm-2688	68	19	-	-	PUNCT
ajlm-2688	68	20	tailed	tail	VERB
ajlm-2688	68	21	t	t	NOUN
ajlm-2688	68	22	-	-	PUNCT
ajlm-2688	68	23	test	test	NOUN
ajlm-2688	68	24	was	be	AUX
ajlm-2688	68	25	used	use	VERB
ajlm-2688	68	26	to	to	PART
ajlm-2688	68	27	determine	determine	VERB
ajlm-2688	68	28	which	which	DET
ajlm-2688	68	29	pairwise	pairwise	NOUN
ajlm-2688	68	30	comparison	comparison	NOUN
ajlm-2688	68	31	of	of	ADP
ajlm-2688	68	32	means	mean	NOUN
ajlm-2688	68	33	(	(	PUNCT
ajlm-2688	68	34	storage	storage	NOUN
ajlm-2688	68	35	time	time	NOUN
ajlm-2688	68	36	versus	versus	ADP
ajlm-2688	68	37	storage	storage	NOUN
ajlm-2688	68	38	temperature	temperature	NOUN
ajlm-2688	68	39	)	)	PUNCT
ajlm-2688	68	40	contributed	contribute	VERB
ajlm-2688	68	41	to	to	ADP
ajlm-2688	68	42	the	the	DET
ajlm-2688	68	43	overall	overall	ADJ
ajlm-2688	68	44	significant	significant	ADJ
ajlm-2688	68	45	difference	difference	NOUN
ajlm-2688	68	46	.	.	PUNCT
ajlm-2688	69	1	analysis	analysis	NOUN
ajlm-2688	69	2	was	be	AUX
ajlm-2688	69	3	performed	perform	VERB
ajlm-2688	69	4	using	use	VERB
ajlm-2688	69	5	microsoft	microsoft	PROPN
ajlm-2688	69	6	®	®	PROPN
ajlm-2688	69	7	excel	excel	NOUN
ajlm-2688	69	8	®	®	PROPN
ajlm-2688	69	9	(	(	PUNCT
ajlm-2688	69	10	microsoft	microsoft	PROPN
ajlm-2688	69	11	corporation	corporation	PROPN
ajlm-2688	69	12	,	,	PUNCT
ajlm-2688	69	13	redmond	redmond	PROPN
ajlm-2688	69	14	,	,	PUNCT
ajlm-2688	69	15	washington	washington	PROPN
ajlm-2688	69	16	,	,	PUNCT
ajlm-2688	69	17	united	united	PROPN
ajlm-2688	69	18	states	states	PROPN
ajlm-2688	69	19	)	)	PUNCT
ajlm-2688	69	20	.	.	PUNCT
ajlm-2688	70	1	results	result	NOUN
ajlm-2688	70	2	samples	sample	NOUN
ajlm-2688	70	3	included	include	VERB
ajlm-2688	70	4	twelve	twelve	NUM
ajlm-2688	70	5	samples	sample	NOUN
ajlm-2688	70	6	were	be	AUX
ajlm-2688	70	7	initially	initially	ADV
ajlm-2688	70	8	screened	screen	VERB
ajlm-2688	70	9	,	,	PUNCT
ajlm-2688	70	10	although	although	SCONJ
ajlm-2688	70	11	only	only	ADV
ajlm-2688	70	12	10	10	NUM
ajlm-2688	70	13	samples	sample	NOUN
ajlm-2688	70	14	were	be	AUX
ajlm-2688	70	15	included	include	VERB
ajlm-2688	70	16	in	in	ADP
ajlm-2688	70	17	the	the	DET
ajlm-2688	70	18	final	final	ADJ
ajlm-2688	70	19	analysis	analysis	NOUN
ajlm-2688	70	20	.	.	PUNCT
ajlm-2688	71	1	two	two	NUM
ajlm-2688	71	2	samples	sample	NOUN
ajlm-2688	71	3	were	be	AUX
ajlm-2688	71	4	excluded	exclude	VERB
ajlm-2688	71	5	because	because	SCONJ
ajlm-2688	71	6	of	of	ADP
ajlm-2688	71	7	‘	'	PUNCT
ajlm-2688	71	8	atypical	atypical	ADJ
ajlm-2688	71	9	’	'	PUNCT
ajlm-2688	71	10	cll	cll	PROPN
ajlm-2688	71	11	scores	score	NOUN
ajlm-2688	71	12	calculated	calculate	VERB
ajlm-2688	71	13	at	at	ADP
ajlm-2688	71	14	baseline	baseline	NOUN
ajlm-2688	71	15	.	.	PUNCT
ajlm-2688	72	1	median	median	ADJ
ajlm-2688	72	2	fluorescence	fluorescence	NOUN
ajlm-2688	72	3	intensity	intensity	NOUN
ajlm-2688	72	4	and	and	CCONJ
ajlm-2688	72	5	median	median	ADJ
ajlm-2688	72	6	fluorescence	fluorescence	NOUN
ajlm-2688	72	7	intensity	intensity	NOUN
ajlm-2688	72	8	difference	difference	NOUN
ajlm-2688	72	9	irrespective	irrespective	ADV
ajlm-2688	72	10	of	of	ADP
ajlm-2688	72	11	storage	storage	NOUN
ajlm-2688	72	12	temperature	temperature	NOUN
ajlm-2688	72	13	,	,	PUNCT
ajlm-2688	72	14	some	some	DET
ajlm-2688	72	15	markers	marker	NOUN
ajlm-2688	72	16	,	,	PUNCT
ajlm-2688	72	17	including	include	VERB
ajlm-2688	72	18	cd23	cd23	PROPN
ajlm-2688	72	19	,	,	PUNCT
ajlm-2688	72	20	cd200	cd200	PROPN
ajlm-2688	72	21	and	and	CCONJ
ajlm-2688	72	22	sigm	sigm	NOUN
ajlm-2688	72	23	,	,	PUNCT
ajlm-2688	72	24	showed	show	VERB
ajlm-2688	72	25	>	>	X
ajlm-2688	72	26	10	10	NUM
ajlm-2688	72	27	%	%	NOUN
ajlm-2688	72	28	decrease	decrease	NOUN
ajlm-2688	72	29	in	in	ADP
ajlm-2688	72	30	mfi	mfi	PROPN
ajlm-2688	72	31	difference	difference	NOUN
ajlm-2688	72	32	(	(	PUNCT
ajlm-2688	72	33	cd23	cd23	PROPN
ajlm-2688	72	34	:	:	PUNCT
ajlm-2688	72	35	p	p	X
ajlm-2688	72	36	=	=	NOUN
ajlm-2688	72	37	0.003	0.003	NUM
ajlm-2688	72	38	;	;	PUNCT
ajlm-2688	72	39	cd200	cd200	PROPN
ajlm-2688	72	40	:	:	PUNCT
ajlm-2688	73	1	p	p	X
ajlm-2688	73	2	=	=	NOUN
ajlm-2688	73	3	0.005	0.005	NUM
ajlm-2688	73	4	;	;	PUNCT
ajlm-2688	73	5	and	and	CCONJ
ajlm-2688	73	6	sigm	sigm	NOUN
ajlm-2688	73	7	:	:	PUNCT
ajlm-2688	73	8	p	p	X
ajlm-2688	73	9	=	=	NOUN
ajlm-2688	73	10	0.07	0.07	NUM
ajlm-2688	73	11	)	)	PUNCT
ajlm-2688	73	12	already	already	ADV
ajlm-2688	73	13	at	at	ADP
ajlm-2688	73	14	24	24	NUM
ajlm-2688	73	15	h.	h.	NOUN
ajlm-2688	73	16	the	the	DET
ajlm-2688	73	17	markers	marker	NOUN
ajlm-2688	73	18	that	that	PRON
ajlm-2688	73	19	did	do	AUX
ajlm-2688	73	20	not	not	PART
ajlm-2688	73	21	show	show	VERB
ajlm-2688	73	22	a	a	DET
ajlm-2688	73	23	significant	significant	ADJ
ajlm-2688	73	24	change	change	NOUN
ajlm-2688	73	25	in	in	ADP
ajlm-2688	73	26	mfi	mfi	PROPN
ajlm-2688	73	27	difference	difference	NOUN
ajlm-2688	73	28	in	in	ADP
ajlm-2688	73	29	relation	relation	NOUN
ajlm-2688	73	30	to	to	ADP
ajlm-2688	73	31	time	time	NOUN
ajlm-2688	73	32	or	or	CCONJ
ajlm-2688	73	33	storage	storage	NOUN
ajlm-2688	73	34	temperature	temperature	NOUN
ajlm-2688	73	35	were	be	AUX
ajlm-2688	73	36	cd20	cd20	PROPN
ajlm-2688	73	37	,	,	PUNCT
ajlm-2688	73	38	cd79b	cd79b	ADJ
ajlm-2688	73	39	,	,	PUNCT
ajlm-2688	73	40	skappa	skappa	ADJ
ajlm-2688	73	41	and	and	CCONJ
ajlm-2688	73	42	slambda	slambda	ADJ
ajlm-2688	73	43	.	.	PUNCT
ajlm-2688	74	1	at	at	ADP
ajlm-2688	74	2	rt	rt	PROPN
ajlm-2688	74	3	,	,	PUNCT
ajlm-2688	74	4	the	the	DET
ajlm-2688	74	5	mfi	mfi	PROPN
ajlm-2688	74	6	difference	difference	NOUN
ajlm-2688	74	7	for	for	ADP
ajlm-2688	74	8	cd5	cd5	PROPN
ajlm-2688	74	9	showed	show	VERB
ajlm-2688	74	10	a	a	DET
ajlm-2688	74	11	statistically	statistically	ADV
ajlm-2688	74	12	significant	significant	ADJ
ajlm-2688	74	13	decrease	decrease	NOUN
ajlm-2688	74	14	only	only	ADV
ajlm-2688	74	15	at	at	ADP
ajlm-2688	74	16	96	96	NUM
ajlm-2688	74	17	h	h	NOUN
ajlm-2688	74	18	(	(	PUNCT
ajlm-2688	74	19	p	p	X
ajlm-2688	74	20	=	=	NOUN
ajlm-2688	74	21	0.028	0.028	NUM
ajlm-2688	74	22	)	)	PUNCT
ajlm-2688	74	23	,	,	PUNCT
ajlm-2688	74	24	whereas	whereas	SCONJ
ajlm-2688	74	25	the	the	DET
ajlm-2688	74	26	samples	sample	NOUN
ajlm-2688	74	27	kept	keep	VERB
ajlm-2688	74	28	at	at	ADP
ajlm-2688	74	29	4	4	NUM
ajlm-2688	74	30	°	°	NOUN
ajlm-2688	74	31	c	c	NOUN
ajlm-2688	74	32	showed	show	VERB
ajlm-2688	74	33	no	no	DET
ajlm-2688	74	34	significant	significant	ADJ
ajlm-2688	74	35	change	change	NOUN
ajlm-2688	74	36	in	in	ADP
ajlm-2688	74	37	mfi	mfi	PROPN
ajlm-2688	74	38	difference	difference	NOUN
ajlm-2688	74	39	over	over	ADP
ajlm-2688	74	40	time	time	NOUN
ajlm-2688	74	41	(	(	PUNCT
ajlm-2688	74	42	p	p	NOUN
ajlm-2688	74	43	=	=	NOUN
ajlm-2688	74	44	0.08	0.08	NUM
ajlm-2688	74	45	at	at	ADP
ajlm-2688	74	46	96	96	NUM
ajlm-2688	74	47	h	h	NOUN
ajlm-2688	74	48	)	)	PUNCT
ajlm-2688	74	49	.	.	PUNCT
ajlm-2688	75	1	cd23	cd23	PROPN
ajlm-2688	75	2	showed	show	VERB
ajlm-2688	75	3	statistically	statistically	ADV
ajlm-2688	75	4	significant	significant	ADJ
ajlm-2688	75	5	changes	change	NOUN
ajlm-2688	75	6	with	with	ADP
ajlm-2688	75	7	storage	storage	NOUN
ajlm-2688	75	8	time	time	NOUN
ajlm-2688	75	9	(	(	PUNCT
ajlm-2688	75	10	p	p	NOUN
ajlm-2688	75	11	≤	≤	NUM
ajlm-2688	75	12	0.001	0.001	NUM
ajlm-2688	75	13	)	)	PUNCT
ajlm-2688	75	14	and	and	CCONJ
ajlm-2688	75	15	storage	storage	NOUN
ajlm-2688	75	16	temperature	temperature	NOUN
ajlm-2688	75	17	(	(	PUNCT
ajlm-2688	75	18	p	p	NOUN
ajlm-2688	75	19	=	=	NOUN
ajlm-2688	75	20	0.025	0.025	NUM
ajlm-2688	75	21	)	)	PUNCT
ajlm-2688	75	22	,	,	PUNCT
ajlm-2688	75	23	with	with	ADP
ajlm-2688	75	24	a	a	DET
ajlm-2688	75	25	decrease	decrease	NOUN
ajlm-2688	75	26	in	in	ADP
ajlm-2688	75	27	the	the	DET
ajlm-2688	75	28	mfi	mfi	PROPN
ajlm-2688	75	29	difference	difference	NOUN
ajlm-2688	75	30	of	of	ADP
ajlm-2688	75	31	>	>	X
ajlm-2688	75	32	15	15	NUM
ajlm-2688	75	33	%	%	NOUN
ajlm-2688	75	34	from	from	ADP
ajlm-2688	75	35	baseline	baseline	NOUN
ajlm-2688	75	36	already	already	ADV
ajlm-2688	75	37	at	at	ADP
ajlm-2688	75	38	24	24	NUM
ajlm-2688	75	39	h	h	NOUN
ajlm-2688	75	40	for	for	ADP
ajlm-2688	75	41	both	both	DET
ajlm-2688	75	42	rt	rt	PROPN
ajlm-2688	75	43	(	(	PUNCT
ajlm-2688	75	44	p	p	X
ajlm-2688	75	45	=	=	NOUN
ajlm-2688	75	46	0.015	0.015	NUM
ajlm-2688	75	47	)	)	PUNCT
ajlm-2688	75	48	and	and	CCONJ
ajlm-2688	75	49	4	4	NUM
ajlm-2688	75	50	°	°	NOUN
ajlm-2688	75	51	c	c	NOUN
ajlm-2688	75	52	(	(	PUNCT
ajlm-2688	75	53	p	p	X
ajlm-2688	75	54	=	=	NOUN
ajlm-2688	75	55	0.032	0.032	NUM
ajlm-2688	75	56	)	)	PUNCT
ajlm-2688	75	57	.	.	PUNCT
ajlm-2688	76	1	cd200	cd200	PROPN
ajlm-2688	76	2	was	be	AUX
ajlm-2688	76	3	more	more	ADV
ajlm-2688	76	4	sensitive	sensitive	ADJ
ajlm-2688	76	5	to	to	ADP
ajlm-2688	76	6	time	time	NOUN
ajlm-2688	76	7	(	(	PUNCT
ajlm-2688	76	8	p	p	NOUN
ajlm-2688	76	9	=	=	NOUN
ajlm-2688	76	10	0.05	0.05	NUM
ajlm-2688	76	11	)	)	PUNCT
ajlm-2688	76	12	compared	compare	VERB
ajlm-2688	76	13	to	to	ADP
ajlm-2688	76	14	temperature	temperature	NOUN
ajlm-2688	76	15	(	(	PUNCT
ajlm-2688	76	16	p	p	NOUN
ajlm-2688	76	17	=	=	NOUN
ajlm-2688	76	18	0.07	0.07	NUM
ajlm-2688	76	19	)	)	PUNCT
ajlm-2688	76	20	,	,	PUNCT
ajlm-2688	76	21	with	with	ADP
ajlm-2688	76	22	>	>	X
ajlm-2688	76	23	25	25	NUM
ajlm-2688	76	24	%	%	NOUN
ajlm-2688	76	25	decrease	decrease	NOUN
ajlm-2688	76	26	in	in	ADP
ajlm-2688	76	27	mfi	mfi	PROPN
ajlm-2688	76	28	difference	difference	NOUN
ajlm-2688	76	29	at	at	ADP
ajlm-2688	76	30	48	48	NUM
ajlm-2688	76	31	h	h	NOUN
ajlm-2688	76	32	(	(	PUNCT
ajlm-2688	76	33	p	p	X
ajlm-2688	76	34	=	=	NOUN
ajlm-2688	76	35	0.013	0.013	NUM
ajlm-2688	76	36	)	)	PUNCT
ajlm-2688	76	37	in	in	ADP
ajlm-2688	76	38	the	the	DET
ajlm-2688	76	39	rt	rt	PROPN
ajlm-2688	76	40	samples	sample	NOUN
ajlm-2688	76	41	.	.	PUNCT
ajlm-2688	77	1	however	however	ADV
ajlm-2688	77	2	,	,	PUNCT
ajlm-2688	77	3	the	the	DET
ajlm-2688	77	4	samples	sample	NOUN
ajlm-2688	77	5	kept	keep	VERB
ajlm-2688	77	6	at	at	ADP
ajlm-2688	77	7	4	4	NUM
ajlm-2688	77	8	°	°	NOUN
ajlm-2688	77	9	c	c	NOUN
ajlm-2688	77	10	showed	show	VERB
ajlm-2688	77	11	no	no	DET
ajlm-2688	77	12	significant	significant	ADJ
ajlm-2688	77	13	change	change	NOUN
ajlm-2688	77	14	in	in	ADP
ajlm-2688	77	15	mfi	mfi	PROPN
ajlm-2688	77	16	difference	difference	NOUN
ajlm-2688	77	17	over	over	ADP
ajlm-2688	77	18	time	time	NOUN
ajlm-2688	77	19	(	(	PUNCT
ajlm-2688	77	20	p	p	NOUN
ajlm-2688	77	21	=	=	NOUN
ajlm-2688	77	22	0.08	0.08	NUM
ajlm-2688	77	23	at	at	ADP
ajlm-2688	77	24	96	96	NUM
ajlm-2688	77	25	h	h	NOUN
ajlm-2688	77	26	)	)	PUNCT
ajlm-2688	77	27	.	.	PUNCT
ajlm-2688	78	1	storage	storage	NOUN
ajlm-2688	78	2	temperature	temperature	NOUN
ajlm-2688	78	3	rather	rather	ADV
ajlm-2688	78	4	than	than	ADP
ajlm-2688	78	5	time	time	NOUN
ajlm-2688	78	6	played	play	VERB
ajlm-2688	78	7	a	a	DET
ajlm-2688	78	8	statistically	statistically	ADV
ajlm-2688	78	9	significant	significant	ADJ
ajlm-2688	78	10	role	role	NOUN
ajlm-2688	78	11	in	in	ADP
ajlm-2688	78	12	sigm	sigm	ADJ
ajlm-2688	78	13	expression	expression	NOUN
ajlm-2688	78	14	(	(	PUNCT
ajlm-2688	78	15	p	p	X
ajlm-2688	78	16	=	=	NOUN
ajlm-2688	78	17	0.006	0.006	NUM
ajlm-2688	78	18	)	)	PUNCT
ajlm-2688	78	19	.	.	PUNCT
ajlm-2688	79	1	it	it	PRON
ajlm-2688	79	2	was	be	AUX
ajlm-2688	79	3	noteworthy	noteworthy	ADJ
ajlm-2688	79	4	that	that	SCONJ
ajlm-2688	79	5	the	the	DET
ajlm-2688	79	6	sigm	sigm	NOUN
ajlm-2688	79	7	mfi	mfi	PROPN
ajlm-2688	79	8	difference	difference	NOUN
ajlm-2688	79	9	was	be	AUX
ajlm-2688	79	10	more	more	ADV
ajlm-2688	79	11	stable	stable	ADJ
ajlm-2688	79	12	at	at	ADP
ajlm-2688	79	13	rt	rt	PROPN
ajlm-2688	79	14	,	,	PUNCT
ajlm-2688	79	15	while	while	SCONJ
ajlm-2688	79	16	a	a	DET
ajlm-2688	79	17	decrease	decrease	NOUN
ajlm-2688	79	18	of	of	ADP
ajlm-2688	79	19	>	>	SYM
ajlm-2688	79	20	90	90	NUM
ajlm-2688	79	21	%	%	NOUN
ajlm-2688	79	22	was	be	AUX
ajlm-2688	79	23	observed	observe	VERB
ajlm-2688	79	24	in	in	ADP
ajlm-2688	79	25	the	the	DET
ajlm-2688	79	26	4	4	NUM
ajlm-2688	79	27	°	°	NOUN
ajlm-2688	79	28	c	c	NOUN
ajlm-2688	79	29	samples	sample	NOUN
ajlm-2688	79	30	at	at	ADP
ajlm-2688	79	31	48	48	NUM
ajlm-2688	79	32	h	h	NOUN
ajlm-2688	79	33	(	(	PUNCT
ajlm-2688	79	34	p	p	X
ajlm-2688	79	35	=	=	NOUN
ajlm-2688	79	36	0.022	0.022	NUM
ajlm-2688	79	37	)	)	PUNCT
ajlm-2688	79	38	.	.	PUNCT
ajlm-2688	80	1	in	in	ADP
ajlm-2688	80	2	addition	addition	NOUN
ajlm-2688	80	3	,	,	PUNCT
ajlm-2688	80	4	skappa	skappa	ADJ
ajlm-2688	80	5	and	and	CCONJ
ajlm-2688	80	6	slambda	slambda	ADJ
ajlm-2688	80	7	were	be	AUX
ajlm-2688	80	8	more	more	ADV
ajlm-2688	80	9	stable	stable	ADJ
ajlm-2688	80	10	at	at	ADP
ajlm-2688	80	11	rt	rt	PROPN
ajlm-2688	80	12	,	,	PUNCT
ajlm-2688	80	13	compared	compare	VERB
ajlm-2688	80	14	to	to	ADP
ajlm-2688	80	15	samples	sample	NOUN
ajlm-2688	80	16	kept	keep	VERB
ajlm-2688	80	17	at	at	ADP
ajlm-2688	80	18	4	4	NUM
ajlm-2688	80	19	°	°	NOUN
ajlm-2688	80	20	c	c	NOUN
ajlm-2688	80	21	.	.	PUNCT
ajlm-2688	81	1	there	there	PRON
ajlm-2688	81	2	was	be	VERB
ajlm-2688	81	3	,	,	PUNCT
ajlm-2688	81	4	however	however	ADV
ajlm-2688	81	5	,	,	PUNCT
ajlm-2688	81	6	no	no	DET
ajlm-2688	81	7	clinically	clinically	ADV
ajlm-2688	81	8	significant	significant	ADJ
ajlm-2688	81	9	decrease	decrease	NOUN
ajlm-2688	81	10	in	in	ADP
ajlm-2688	81	11	the	the	DET
ajlm-2688	81	12	4	4	NUM
ajlm-2688	81	13	°	°	NOUN
ajlm-2688	81	14	c	c	NOUN
ajlm-2688	81	15	samples	sample	NOUN
ajlm-2688	81	16	,	,	PUNCT
ajlm-2688	81	17	even	even	ADV
ajlm-2688	81	18	at	at	ADP
ajlm-2688	81	19	96	96	NUM
ajlm-2688	81	20	h	h	NOUN
ajlm-2688	81	21	(	(	PUNCT
ajlm-2688	81	22	p	p	X
ajlm-2688	81	23	=	=	PUNCT
ajlm-2688	81	24	0.11	0.11	NUM
ajlm-2688	81	25	for	for	ADP
ajlm-2688	81	26	skappa	skappa	ADJ
ajlm-2688	81	27	and	and	CCONJ
ajlm-2688	81	28	p	p	X
ajlm-2688	81	29	=	=	PROPN
ajlm-2688	81	30	0.13	0.13	NUM
ajlm-2688	81	31	for	for	ADP
ajlm-2688	81	32	slambda	slambda	NOUN
ajlm-2688	81	33	)	)	PUNCT
ajlm-2688	81	34	(	(	PUNCT
ajlm-2688	81	35	figure	figure	NOUN
ajlm-2688	81	36	3	3	NUM
ajlm-2688	81	37	)	)	PUNCT
ajlm-2688	81	38	.	.	PUNCT
ajlm-2688	82	1	figure	figure	VERB
ajlm-2688	82	2	3	3	NUM
ajlm-2688	82	3	:	:	PUNCT
ajlm-2688	82	4	changes	change	NOUN
ajlm-2688	82	5	in	in	ADP
ajlm-2688	82	6	median	median	ADJ
ajlm-2688	82	7	fluorescence	fluorescence	NOUN
ajlm-2688	82	8	intensity	intensity	NOUN
ajlm-2688	82	9	difference	difference	NOUN
ajlm-2688	82	10	over	over	ADP
ajlm-2688	82	11	time	time	NOUN
ajlm-2688	82	12	for	for	ADP
ajlm-2688	82	13	each	each	DET
ajlm-2688	82	14	marker	marker	NOUN
ajlm-2688	82	15	,	,	PUNCT
ajlm-2688	82	16	cd23	cd23	PROPN
ajlm-2688	82	17	(	(	PUNCT
ajlm-2688	82	18	a	a	X
ajlm-2688	82	19	)	)	PUNCT
ajlm-2688	82	20	,	,	PUNCT
ajlm-2688	82	21	cd200	cd200	PROPN
ajlm-2688	82	22	(	(	PUNCT
ajlm-2688	82	23	b	b	NOUN
ajlm-2688	82	24	)	)	PUNCT
ajlm-2688	82	25	,	,	PUNCT
ajlm-2688	82	26	cd5	cd5	PROPN
ajlm-2688	82	27	(	(	PUNCT
ajlm-2688	82	28	c	c	NOUN
ajlm-2688	82	29	)	)	PUNCT
ajlm-2688	82	30	,	,	PUNCT
ajlm-2688	82	31	slgm	slgm	X
ajlm-2688	82	32	(	(	PUNCT
ajlm-2688	82	33	d	d	NOUN
ajlm-2688	82	34	)	)	PUNCT
ajlm-2688	82	35	,	,	PUNCT
ajlm-2688	82	36	cd20	cd20	PROPN
ajlm-2688	82	37	(	(	PUNCT
ajlm-2688	82	38	e	e	NOUN
ajlm-2688	82	39	)	)	PUNCT
ajlm-2688	82	40	,	,	PUNCT
ajlm-2688	82	41	cd79b	cd79b	X
ajlm-2688	82	42	(	(	PUNCT
ajlm-2688	82	43	f	f	X
ajlm-2688	82	44	)	)	PUNCT
ajlm-2688	82	45	,	,	PUNCT
ajlm-2688	82	46	kappa	kappa	X
ajlm-2688	82	47	(	(	PUNCT
ajlm-2688	82	48	g	g	NOUN
ajlm-2688	82	49	)	)	PUNCT
ajlm-2688	82	50	and	and	CCONJ
ajlm-2688	82	51	lambda	lambda	NOUN
ajlm-2688	82	52	(	(	PUNCT
ajlm-2688	82	53	h	h	NOUN
ajlm-2688	82	54	)	)	PUNCT
ajlm-2688	82	55	,	,	PUNCT
ajlm-2688	82	56	at	at	ADP
ajlm-2688	82	57	the	the	DET
ajlm-2688	82	58	different	different	ADJ
ajlm-2688	82	59	storage	storage	NOUN
ajlm-2688	82	60	temperatures	temperature	NOUN
ajlm-2688	82	61	at	at	ADP
ajlm-2688	82	62	universitas	universita	NOUN
ajlm-2688	82	63	academic	academic	ADJ
ajlm-2688	82	64	hospital	hospital	NOUN
ajlm-2688	82	65	,	,	PUNCT
ajlm-2688	82	66	bloemfontein	bloemfontein	PROPN
ajlm-2688	82	67	,	,	PUNCT
ajlm-2688	82	68	south	south	PROPN
ajlm-2688	82	69	africa	africa	PROPN
ajlm-2688	82	70	,	,	PUNCT
ajlm-2688	82	71	january	january	PROPN
ajlm-2688	82	72	2022	2022	NUM
ajlm-2688	82	73	to	to	ADP
ajlm-2688	82	74	march	march	PROPN
ajlm-2688	82	75	2023	2023	NUM
ajlm-2688	82	76	.	.	PUNCT
ajlm-2688	83	1	the	the	DET
ajlm-2688	83	2	solid	solid	ADJ
ajlm-2688	83	3	line	line	NOUN
ajlm-2688	83	4	represents	represent	VERB
ajlm-2688	83	5	the	the	DET
ajlm-2688	83	6	means	mean	NOUN
ajlm-2688	83	7	of	of	ADP
ajlm-2688	83	8	the	the	DET
ajlm-2688	83	9	median	median	ADJ
ajlm-2688	83	10	fluorescence	fluorescence	NOUN
ajlm-2688	83	11	intensity	intensity	NOUN
ajlm-2688	83	12	difference	difference	NOUN
ajlm-2688	83	13	and	and	CCONJ
ajlm-2688	83	14	the	the	DET
ajlm-2688	83	15	shaded	shaded	ADJ
ajlm-2688	83	16	area	area	NOUN
ajlm-2688	83	17	indicates	indicate	VERB
ajlm-2688	83	18	the	the	DET
ajlm-2688	83	19	range	range	NOUN
ajlm-2688	83	20	of	of	ADP
ajlm-2688	83	21	results	result	NOUN
ajlm-2688	83	22	at	at	ADP
ajlm-2688	83	23	the	the	DET
ajlm-2688	83	24	various	various	ADJ
ajlm-2688	83	25	time	time	NOUN
ajlm-2688	83	26	points	point	NOUN
ajlm-2688	83	27	.	.	PUNCT
ajlm-2688	84	1	chronic	chronic	ADJ
ajlm-2688	84	2	lymphocytic	lymphocytic	ADJ
ajlm-2688	84	3	leukaemia	leukaemia	NOUN
ajlm-2688	84	4	scores	score	NOUN
ajlm-2688	84	5	to	to	PART
ajlm-2688	84	6	determine	determine	VERB
ajlm-2688	84	7	whether	whether	SCONJ
ajlm-2688	84	8	storage	storage	NOUN
ajlm-2688	84	9	time	time	NOUN
ajlm-2688	84	10	or	or	CCONJ
ajlm-2688	84	11	temperature	temperature	NOUN
ajlm-2688	84	12	would	would	AUX
ajlm-2688	84	13	affect	affect	VERB
ajlm-2688	84	14	the	the	DET
ajlm-2688	84	15	cll	cll	PROPN
ajlm-2688	84	16	diagnostic	diagnostic	ADJ
ajlm-2688	84	17	scores	score	NOUN
ajlm-2688	84	18	,	,	PUNCT
ajlm-2688	84	19	the	the	DET
ajlm-2688	84	20	moreau	moreau	PROPN
ajlm-2688	84	21	and	and	CCONJ
ajlm-2688	84	22	adapted	adapt	VERB
ajlm-2688	84	23	matutes	matute	NOUN
ajlm-2688	84	24	scores	score	NOUN
ajlm-2688	84	25	were	be	AUX
ajlm-2688	84	26	calculated	calculate	VERB
ajlm-2688	84	27	at	at	ADP
ajlm-2688	84	28	various	various	ADJ
ajlm-2688	84	29	time	time	NOUN
ajlm-2688	84	30	points	point	NOUN
ajlm-2688	84	31	.	.	PUNCT
ajlm-2688	85	1	a	a	DET
ajlm-2688	85	2	two	two	NUM
ajlm-2688	85	3	-	-	PUNCT
ajlm-2688	85	4	way	way	NOUN
ajlm-2688	85	5	analysis	analysis	NOUN
ajlm-2688	85	6	of	of	ADP
ajlm-2688	85	7	variance	variance	NOUN
ajlm-2688	85	8	was	be	AUX
ajlm-2688	85	9	performed	perform	VERB
ajlm-2688	85	10	to	to	PART
ajlm-2688	85	11	compare	compare	VERB
ajlm-2688	85	12	the	the	DET
ajlm-2688	85	13	effect	effect	NOUN
ajlm-2688	85	14	of	of	ADP
ajlm-2688	85	15	storage	storage	NOUN
ajlm-2688	85	16	time	time	NOUN
ajlm-2688	85	17	and	and	CCONJ
ajlm-2688	85	18	temperature	temperature	NOUN
ajlm-2688	85	19	on	on	ADP
ajlm-2688	85	20	the	the	DET
ajlm-2688	85	21	mfi	mfi	PROPN
ajlm-2688	85	22	for	for	ADP
ajlm-2688	85	23	the	the	DET
ajlm-2688	85	24	markers	marker	NOUN
ajlm-2688	85	25	included	include	VERB
ajlm-2688	85	26	in	in	ADP
ajlm-2688	85	27	the	the	DET
ajlm-2688	85	28	cll	cll	PROPN
ajlm-2688	85	29	scores	score	NOUN
ajlm-2688	85	30	.	.	PUNCT
ajlm-2688	86	1	both	both	CCONJ
ajlm-2688	86	2	the	the	DET
ajlm-2688	86	3	moreau	moreau	PROPN
ajlm-2688	86	4	and	and	CCONJ
ajlm-2688	86	5	the	the	DET
ajlm-2688	86	6	adapted	adapt	VERB
ajlm-2688	86	7	matutes	matute	NOUN
ajlm-2688	86	8	scores	score	NOUN
ajlm-2688	86	9	showed	show	VERB
ajlm-2688	86	10	statistically	statistically	ADV
ajlm-2688	86	11	significant	significant	ADJ
ajlm-2688	86	12	variation	variation	NOUN
ajlm-2688	86	13	with	with	ADP
ajlm-2688	86	14	temperature	temperature	NOUN
ajlm-2688	86	15	(	(	PUNCT
ajlm-2688	86	16	moreau	moreau	NOUN
ajlm-2688	86	17	:	:	PUNCT
ajlm-2688	86	18	p	p	X
ajlm-2688	86	19	=	=	PROPN
ajlm-2688	86	20	0.007	0.007	NUM
ajlm-2688	86	21	;	;	PUNCT
ajlm-2688	86	22	and	and	CCONJ
ajlm-2688	86	23	adapted	adapt	VERB
ajlm-2688	86	24	matutes	matute	NOUN
ajlm-2688	86	25	:	:	PUNCT
ajlm-2688	87	1	p	p	X
ajlm-2688	87	2	=	=	NOUN
ajlm-2688	87	3	0.005	0.005	NUM
ajlm-2688	87	4	)	)	PUNCT
ajlm-2688	87	5	and	and	CCONJ
ajlm-2688	87	6	time	time	NOUN
ajlm-2688	87	7	(	(	PUNCT
ajlm-2688	87	8	moreau	moreau	PROPN
ajlm-2688	87	9	:	:	PUNCT
ajlm-2688	87	10	p	p	X
ajlm-2688	87	11	≤	≤	NOUN
ajlm-2688	87	12	0.001	0.001	NUM
ajlm-2688	87	13	;	;	PUNCT
ajlm-2688	87	14	and	and	CCONJ
ajlm-2688	87	15	adapted	adapt	VERB
ajlm-2688	87	16	matutes	matute	NOUN
ajlm-2688	87	17	:	:	PUNCT
ajlm-2688	88	1	p	p	X
ajlm-2688	88	2	≤	≤	NUM
ajlm-2688	88	3	0.001	0.001	NUM
ajlm-2688	88	4	)	)	PUNCT
ajlm-2688	88	5	.	.	PUNCT
ajlm-2688	89	1	a	a	DET
ajlm-2688	89	2	post	post	ADJ
ajlm-2688	89	3	-	-	ADJ
ajlm-2688	89	4	hoc	hoc	ADJ
ajlm-2688	89	5	analysis	analysis	NOUN
ajlm-2688	89	6	confirmed	confirm	VERB
ajlm-2688	89	7	48	48	NUM
ajlm-2688	89	8	h	h	NOUN
ajlm-2688	89	9	to	to	PART
ajlm-2688	89	10	be	be	AUX
ajlm-2688	89	11	the	the	DET
ajlm-2688	89	12	most	most	ADV
ajlm-2688	89	13	significant	significant	ADJ
ajlm-2688	89	14	time	time	NOUN
ajlm-2688	89	15	point	point	NOUN
ajlm-2688	89	16	for	for	ADP
ajlm-2688	89	17	both	both	DET
ajlm-2688	89	18	scoring	score	VERB
ajlm-2688	89	19	systems	system	NOUN
ajlm-2688	89	20	in	in	ADP
ajlm-2688	89	21	rt	rt	PROPN
ajlm-2688	89	22	samples	sample	NOUN
ajlm-2688	89	23	(	(	PUNCT
ajlm-2688	89	24	moreau	moreau	NOUN
ajlm-2688	89	25	:	:	PUNCT
ajlm-2688	89	26	p	p	X
ajlm-2688	89	27	=	=	NOUN
ajlm-2688	89	28	0.002	0.002	NUM
ajlm-2688	89	29	;	;	PUNCT
ajlm-2688	89	30	and	and	CCONJ
ajlm-2688	89	31	adapted	adapt	VERB
ajlm-2688	89	32	matutes	matute	NOUN
ajlm-2688	89	33	:	:	PUNCT
ajlm-2688	89	34	p	p	X
ajlm-2688	89	35	=	=	NOUN
ajlm-2688	89	36	0.011	0.011	NUM
ajlm-2688	89	37	)	)	PUNCT
ajlm-2688	89	38	as	as	ADV
ajlm-2688	89	39	well	well	ADV
ajlm-2688	89	40	as	as	ADP
ajlm-2688	89	41	the	the	DET
ajlm-2688	89	42	4	4	NUM
ajlm-2688	89	43	°	°	NOUN
ajlm-2688	89	44	c	c	NOUN
ajlm-2688	89	45	samples	sample	NOUN
ajlm-2688	89	46	(	(	PUNCT
ajlm-2688	89	47	moreau	moreau	NOUN
ajlm-2688	89	48	:	:	PUNCT
ajlm-2688	89	49	p	p	X
ajlm-2688	89	50	=	=	NOUN
ajlm-2688	89	51	0.018	0.018	NUM
ajlm-2688	89	52	;	;	PUNCT
ajlm-2688	89	53	and	and	CCONJ
ajlm-2688	89	54	adapted	adapt	VERB
ajlm-2688	89	55	matutes	matute	NOUN
ajlm-2688	89	56	:	:	PUNCT
ajlm-2688	89	57	p	p	X
ajlm-2688	89	58	=	=	NOUN
ajlm-2688	89	59	0.040	0.040	NUM
ajlm-2688	89	60	)	)	PUNCT
ajlm-2688	89	61	.	.	PUNCT
ajlm-2688	90	1	the	the	DET
ajlm-2688	90	2	moreau	moreau	PROPN
ajlm-2688	90	3	score	score	NOUN
ajlm-2688	90	4	of	of	ADP
ajlm-2688	90	5	most	most	ADJ
ajlm-2688	90	6	rt	rt	NOUN
ajlm-2688	90	7	samples	sample	NOUN
ajlm-2688	90	8	(	(	PUNCT
ajlm-2688	90	9	n	n	NOUN
ajlm-2688	90	10	=	=	SYM
ajlm-2688	90	11	6	6	NUM
ajlm-2688	90	12	)	)	PUNCT
ajlm-2688	90	13	and	and	CCONJ
ajlm-2688	90	14	four	four	NUM
ajlm-2688	90	15	of	of	ADP
ajlm-2688	90	16	the	the	DET
ajlm-2688	90	17	4	4	NUM
ajlm-2688	90	18	°	°	NOUN
ajlm-2688	90	19	c	c	NOUN
ajlm-2688	90	20	samples	sample	NOUN
ajlm-2688	90	21	changed	change	VERB
ajlm-2688	90	22	to	to	ADP
ajlm-2688	90	23	atypical	atypical	ADJ
ajlm-2688	90	24	cll	cll	PROPN
ajlm-2688	90	25	at	at	ADP
ajlm-2688	90	26	48	48	NUM
ajlm-2688	90	27	h.	h.	NOUN
ajlm-2688	90	28	a	a	DET
ajlm-2688	90	29	majority	majority	NOUN
ajlm-2688	90	30	shift	shift	NOUN
ajlm-2688	90	31	(	(	PUNCT
ajlm-2688	90	32	n	n	NOUN
ajlm-2688	90	33	=	=	SYM
ajlm-2688	90	34	8	8	NUM
ajlm-2688	90	35	for	for	ADP
ajlm-2688	90	36	the	the	DET
ajlm-2688	90	37	moreau	moreau	PROPN
ajlm-2688	90	38	score	score	NOUN
ajlm-2688	90	39	;	;	PUNCT
ajlm-2688	90	40	n	n	NOUN
ajlm-2688	90	41	=	=	SYM
ajlm-2688	90	42	7	7	NUM
ajlm-2688	90	43	for	for	ADP
ajlm-2688	90	44	the	the	DET
ajlm-2688	90	45	adapted	adapt	VERB
ajlm-2688	90	46	matutes	matute	NOUN
ajlm-2688	90	47	score	score	NOUN
ajlm-2688	90	48	)	)	PUNCT
ajlm-2688	90	49	in	in	ADP
ajlm-2688	90	50	diagnosis	diagnosis	NOUN
ajlm-2688	90	51	from	from	ADP
ajlm-2688	90	52	typical	typical	ADJ
ajlm-2688	90	53	cll	cll	PROPN
ajlm-2688	90	54	to	to	ADP
ajlm-2688	90	55	atypical	atypical	ADJ
ajlm-2688	90	56	cll	cll	PROPN
ajlm-2688	90	57	for	for	ADP
ajlm-2688	90	58	the	the	DET
ajlm-2688	90	59	4	4	NUM
ajlm-2688	90	60	°	°	NOUN
ajlm-2688	90	61	c	c	NOUN
ajlm-2688	90	62	samples	sample	NOUN
ajlm-2688	90	63	was	be	AUX
ajlm-2688	90	64	only	only	ADV
ajlm-2688	90	65	seen	see	VERB
ajlm-2688	90	66	at	at	ADP
ajlm-2688	90	67	96	96	NUM
ajlm-2688	90	68	h	h	NOUN
ajlm-2688	90	69	(	(	PUNCT
ajlm-2688	90	70	figure	figure	NOUN
ajlm-2688	90	71	4	4	NUM
ajlm-2688	90	72	)	)	PUNCT
ajlm-2688	90	73	.	.	PUNCT
ajlm-2688	91	1	figure	figure	VERB
ajlm-2688	91	2	4	4	NUM
ajlm-2688	91	3	:	:	PUNCT
ajlm-2688	91	4	temporal	temporal	ADJ
ajlm-2688	91	5	evolution	evolution	NOUN
ajlm-2688	91	6	of	of	ADP
ajlm-2688	91	7	the	the	DET
ajlm-2688	91	8	chronic	chronic	ADJ
ajlm-2688	91	9	lymphocytic	lymphocytic	ADJ
ajlm-2688	91	10	leukaemia	leukaemia	NOUN
ajlm-2688	91	11	diagnoses	diagnosis	NOUN
ajlm-2688	91	12	(	(	PUNCT
ajlm-2688	91	13	from	from	ADP
ajlm-2688	91	14	baseline	baseline	NOUN
ajlm-2688	91	15	to	to	ADP
ajlm-2688	91	16	96	96	NUM
ajlm-2688	91	17	h	h	NOUN
ajlm-2688	91	18	)	)	PUNCT
ajlm-2688	91	19	at	at	ADP
ajlm-2688	91	20	universitas	universitas	PROPN
ajlm-2688	91	21	academic	academic	ADJ
ajlm-2688	91	22	hospital	hospital	NOUN
ajlm-2688	91	23	,	,	PUNCT
ajlm-2688	91	24	bloemfontein	bloemfontein	PROPN
ajlm-2688	91	25	,	,	PUNCT
ajlm-2688	91	26	south	south	PROPN
ajlm-2688	91	27	africa	africa	PROPN
ajlm-2688	91	28	,	,	PUNCT
ajlm-2688	91	29	january	january	PROPN
ajlm-2688	91	30	2022	2022	NUM
ajlm-2688	91	31	to	to	ADP
ajlm-2688	91	32	march	march	PROPN
ajlm-2688	91	33	2023	2023	NUM
ajlm-2688	91	34	.	.	PUNCT
ajlm-2688	92	1	top	top	ADJ
ajlm-2688	92	2	:	:	PUNCT
ajlm-2688	92	3	moreau	moreau	PROPN
ajlm-2688	92	4	score	score	NOUN
ajlm-2688	92	5	at	at	ADP
ajlm-2688	92	6	room	room	NOUN
ajlm-2688	92	7	temperature	temperature	NOUN
ajlm-2688	92	8	(	(	PUNCT
ajlm-2688	92	9	a	a	NOUN
ajlm-2688	92	10	)	)	PUNCT
ajlm-2688	92	11	and	and	CCONJ
ajlm-2688	92	12	4	4	NUM
ajlm-2688	92	13	°	°	NOUN
ajlm-2688	92	14	c	c	X
ajlm-2688	92	15	(	(	PUNCT
ajlm-2688	92	16	b	b	NOUN
ajlm-2688	92	17	)	)	PUNCT
ajlm-2688	92	18	.	.	PUNCT
ajlm-2688	93	1	bottom	bottom	NOUN
ajlm-2688	93	2	:	:	PUNCT
ajlm-2688	93	3	adapted	adapt	VERB
ajlm-2688	93	4	matutes	matute	NOUN
ajlm-2688	93	5	score	score	NOUN
ajlm-2688	93	6	at	at	ADP
ajlm-2688	93	7	room	room	NOUN
ajlm-2688	93	8	temperature	temperature	NOUN
ajlm-2688	93	9	(	(	PUNCT
ajlm-2688	93	10	c	c	NOUN
ajlm-2688	93	11	)	)	PUNCT
ajlm-2688	93	12	and	and	CCONJ
ajlm-2688	93	13	4	4	NUM
ajlm-2688	93	14	°	°	NOUN
ajlm-2688	93	15	c	c	X
ajlm-2688	93	16	(	(	PUNCT
ajlm-2688	93	17	d	d	NOUN
ajlm-2688	93	18	)	)	PUNCT
ajlm-2688	93	19	.	.	PUNCT
ajlm-2688	94	1	discussion	discussion	NOUN
ajlm-2688	94	2	in	in	ADP
ajlm-2688	94	3	this	this	DET
ajlm-2688	94	4	study	study	NOUN
ajlm-2688	94	5	,	,	PUNCT
ajlm-2688	94	6	we	we	PRON
ajlm-2688	94	7	observed	observe	VERB
ajlm-2688	94	8	statistically	statistically	ADV
ajlm-2688	94	9	significant	significant	ADJ
ajlm-2688	94	10	changes	change	NOUN
ajlm-2688	94	11	in	in	ADP
ajlm-2688	94	12	cd5	cd5	PROPN
ajlm-2688	94	13	,	,	PUNCT
ajlm-2688	94	14	cd23	cd23	PROPN
ajlm-2688	94	15	,	,	PUNCT
ajlm-2688	94	16	and	and	CCONJ
ajlm-2688	94	17	cd200	cd200	NOUN
ajlm-2688	95	1	antigen	antigen	ADJ
ajlm-2688	95	2	expression	expression	NOUN
ajlm-2688	95	3	,	,	PUNCT
ajlm-2688	95	4	with	with	ADP
ajlm-2688	95	5	antigen	antigen	ADJ
ajlm-2688	95	6	stability	stability	NOUN
ajlm-2688	95	7	notably	notably	ADV
ajlm-2688	95	8	improved	improve	VERB
ajlm-2688	95	9	under	under	ADP
ajlm-2688	95	10	refrigerated	refrigerate	VERB
ajlm-2688	95	11	conditions	condition	NOUN
ajlm-2688	95	12	.	.	PUNCT
ajlm-2688	96	1	the	the	DET
ajlm-2688	96	2	majority	majority	NOUN
ajlm-2688	96	3	of	of	ADP
ajlm-2688	96	4	samples	sample	NOUN
ajlm-2688	96	5	stored	store	VERB
ajlm-2688	96	6	at	at	ADP
ajlm-2688	96	7	rt	rt	PROPN
ajlm-2688	96	8	(	(	PUNCT
ajlm-2688	96	9	n	n	NOUN
ajlm-2688	96	10	=	=	SYM
ajlm-2688	96	11	6	6	NUM
ajlm-2688	96	12	)	)	PUNCT
ajlm-2688	96	13	and	and	CCONJ
ajlm-2688	96	14	only	only	ADV
ajlm-2688	96	15	four	four	NUM
ajlm-2688	96	16	of	of	ADP
ajlm-2688	96	17	the	the	DET
ajlm-2688	96	18	refrigerator	refrigerator	NOUN
ajlm-2688	96	19	samples	sample	NOUN
ajlm-2688	96	20	displayed	display	VERB
ajlm-2688	96	21	a	a	DET
ajlm-2688	96	22	shift	shift	NOUN
ajlm-2688	96	23	in	in	ADP
ajlm-2688	96	24	diagnosis	diagnosis	NOUN
ajlm-2688	96	25	towards	towards	ADP
ajlm-2688	96	26	acll	acll	NOUN
ajlm-2688	96	27	at	at	ADP
ajlm-2688	96	28	the	the	DET
ajlm-2688	96	29	48	48	NUM
ajlm-2688	96	30	h	h	NOUN
ajlm-2688	96	31	mark	mark	NOUN
ajlm-2688	96	32	.	.	PUNCT
ajlm-2688	97	1	however	however	ADV
ajlm-2688	97	2	,	,	PUNCT
ajlm-2688	97	3	a	a	DET
ajlm-2688	97	4	majority	majority	NOUN
ajlm-2688	97	5	shift	shift	NOUN
ajlm-2688	97	6	in	in	ADP
ajlm-2688	97	7	diagnosis	diagnosis	NOUN
ajlm-2688	97	8	from	from	ADP
ajlm-2688	97	9	cll	cll	PROPN
ajlm-2688	97	10	to	to	PART
ajlm-2688	97	11	acll	acll	PROPN
ajlm-2688	97	12	/	/	SYM
ajlm-2688	97	13	non	non	NOUN
ajlm-2688	97	14	-	-	NOUN
ajlm-2688	97	15	cll	cll	NOUN
ajlm-2688	97	16	for	for	ADP
ajlm-2688	97	17	the	the	DET
ajlm-2688	97	18	refrigerator	refrigerator	NOUN
ajlm-2688	97	19	samples	sample	NOUN
ajlm-2688	97	20	was	be	AUX
ajlm-2688	97	21	only	only	ADV
ajlm-2688	97	22	evident	evident	ADJ
ajlm-2688	97	23	after	after	ADP
ajlm-2688	97	24	a	a	DET
ajlm-2688	97	25	96	96	NUM
ajlm-2688	97	26	h	h	NOUN
ajlm-2688	97	27	storage	storage	NOUN
ajlm-2688	97	28	duration	duration	NOUN
ajlm-2688	97	29	.	.	PUNCT
ajlm-2688	98	1	the	the	DET
ajlm-2688	98	2	international	international	ADJ
ajlm-2688	98	3	council	council	NOUN
ajlm-2688	98	4	for	for	ADP
ajlm-2688	98	5	standardisation	standardisation	NOUN
ajlm-2688	98	6	of	of	ADP
ajlm-2688	98	7	haematology	haematology	NOUN
ajlm-2688	98	8	and	and	CCONJ
ajlm-2688	98	9	the	the	DET
ajlm-2688	98	10	international	international	ADJ
ajlm-2688	98	11	clinical	clinical	ADJ
ajlm-2688	98	12	cytometry	cytometry	PROPN
ajlm-2688	98	13	society	society	NOUN
ajlm-2688	98	14	emphasise	emphasise	VERB
ajlm-2688	98	15	the	the	DET
ajlm-2688	98	16	need	need	NOUN
ajlm-2688	98	17	for	for	ADP
ajlm-2688	98	18	standardised	standardised	ADJ
ajlm-2688	98	19	pre	pre	ADJ
ajlm-2688	98	20	-	-	ADJ
ajlm-2688	98	21	analytical	analytical	ADJ
ajlm-2688	98	22	procedures	procedure	NOUN
ajlm-2688	98	23	,	,	PUNCT
ajlm-2688	98	24	with	with	ADP
ajlm-2688	98	25	recommendations	recommendation	NOUN
ajlm-2688	98	26	that	that	PRON
ajlm-2688	98	27	samples	sample	NOUN
ajlm-2688	98	28	be	be	AUX
ajlm-2688	98	29	analysed	analyse	VERB
ajlm-2688	98	30	within	within	ADP
ajlm-2688	98	31	48	48	NUM
ajlm-2688	98	32	h	h	NOUN
ajlm-2688	98	33	when	when	SCONJ
ajlm-2688	98	34	stored	store	VERB
ajlm-2688	98	35	at	at	ADP
ajlm-2688	98	36	rt.20	rt.20	NOUN
ajlm-2688	98	37	however	however	ADV
ajlm-2688	98	38	,	,	PUNCT
ajlm-2688	98	39	bain	bain	PROPN
ajlm-2688	98	40	et	et	PROPN
ajlm-2688	98	41	al	al	PROPN
ajlm-2688	98	42	.	.	PROPN
ajlm-2688	98	43	suggest	suggest	VERB
ajlm-2688	98	44	that	that	SCONJ
ajlm-2688	98	45	samples	sample	NOUN
ajlm-2688	98	46	should	should	AUX
ajlm-2688	98	47	ideally	ideally	ADV
ajlm-2688	98	48	be	be	AUX
ajlm-2688	98	49	analysed	analyse	VERB
ajlm-2688	98	50	within	within	ADP
ajlm-2688	98	51	24	24	NUM
ajlm-2688	98	52	h	h	NOUN
ajlm-2688	98	53	if	if	SCONJ
ajlm-2688	98	54	transported	transport	VERB
ajlm-2688	98	55	and	and	CCONJ
ajlm-2688	98	56	stored	store	VERB
ajlm-2688	98	57	at	at	ADP
ajlm-2688	98	58	rt	rt	PROPN
ajlm-2688	98	59	,	,	PUNCT
ajlm-2688	98	60	particularly	particularly	ADV
ajlm-2688	98	61	when	when	SCONJ
ajlm-2688	98	62	referral	referral	NOUN
ajlm-2688	98	63	to	to	ADP
ajlm-2688	98	64	central	central	ADJ
ajlm-2688	98	65	laboratories	laboratory	NOUN
ajlm-2688	98	66	is	be	AUX
ajlm-2688	98	67	involved.27	involved.27	ADJ
ajlm-2688	98	68	other	other	ADJ
ajlm-2688	98	69	studies	study	NOUN
ajlm-2688	98	70	,	,	PUNCT
ajlm-2688	98	71	like	like	ADP
ajlm-2688	98	72	those	those	PRON
ajlm-2688	98	73	by	by	ADP
ajlm-2688	98	74	diks	dik	NOUN
ajlm-2688	98	75	et	et	PROPN
ajlm-2688	98	76	al	al	PROPN
ajlm-2688	98	77	.	.	PROPN
ajlm-2688	98	78	,19	,19	PROPN
ajlm-2688	98	79	have	have	AUX
ajlm-2688	98	80	highlighted	highlight	VERB
ajlm-2688	98	81	the	the	DET
ajlm-2688	98	82	impact	impact	NOUN
ajlm-2688	98	83	of	of	ADP
ajlm-2688	98	84	pre	pre	ADJ
ajlm-2688	98	85	-	-	ADJ
ajlm-2688	98	86	analytical	analytical	ADJ
ajlm-2688	98	87	handling	handling	NOUN
ajlm-2688	98	88	on	on	ADP
ajlm-2688	98	89	data	datum	NOUN
ajlm-2688	98	90	quality	quality	NOUN
ajlm-2688	98	91	,	,	PUNCT
ajlm-2688	98	92	noting	note	VERB
ajlm-2688	98	93	that	that	SCONJ
ajlm-2688	98	94	sample	sample	NOUN
ajlm-2688	98	95	processing	processing	NOUN
ajlm-2688	98	96	should	should	AUX
ajlm-2688	98	97	be	be	AUX
ajlm-2688	98	98	tailored	tailor	VERB
ajlm-2688	98	99	to	to	ADP
ajlm-2688	98	100	the	the	DET
ajlm-2688	98	101	cell	cell	NOUN
ajlm-2688	98	102	type	type	NOUN
ajlm-2688	98	103	and	and	CCONJ
ajlm-2688	98	104	clinical	clinical	ADJ
ajlm-2688	98	105	context	context	NOUN
ajlm-2688	98	106	.	.	PUNCT
ajlm-2688	99	1	notably	notably	ADV
ajlm-2688	99	2	,	,	PUNCT
ajlm-2688	99	3	most	most	ADJ
ajlm-2688	99	4	of	of	ADP
ajlm-2688	99	5	these	these	DET
ajlm-2688	99	6	investigations	investigation	NOUN
ajlm-2688	99	7	used	use	VERB
ajlm-2688	99	8	samples	sample	NOUN
ajlm-2688	99	9	from	from	ADP
ajlm-2688	99	10	healthy	healthy	ADJ
ajlm-2688	99	11	donors	donor	NOUN
ajlm-2688	99	12	,	,	PUNCT
ajlm-2688	99	13	not	not	PART
ajlm-2688	99	14	individuals	individual	NOUN
ajlm-2688	99	15	with	with	ADP
ajlm-2688	99	16	haematological	haematological	ADJ
ajlm-2688	99	17	malignancies.17,18,19	malignancies.17,18,19	CCONJ
ajlm-2688	99	18	comparative	comparative	ADJ
ajlm-2688	99	19	studies	study	NOUN
ajlm-2688	99	20	on	on	ADP
ajlm-2688	99	21	optimal	optimal	ADJ
ajlm-2688	99	22	pre	pre	ADJ
ajlm-2688	99	23	-	-	ADJ
ajlm-2688	99	24	analytical	analytical	ADJ
ajlm-2688	99	25	conditions	condition	NOUN
ajlm-2688	99	26	for	for	ADP
ajlm-2688	99	27	b	b	PROPN
ajlm-2688	99	28	-	-	PUNCT
ajlm-2688	99	29	lpd	lpd	PROPN
ajlm-2688	99	30	specimens	specimen	NOUN
ajlm-2688	99	31	remain	remain	VERB
ajlm-2688	99	32	limited,19	limited,19	PROPN
ajlm-2688	99	33	underscoring	underscore	VERB
ajlm-2688	99	34	a	a	DET
ajlm-2688	99	35	gap	gap	NOUN
ajlm-2688	99	36	that	that	PRON
ajlm-2688	99	37	our	our	PRON
ajlm-2688	99	38	research	research	NOUN
ajlm-2688	99	39	set	set	VERB
ajlm-2688	99	40	out	out	ADP
ajlm-2688	99	41	to	to	PART
ajlm-2688	99	42	address	address	VERB
ajlm-2688	99	43	.	.	PUNCT
ajlm-2688	100	1	our	our	PRON
ajlm-2688	100	2	findings	finding	NOUN
ajlm-2688	100	3	align	align	VERB
ajlm-2688	100	4	with	with	ADP
ajlm-2688	100	5	the	the	DET
ajlm-2688	100	6	euroflow	euroflow	PROPN
ajlm-2688	100	7	consortium	consortium	NOUN
ajlm-2688	100	8	,	,	PUNCT
ajlm-2688	100	9	which	which	PRON
ajlm-2688	100	10	examined	examine	VERB
ajlm-2688	100	11	pre	pre	ADJ
ajlm-2688	100	12	-	-	ADJ
ajlm-2688	100	13	analytical	analytical	ADJ
ajlm-2688	100	14	variables	variable	NOUN
ajlm-2688	100	15	on	on	ADP
ajlm-2688	100	16	samples	sample	NOUN
ajlm-2688	100	17	from	from	ADP
ajlm-2688	100	18	patients	patient	NOUN
ajlm-2688	100	19	with	with	ADP
ajlm-2688	100	20	haematological	haematological	ADJ
ajlm-2688	100	21	malignancies	malignancy	NOUN
ajlm-2688	100	22	and	and	CCONJ
ajlm-2688	100	23	suggested	suggest	VERB
ajlm-2688	100	24	that	that	SCONJ
ajlm-2688	100	25	protocols	protocol	NOUN
ajlm-2688	100	26	may	may	AUX
ajlm-2688	100	27	need	need	VERB
ajlm-2688	100	28	adjustments	adjustment	NOUN
ajlm-2688	100	29	based	base	VERB
ajlm-2688	100	30	on	on	ADP
ajlm-2688	100	31	sample	sample	NOUN
ajlm-2688	100	32	type	type	NOUN
ajlm-2688	100	33	and	and	CCONJ
ajlm-2688	100	34	markers	marker	NOUN
ajlm-2688	100	35	analysed.28	analysed.28	PROPN
ajlm-2688	100	36	notably	notably	ADV
ajlm-2688	100	37	,	,	PUNCT
ajlm-2688	100	38	we	we	PRON
ajlm-2688	100	39	found	find	VERB
ajlm-2688	100	40	that	that	SCONJ
ajlm-2688	100	41	cll	cll	PROPN
ajlm-2688	100	42	antigen	antigen	ADJ
ajlm-2688	100	43	expression	expression	NOUN
ajlm-2688	100	44	is	be	AUX
ajlm-2688	100	45	better	well	ADV
ajlm-2688	100	46	preserved	preserve	VERB
ajlm-2688	100	47	at	at	ADP
ajlm-2688	100	48	refrigerator	refrigerator	NOUN
ajlm-2688	100	49	temperatures	temperature	NOUN
ajlm-2688	100	50	than	than	ADP
ajlm-2688	100	51	rt	rt	PROPN
ajlm-2688	100	52	,	,	PUNCT
ajlm-2688	100	53	which	which	PRON
ajlm-2688	100	54	contrasts	contrast	VERB
ajlm-2688	100	55	with	with	ADP
ajlm-2688	100	56	previous	previous	ADJ
ajlm-2688	100	57	reports.27	reports.27	PROPN
ajlm-2688	100	58	among	among	ADP
ajlm-2688	100	59	the	the	DET
ajlm-2688	100	60	assessed	assessed	ADJ
ajlm-2688	100	61	markers	marker	NOUN
ajlm-2688	100	62	,	,	PUNCT
ajlm-2688	100	63	cd23	cd23	PROPN
ajlm-2688	100	64	and	and	CCONJ
ajlm-2688	100	65	cd200	cd200	PROPN
ajlm-2688	100	66	showed	show	VERB
ajlm-2688	100	67	statistically	statistically	ADV
ajlm-2688	100	68	significant	significant	ADJ
ajlm-2688	100	69	expression	expression	NOUN
ajlm-2688	100	70	changes	change	NOUN
ajlm-2688	100	71	over	over	ADP
ajlm-2688	100	72	time	time	NOUN
ajlm-2688	100	73	,	,	PUNCT
ajlm-2688	100	74	with	with	ADP
ajlm-2688	100	75	better	well	ADJ
ajlm-2688	100	76	stability	stability	NOUN
ajlm-2688	100	77	at	at	ADP
ajlm-2688	100	78	refrigerated	refrigerate	VERB
ajlm-2688	100	79	temperatures	temperature	NOUN
ajlm-2688	100	80	.	.	PUNCT
ajlm-2688	101	1	different	different	ADJ
ajlm-2688	101	2	definitions	definition	NOUN
ajlm-2688	101	3	of	of	ADP
ajlm-2688	101	4	rt	rt	PROPN
ajlm-2688	101	5	worldwide	worldwide	ADV
ajlm-2688	101	6	could	could	AUX
ajlm-2688	101	7	partially	partially	ADV
ajlm-2688	101	8	explain	explain	VERB
ajlm-2688	101	9	these	these	DET
ajlm-2688	101	10	discrepancies	discrepancy	NOUN
ajlm-2688	101	11	.	.	PUNCT
ajlm-2688	102	1	for	for	ADP
ajlm-2688	102	2	instance	instance	NOUN
ajlm-2688	102	3	,	,	PUNCT
ajlm-2688	102	4	rt	rt	PROPN
ajlm-2688	102	5	standards	standard	NOUN
ajlm-2688	102	6	range	range	VERB
ajlm-2688	102	7	from	from	ADP
ajlm-2688	102	8	15	15	NUM
ajlm-2688	102	9	°	°	NOUN
ajlm-2688	102	10	c	c	NOUN
ajlm-2688	102	11	to	to	ADP
ajlm-2688	102	12	30	30	NUM
ajlm-2688	102	13	°	°	ADP
ajlm-2688	102	14	c	c	NOUN
ajlm-2688	102	15	globally	globally	ADV
ajlm-2688	102	16	,	,	PUNCT
ajlm-2688	102	17	depending	depend	VERB
ajlm-2688	102	18	on	on	ADP
ajlm-2688	102	19	climate	climate	NOUN
ajlm-2688	102	20	and	and	CCONJ
ajlm-2688	102	21	regulatory	regulatory	ADJ
ajlm-2688	102	22	guidelines.29,30	guidelines.29,30	NOUN
ajlm-2688	102	23	in	in	ADP
ajlm-2688	102	24	south	south	PROPN
ajlm-2688	102	25	africa	africa	PROPN
ajlm-2688	102	26	,	,	PUNCT
ajlm-2688	102	27	where	where	SCONJ
ajlm-2688	102	28	this	this	DET
ajlm-2688	102	29	study	study	NOUN
ajlm-2688	102	30	was	be	AUX
ajlm-2688	102	31	conducted	conduct	VERB
ajlm-2688	102	32	,	,	PUNCT
ajlm-2688	102	33	rt	rt	PROPN
ajlm-2688	102	34	typically	typically	ADV
ajlm-2688	102	35	falls	fall	VERB
ajlm-2688	102	36	between	between	ADP
ajlm-2688	102	37	21	21	NUM
ajlm-2688	102	38	°	°	NOUN
ajlm-2688	102	39	c	c	NOUN
ajlm-2688	102	40	and	and	CCONJ
ajlm-2688	102	41	26	26	NUM
ajlm-2688	102	42	°	°	NOUN
ajlm-2688	102	43	c,31	c,31	NOUN
ajlm-2688	102	44	with	with	ADP
ajlm-2688	102	45	22	22	NUM
ajlm-2688	102	46	°	°	NOUN
ajlm-2688	102	47	c	c	NOUN
ajlm-2688	102	48	±	±	NUM
ajlm-2688	102	49	2	2	NUM
ajlm-2688	102	50	°	°	PRON
ajlm-2688	102	51	c	c	NOUN
ajlm-2688	102	52	advised	advise	VERB
ajlm-2688	102	53	for	for	ADP
ajlm-2688	102	54	blood	blood	NOUN
ajlm-2688	102	55	-	-	PUNCT
ajlm-2688	102	56	handling	handling	NOUN
ajlm-2688	102	57	facilities.31,32	facilities.31,32	NOUN
ajlm-2688	102	58	additionally	additionally	ADV
ajlm-2688	102	59	,	,	PUNCT
ajlm-2688	102	60	structural	structural	ADJ
ajlm-2688	102	61	similarities	similarity	NOUN
ajlm-2688	102	62	between	between	ADP
ajlm-2688	102	63	cd23	cd23	PROPN
ajlm-2688	102	64	and	and	CCONJ
ajlm-2688	102	65	cd200	cd200	PROPN
ajlm-2688	102	66	–	–	PUNCT
ajlm-2688	102	67	both	both	PRON
ajlm-2688	102	68	containing	contain	VERB
ajlm-2688	102	69	immunoglobulin	immunoglobulin	NOUN
ajlm-2688	102	70	-	-	PUNCT
ajlm-2688	102	71	like	like	ADJ
ajlm-2688	102	72	domains	domain	NOUN
ajlm-2688	102	73	–	–	PUNCT
ajlm-2688	102	74	might	might	AUX
ajlm-2688	102	75	influence	influence	VERB
ajlm-2688	102	76	their	their	PRON
ajlm-2688	102	77	stability	stability	NOUN
ajlm-2688	102	78	under	under	ADP
ajlm-2688	102	79	varying	vary	VERB
ajlm-2688	102	80	conditions.33,34	conditions.33,34	NOUN
ajlm-2688	102	81	our	our	PRON
ajlm-2688	102	82	study	study	NOUN
ajlm-2688	102	83	suggests	suggest	VERB
ajlm-2688	102	84	that	that	SCONJ
ajlm-2688	102	85	maintaining	maintain	VERB
ajlm-2688	102	86	samples	sample	NOUN
ajlm-2688	102	87	at	at	ADP
ajlm-2688	102	88	refrigerator	refrigerator	NOUN
ajlm-2688	102	89	temperature	temperature	NOUN
ajlm-2688	102	90	,	,	PUNCT
ajlm-2688	102	91	rather	rather	ADV
ajlm-2688	102	92	than	than	ADP
ajlm-2688	102	93	rt	rt	PROPN
ajlm-2688	102	94	,	,	PUNCT
ajlm-2688	102	95	may	may	AUX
ajlm-2688	102	96	better	well	ADV
ajlm-2688	102	97	preserve	preserve	VERB
ajlm-2688	102	98	sample	sample	NOUN
ajlm-2688	102	99	integrity	integrity	NOUN
ajlm-2688	102	100	and	and	CCONJ
ajlm-2688	102	101	accuracy	accuracy	NOUN
ajlm-2688	102	102	in	in	ADP
ajlm-2688	102	103	flow	flow	NOUN
ajlm-2688	102	104	cytometric	cytometric	ADJ
ajlm-2688	102	105	analyses	analysis	NOUN
ajlm-2688	102	106	.	.	PUNCT
ajlm-2688	103	1	this	this	DET
ajlm-2688	103	2	principle	principle	NOUN
ajlm-2688	103	3	applies	apply	VERB
ajlm-2688	103	4	not	not	PART
ajlm-2688	103	5	only	only	ADV
ajlm-2688	103	6	to	to	PART
ajlm-2688	103	7	flow	flow	VERB
ajlm-2688	103	8	cytometry	cytometry	NOUN
ajlm-2688	103	9	samples	sample	NOUN
ajlm-2688	103	10	but	but	CCONJ
ajlm-2688	103	11	has	have	AUX
ajlm-2688	103	12	also	also	ADV
ajlm-2688	103	13	been	be	AUX
ajlm-2688	103	14	shown	show	VERB
ajlm-2688	103	15	to	to	PART
ajlm-2688	103	16	be	be	AUX
ajlm-2688	103	17	true	true	ADJ
ajlm-2688	103	18	for	for	ADP
ajlm-2688	103	19	full	full	ADJ
ajlm-2688	103	20	blood	blood	NOUN
ajlm-2688	103	21	count	count	NOUN
ajlm-2688	103	22	parameters	parameter	NOUN
ajlm-2688	103	23	when	when	SCONJ
ajlm-2688	103	24	processing	processing	NOUN
ajlm-2688	103	25	is	be	AUX
ajlm-2688	103	26	delayed.35	delayed.35	VERB
ajlm-2688	103	27	interestingly	interestingly	ADV
ajlm-2688	103	28	,	,	PUNCT
ajlm-2688	103	29	sigm	sigm	ADJ
ajlm-2688	103	30	levels	level	NOUN
ajlm-2688	103	31	decreased	decrease	VERB
ajlm-2688	103	32	significantly	significantly	ADV
ajlm-2688	103	33	under	under	ADP
ajlm-2688	103	34	refrigerated	refrigerated	ADJ
ajlm-2688	103	35	conditions	condition	NOUN
ajlm-2688	103	36	,	,	PUNCT
ajlm-2688	103	37	potentially	potentially	ADV
ajlm-2688	103	38	because	because	SCONJ
ajlm-2688	103	39	of	of	ADP
ajlm-2688	103	40	its	its	PRON
ajlm-2688	103	41	low	low	ADJ
ajlm-2688	103	42	baseline	baseline	NOUN
ajlm-2688	103	43	expression	expression	NOUN
ajlm-2688	103	44	in	in	ADP
ajlm-2688	103	45	cll	cll	PROPN
ajlm-2688	103	46	cells	cell	NOUN
ajlm-2688	103	47	,	,	PUNCT
ajlm-2688	103	48	making	make	VERB
ajlm-2688	103	49	it	it	PRON
ajlm-2688	103	50	more	more	ADV
ajlm-2688	103	51	susceptible	susceptible	ADJ
ajlm-2688	103	52	to	to	ADP
ajlm-2688	103	53	degradation	degradation	NOUN
ajlm-2688	103	54	.	.	PUNCT
ajlm-2688	104	1	alternatively	alternatively	ADV
ajlm-2688	104	2	,	,	PUNCT
ajlm-2688	104	3	guo	guo	PROPN
ajlm-2688	104	4	et	et	PROPN
ajlm-2688	104	5	al	al	PROPN
ajlm-2688	104	6	.	.	PROPN
ajlm-2688	104	7	found	find	VERB
ajlm-2688	104	8	that	that	SCONJ
ajlm-2688	104	9	interleukin-4	interleukin-4	NOUN
ajlm-2688	104	10	(	(	PUNCT
ajlm-2688	104	11	not	not	PART
ajlm-2688	104	12	assessed	assess	VERB
ajlm-2688	104	13	in	in	ADP
ajlm-2688	104	14	this	this	DET
ajlm-2688	104	15	study	study	NOUN
ajlm-2688	104	16	)	)	PUNCT
ajlm-2688	104	17	could	could	AUX
ajlm-2688	104	18	increase	increase	VERB
ajlm-2688	104	19	sigm	sigm	ADJ
ajlm-2688	104	20	expression	expression	NOUN
ajlm-2688	104	21	in	in	ADP
ajlm-2688	104	22	cll,36	cll,36	NOUN
ajlm-2688	104	23	while	while	SCONJ
ajlm-2688	104	24	jackson	jackson	PROPN
ajlm-2688	104	25	et	et	PROPN
ajlm-2688	104	26	al	al	PROPN
ajlm-2688	104	27	.	.	PROPN
ajlm-2688	104	28	reported	report	VERB
ajlm-2688	104	29	lower	low	ADJ
ajlm-2688	104	30	interleukin-4	interleukin-4	NOUN
ajlm-2688	104	31	levels	level	NOUN
ajlm-2688	104	32	at	at	ADP
ajlm-2688	104	33	4	4	NUM
ajlm-2688	104	34	°	°	ADP
ajlm-2688	104	35	c	c	NOUN
ajlm-2688	104	36	compared	compare	VERB
ajlm-2688	104	37	to	to	PART
ajlm-2688	104	38	rt,37	rt,37	VERB
ajlm-2688	104	39	potentially	potentially	ADV
ajlm-2688	104	40	explaining	explain	VERB
ajlm-2688	104	41	the	the	DET
ajlm-2688	104	42	observations	observation	NOUN
ajlm-2688	104	43	.	.	PUNCT
ajlm-2688	105	1	although	although	SCONJ
ajlm-2688	105	2	the	the	DET
ajlm-2688	105	3	evaluation	evaluation	NOUN
ajlm-2688	105	4	of	of	ADP
ajlm-2688	105	5	cd200	cd200	PROPN
ajlm-2688	105	6	is	be	AUX
ajlm-2688	105	7	not	not	PART
ajlm-2688	105	8	a	a	DET
ajlm-2688	105	9	mandatory	mandatory	ADJ
ajlm-2688	105	10	criterion	criterion	NOUN
ajlm-2688	105	11	in	in	ADP
ajlm-2688	105	12	cll	cll	PROPN
ajlm-2688	105	13	diagnosis	diagnosis	NOUN
ajlm-2688	105	14	as	as	SCONJ
ajlm-2688	105	15	defined	define	VERB
ajlm-2688	105	16	by	by	ADP
ajlm-2688	105	17	the	the	DET
ajlm-2688	105	18	world	world	PROPN
ajlm-2688	105	19	health	health	PROPN
ajlm-2688	105	20	organization,3	organization,3	NOUN
ajlm-2688	105	21	its	its	PRON
ajlm-2688	105	22	inclusion	inclusion	NOUN
ajlm-2688	105	23	has	have	AUX
ajlm-2688	105	24	been	be	AUX
ajlm-2688	105	25	advocated	advocate	VERB
ajlm-2688	105	26	in	in	ADP
ajlm-2688	105	27	the	the	DET
ajlm-2688	105	28	euroflow	euroflow	NOUN
ajlm-2688	105	29	guidelines	guideline	NOUN
ajlm-2688	105	30	,	,	PUNCT
ajlm-2688	105	31	and	and	CCONJ
ajlm-2688	105	32	previous	previous	ADJ
ajlm-2688	105	33	research	research	NOUN
ajlm-2688	105	34	has	have	AUX
ajlm-2688	105	35	attested	attest	VERB
ajlm-2688	105	36	to	to	ADP
ajlm-2688	105	37	its	its	PRON
ajlm-2688	105	38	high	high	ADJ
ajlm-2688	105	39	diagnostic	diagnostic	ADJ
ajlm-2688	105	40	utility	utility	NOUN
ajlm-2688	105	41	,	,	PUNCT
ajlm-2688	105	42	especially	especially	ADV
ajlm-2688	105	43	in	in	ADP
ajlm-2688	105	44	distinguishing	distinguish	VERB
ajlm-2688	105	45	cll	cll	PROPN
ajlm-2688	105	46	from	from	ADP
ajlm-2688	105	47	mantle	mantle	ADJ
ajlm-2688	105	48	cell	cell	NOUN
ajlm-2688	105	49	lymphoma.38	lymphoma.38	PROPN
ajlm-2688	105	50	the	the	DET
ajlm-2688	105	51	adapted	adapt	VERB
ajlm-2688	105	52	matutes	matute	NOUN
ajlm-2688	105	53	score	score	NOUN
ajlm-2688	105	54	represents	represent	VERB
ajlm-2688	105	55	a	a	DET
ajlm-2688	105	56	four	four	NUM
ajlm-2688	105	57	-	-	PUNCT
ajlm-2688	105	58	marker	marker	NOUN
ajlm-2688	105	59	scoring	scoring	NOUN
ajlm-2688	105	60	system	system	NOUN
ajlm-2688	105	61	,	,	PUNCT
ajlm-2688	105	62	which	which	PRON
ajlm-2688	105	63	incorporates	incorporate	VERB
ajlm-2688	105	64	cd200	cd200	PROPN
ajlm-2688	105	65	,	,	PUNCT
ajlm-2688	105	66	streamlining	streamline	VERB
ajlm-2688	105	67	the	the	DET
ajlm-2688	105	68	antibody	antibody	NOUN
ajlm-2688	105	69	requirements	requirement	NOUN
ajlm-2688	105	70	for	for	ADP
ajlm-2688	105	71	cll	cll	PROPN
ajlm-2688	105	72	diagnosis	diagnosis	NOUN
ajlm-2688	105	73	,	,	PUNCT
ajlm-2688	105	74	and	and	CCONJ
ajlm-2688	105	75	offering	offer	VERB
ajlm-2688	105	76	valuable	valuable	ADJ
ajlm-2688	105	77	advantages	advantage	NOUN
ajlm-2688	105	78	in	in	ADP
ajlm-2688	105	79	resource	resource	NOUN
ajlm-2688	105	80	-	-	PUNCT
ajlm-2688	105	81	constrained	constrain	VERB
ajlm-2688	105	82	settings.10	settings.10	NOUN
ajlm-2688	105	83	in	in	ADP
ajlm-2688	105	84	the	the	DET
ajlm-2688	105	85	current	current	ADJ
ajlm-2688	105	86	research	research	NOUN
ajlm-2688	105	87	,	,	PUNCT
ajlm-2688	105	88	the	the	DET
ajlm-2688	105	89	adapted	adapt	VERB
ajlm-2688	105	90	matutes	matute	NOUN
ajlm-2688	105	91	score	score	NOUN
ajlm-2688	105	92	exhibited	exhibit	VERB
ajlm-2688	105	93	greater	great	ADJ
ajlm-2688	105	94	diagnostic	diagnostic	ADJ
ajlm-2688	105	95	accuracy	accuracy	NOUN
ajlm-2688	105	96	for	for	ADP
ajlm-2688	105	97	cll	cll	PROPN
ajlm-2688	105	98	than	than	ADP
ajlm-2688	105	99	the	the	DET
ajlm-2688	105	100	moreau	moreau	PROPN
ajlm-2688	105	101	score	score	NOUN
ajlm-2688	105	102	when	when	SCONJ
ajlm-2688	105	103	dealing	deal	VERB
ajlm-2688	105	104	with	with	ADP
ajlm-2688	105	105	samples	sample	NOUN
ajlm-2688	105	106	subjected	subject	VERB
ajlm-2688	105	107	to	to	ADP
ajlm-2688	105	108	delayed	delay	VERB
ajlm-2688	105	109	analysis	analysis	NOUN
ajlm-2688	105	110	.	.	PUNCT
ajlm-2688	106	1	arguably	arguably	ADV
ajlm-2688	106	2	,	,	PUNCT
ajlm-2688	106	3	the	the	DET
ajlm-2688	106	4	inclusion	inclusion	NOUN
ajlm-2688	106	5	of	of	ADP
ajlm-2688	106	6	fewer	few	ADJ
ajlm-2688	106	7	markers	marker	NOUN
ajlm-2688	106	8	susceptible	susceptible	ADJ
ajlm-2688	106	9	to	to	ADP
ajlm-2688	106	10	time	time	NOUN
ajlm-2688	106	11	and	and	CCONJ
ajlm-2688	106	12	temperature	temperature	NOUN
ajlm-2688	106	13	-	-	PUNCT
ajlm-2688	106	14	dependent	dependent	ADJ
ajlm-2688	106	15	changes	change	NOUN
ajlm-2688	106	16	may	may	AUX
ajlm-2688	106	17	translate	translate	VERB
ajlm-2688	106	18	to	to	ADP
ajlm-2688	106	19	a	a	DET
ajlm-2688	106	20	more	more	ADV
ajlm-2688	106	21	robust	robust	ADJ
ajlm-2688	106	22	scoring	scoring	NOUN
ajlm-2688	106	23	system	system	NOUN
ajlm-2688	106	24	with	with	ADP
ajlm-2688	106	25	heightened	heightened	ADJ
ajlm-2688	106	26	accuracy	accuracy	NOUN
ajlm-2688	106	27	.	.	PUNCT
ajlm-2688	107	1	the	the	DET
ajlm-2688	107	2	influence	influence	NOUN
ajlm-2688	107	3	of	of	ADP
ajlm-2688	107	4	storage	storage	NOUN
ajlm-2688	107	5	conditions	condition	NOUN
ajlm-2688	107	6	on	on	ADP
ajlm-2688	107	7	the	the	DET
ajlm-2688	107	8	percentage	percentage	NOUN
ajlm-2688	107	9	antigen	antigen	NOUN
ajlm-2688	107	10	expression	expression	NOUN
ajlm-2688	107	11	and	and	CCONJ
ajlm-2688	107	12	mfi	mfi	PROPN
ajlm-2688	107	13	of	of	ADP
ajlm-2688	107	14	markers	marker	NOUN
ajlm-2688	107	15	employed	employ	VERB
ajlm-2688	107	16	in	in	ADP
ajlm-2688	107	17	the	the	DET
ajlm-2688	107	18	cll	cll	PROPN
ajlm-2688	107	19	scoring	scoring	NOUN
ajlm-2688	107	20	systems	system	NOUN
ajlm-2688	107	21	allowed	allow	VERB
ajlm-2688	107	22	a	a	DET
ajlm-2688	107	23	shift	shift	NOUN
ajlm-2688	107	24	in	in	ADP
ajlm-2688	107	25	the	the	DET
ajlm-2688	107	26	calculated	calculate	VERB
ajlm-2688	107	27	scores	score	NOUN
ajlm-2688	107	28	to	to	PART
ajlm-2688	107	29	support	support	VERB
ajlm-2688	107	30	a	a	DET
ajlm-2688	107	31	diagnosis	diagnosis	NOUN
ajlm-2688	107	32	of	of	ADP
ajlm-2688	107	33	acll	acll	NOUN
ajlm-2688	107	34	or	or	CCONJ
ajlm-2688	107	35	even	even	ADV
ajlm-2688	107	36	another	another	DET
ajlm-2688	107	37	b	b	PROPN
ajlm-2688	107	38	-	-	PUNCT
ajlm-2688	107	39	lpd	lpd	PROPN
ajlm-2688	107	40	.	.	PROPN
ajlm-2688	108	1	notable	notable	ADJ
ajlm-2688	108	2	deviations	deviation	NOUN
ajlm-2688	108	3	in	in	ADP
ajlm-2688	108	4	the	the	DET
ajlm-2688	108	5	adapted	adapt	VERB
ajlm-2688	108	6	matutes	matute	NOUN
ajlm-2688	108	7	and	and	CCONJ
ajlm-2688	108	8	moreau	moreau	PROPN
ajlm-2688	108	9	scores	score	NOUN
ajlm-2688	108	10	were	be	AUX
ajlm-2688	108	11	discerned	discern	VERB
ajlm-2688	108	12	in	in	ADP
ajlm-2688	108	13	two	two	NUM
ajlm-2688	108	14	samples	sample	NOUN
ajlm-2688	108	15	after	after	ADP
ajlm-2688	108	16	only	only	ADV
ajlm-2688	108	17	24	24	NUM
ajlm-2688	108	18	h	h	NOUN
ajlm-2688	108	19	of	of	ADP
ajlm-2688	108	20	storage	storage	NOUN
ajlm-2688	108	21	,	,	PUNCT
ajlm-2688	108	22	irrespective	irrespective	ADV
ajlm-2688	108	23	of	of	ADP
ajlm-2688	108	24	the	the	DET
ajlm-2688	108	25	temperature	temperature	NOUN
ajlm-2688	108	26	setting	setting	NOUN
ajlm-2688	108	27	.	.	PUNCT
ajlm-2688	109	1	this	this	PRON
ajlm-2688	109	2	may	may	AUX
ajlm-2688	109	3	partly	partly	ADV
ajlm-2688	109	4	be	be	AUX
ajlm-2688	109	5	explained	explain	VERB
ajlm-2688	109	6	by	by	ADP
ajlm-2688	109	7	the	the	DET
ajlm-2688	109	8	elevated	elevate	VERB
ajlm-2688	109	9	white	white	ADJ
ajlm-2688	109	10	cell	cell	NOUN
ajlm-2688	109	11	counts	count	NOUN
ajlm-2688	109	12	(	(	PUNCT
ajlm-2688	109	13	±	±	NOUN
ajlm-2688	109	14	200	200	NUM
ajlm-2688	109	15	×	×	NOUN
ajlm-2688	109	16	109	109	NUM
ajlm-2688	109	17	/	/	SYM
ajlm-2688	109	18	l	l	NOUN
ajlm-2688	109	19	)	)	PUNCT
ajlm-2688	109	20	observed	observe	VERB
ajlm-2688	109	21	in	in	ADP
ajlm-2688	109	22	these	these	DET
ajlm-2688	109	23	two	two	NUM
ajlm-2688	109	24	samples	sample	NOUN
ajlm-2688	109	25	.	.	PUNCT
ajlm-2688	110	1	however	however	ADV
ajlm-2688	110	2	,	,	PUNCT
ajlm-2688	110	3	underlying	underlying	ADJ
ajlm-2688	110	4	genetic	genetic	ADJ
ajlm-2688	110	5	aberrations	aberration	NOUN
ajlm-2688	110	6	may	may	AUX
ajlm-2688	110	7	also	also	ADV
ajlm-2688	110	8	have	have	AUX
ajlm-2688	110	9	contributed	contribute	VERB
ajlm-2688	110	10	.	.	PUNCT
ajlm-2688	111	1	the	the	DET
ajlm-2688	111	2	clinical	clinical	ADJ
ajlm-2688	111	3	significance	significance	NOUN
ajlm-2688	111	4	of	of	ADP
ajlm-2688	111	5	acll	acll	NOUN
ajlm-2688	111	6	remains	remain	VERB
ajlm-2688	111	7	debatable	debatable	ADJ
ajlm-2688	111	8	,	,	PUNCT
ajlm-2688	111	9	and	and	CCONJ
ajlm-2688	111	10	in	in	ADP
ajlm-2688	111	11	the	the	DET
ajlm-2688	111	12	absence	absence	NOUN
ajlm-2688	111	13	of	of	ADP
ajlm-2688	111	14	a	a	DET
ajlm-2688	111	15	standardised	standardised	ADJ
ajlm-2688	111	16	and	and	CCONJ
ajlm-2688	111	17	universally	universally	ADV
ajlm-2688	111	18	accepted	accept	VERB
ajlm-2688	111	19	definition	definition	NOUN
ajlm-2688	111	20	for	for	ADP
ajlm-2688	111	21	acll,14	acll,14	NOUN
ajlm-2688	111	22	the	the	DET
ajlm-2688	111	23	term	term	NOUN
ajlm-2688	111	24	is	be	AUX
ajlm-2688	111	25	often	often	ADV
ajlm-2688	111	26	used	use	VERB
ajlm-2688	111	27	more	more	ADV
ajlm-2688	111	28	broadly	broadly	ADV
ajlm-2688	111	29	to	to	PART
ajlm-2688	111	30	describe	describe	VERB
ajlm-2688	111	31	cases	case	NOUN
ajlm-2688	111	32	with	with	ADP
ajlm-2688	111	33	an	an	DET
ajlm-2688	111	34	unconventional	unconventional	ADJ
ajlm-2688	111	35	immunophenotype	immunophenotype	NOUN
ajlm-2688	111	36	and	and	CCONJ
ajlm-2688	111	37	is	be	AUX
ajlm-2688	111	38	unlikely	unlikely	ADJ
ajlm-2688	111	39	to	to	PART
ajlm-2688	111	40	represent	represent	VERB
ajlm-2688	111	41	a	a	DET
ajlm-2688	111	42	single	single	ADJ
ajlm-2688	111	43	biological	biological	ADJ
ajlm-2688	111	44	entity.15	entity.15	NOUN
ajlm-2688	111	45	as	as	ADP
ajlm-2688	111	46	such	such	ADJ
ajlm-2688	111	47	,	,	PUNCT
ajlm-2688	111	48	the	the	DET
ajlm-2688	111	49	term	term	NOUN
ajlm-2688	111	50	‘	'	PUNCT
ajlm-2688	111	51	b	b	X
ajlm-2688	111	52	-	-	PUNCT
ajlm-2688	111	53	lpd	lpd	PROPN
ajlm-2688	111	54	other	other	ADJ
ajlm-2688	111	55	than	than	ADP
ajlm-2688	111	56	cll	cll	PROPN
ajlm-2688	111	57	’	'	PUNCT
ajlm-2688	111	58	may	may	AUX
ajlm-2688	111	59	be	be	AUX
ajlm-2688	111	60	more	more	ADV
ajlm-2688	111	61	appropriate	appropriate	ADJ
ajlm-2688	111	62	to	to	PART
ajlm-2688	111	63	prevent	prevent	VERB
ajlm-2688	111	64	the	the	DET
ajlm-2688	111	65	inadvertent	inadvertent	ADJ
ajlm-2688	111	66	exclusion	exclusion	NOUN
ajlm-2688	111	67	of	of	ADP
ajlm-2688	111	68	other	other	ADJ
ajlm-2688	111	69	b	b	PROPN
ajlm-2688	111	70	-	-	PUNCT
ajlm-2688	111	71	lpd	lpd	PROPN
ajlm-2688	111	72	subtypes	subtype	NOUN
ajlm-2688	111	73	.	.	PUNCT
ajlm-2688	112	1	with	with	ADP
ajlm-2688	112	2	treatment	treatment	NOUN
ajlm-2688	112	3	modalities	modality	NOUN
ajlm-2688	112	4	revolutionising	revolutionise	VERB
ajlm-2688	112	5	to	to	ADP
ajlm-2688	112	6	more	more	ADJ
ajlm-2688	112	7	targeted	target	VERB
ajlm-2688	112	8	therapies	therapy	NOUN
ajlm-2688	112	9	,	,	PUNCT
ajlm-2688	112	10	the	the	DET
ajlm-2688	112	11	distinction	distinction	NOUN
ajlm-2688	112	12	between	between	ADP
ajlm-2688	112	13	cll	cll	PROPN
ajlm-2688	112	14	and	and	CCONJ
ajlm-2688	112	15	other	other	ADJ
ajlm-2688	112	16	b	b	PROPN
ajlm-2688	112	17	-	-	PUNCT
ajlm-2688	112	18	lpds	lpds	NOUN
ajlm-2688	112	19	invokes	invoke	VERB
ajlm-2688	112	20	significant	significant	ADJ
ajlm-2688	112	21	treatment	treatment	NOUN
ajlm-2688	112	22	implications	implication	NOUN
ajlm-2688	112	23	.	.	PUNCT
ajlm-2688	113	1	limitations	limitation	NOUN
ajlm-2688	113	2	budgetary	budgetary	ADJ
ajlm-2688	113	3	constraints	constraint	NOUN
ajlm-2688	113	4	imposed	impose	VERB
ajlm-2688	113	5	limitations	limitation	NOUN
ajlm-2688	113	6	on	on	ADP
ajlm-2688	113	7	the	the	DET
ajlm-2688	113	8	number	number	NOUN
ajlm-2688	113	9	of	of	ADP
ajlm-2688	113	10	samples	sample	NOUN
ajlm-2688	113	11	subjected	subject	VERB
ajlm-2688	113	12	to	to	ADP
ajlm-2688	113	13	analysis	analysis	NOUN
ajlm-2688	113	14	.	.	PUNCT
ajlm-2688	114	1	despite	despite	SCONJ
ajlm-2688	114	2	only	only	ADV
ajlm-2688	114	3	including	include	VERB
ajlm-2688	114	4	10	10	NUM
ajlm-2688	114	5	patients	patient	NOUN
ajlm-2688	114	6	in	in	ADP
ajlm-2688	114	7	our	our	PRON
ajlm-2688	114	8	study	study	NOUN
ajlm-2688	114	9	,	,	PUNCT
ajlm-2688	114	10	each	each	DET
ajlm-2688	114	11	patient	patient	NOUN
ajlm-2688	114	12	’s	’s	PART
ajlm-2688	114	13	sample	sample	NOUN
ajlm-2688	114	14	underwent	underwent	NOUN
ajlm-2688	114	15	flow	flow	NOUN
ajlm-2688	114	16	cytometric	cytometric	ADJ
ajlm-2688	114	17	analysis	analysis	NOUN
ajlm-2688	114	18	nine	nine	NUM
ajlm-2688	114	19	times	time	NOUN
ajlm-2688	114	20	,	,	PUNCT
ajlm-2688	114	21	encompassing	encompass	VERB
ajlm-2688	114	22	baseline	baseline	NOUN
ajlm-2688	114	23	assessments	assessment	NOUN
ajlm-2688	114	24	and	and	CCONJ
ajlm-2688	114	25	subsequent	subsequent	ADJ
ajlm-2688	114	26	evaluations	evaluation	NOUN
ajlm-2688	114	27	at	at	ADP
ajlm-2688	114	28	four	four	NUM
ajlm-2688	114	29	different	different	ADJ
ajlm-2688	114	30	time	time	NOUN
ajlm-2688	114	31	points	point	NOUN
ajlm-2688	114	32	,	,	PUNCT
ajlm-2688	114	33	both	both	CCONJ
ajlm-2688	114	34	under	under	ADP
ajlm-2688	114	35	refrigerator	refrigerator	NOUN
ajlm-2688	114	36	and	and	CCONJ
ajlm-2688	114	37	rt	rt	PROPN
ajlm-2688	114	38	conditions	condition	NOUN
ajlm-2688	114	39	.	.	PUNCT
ajlm-2688	115	1	we	we	PRON
ajlm-2688	115	2	enrolled	enrol	VERB
ajlm-2688	115	3	patients	patient	NOUN
ajlm-2688	115	4	exhibiting	exhibit	VERB
ajlm-2688	115	5	morphologically	morphologically	ADV
ajlm-2688	115	6	detectable	detectable	ADJ
ajlm-2688	115	7	cll	cll	NOUN
ajlm-2688	115	8	and	and	CCONJ
ajlm-2688	115	9	a	a	DET
ajlm-2688	115	10	typical	typical	ADJ
ajlm-2688	115	11	baseline	baseline	NOUN
ajlm-2688	115	12	immunophenotype	immunophenotype	NOUN
ajlm-2688	115	13	,	,	PUNCT
ajlm-2688	115	14	irrespective	irrespective	ADV
ajlm-2688	115	15	of	of	ADP
ajlm-2688	115	16	their	their	PRON
ajlm-2688	115	17	treatment	treatment	NOUN
ajlm-2688	115	18	status	status	NOUN
ajlm-2688	115	19	.	.	PUNCT
ajlm-2688	116	1	it	it	PRON
ajlm-2688	116	2	is	be	AUX
ajlm-2688	116	3	important	important	ADJ
ajlm-2688	116	4	to	to	PART
ajlm-2688	116	5	note	note	VERB
ajlm-2688	116	6	that	that	SCONJ
ajlm-2688	116	7	the	the	DET
ajlm-2688	116	8	impact	impact	NOUN
ajlm-2688	116	9	of	of	ADP
ajlm-2688	116	10	treatment	treatment	NOUN
ajlm-2688	116	11	could	could	AUX
ajlm-2688	116	12	potentially	potentially	ADV
ajlm-2688	116	13	alter	alter	VERB
ajlm-2688	116	14	the	the	DET
ajlm-2688	116	15	expression	expression	NOUN
ajlm-2688	116	16	of	of	ADP
ajlm-2688	116	17	specific	specific	ADJ
ajlm-2688	116	18	markers	marker	NOUN
ajlm-2688	116	19	in	in	ADP
ajlm-2688	116	20	cll	cll	PROPN
ajlm-2688	116	21	.	.	PUNCT
ajlm-2688	117	1	for	for	ADP
ajlm-2688	117	2	our	our	PRON
ajlm-2688	117	3	analysis	analysis	NOUN
ajlm-2688	117	4	,	,	PUNCT
ajlm-2688	117	5	we	we	PRON
ajlm-2688	117	6	adhered	adhere	VERB
ajlm-2688	117	7	to	to	ADP
ajlm-2688	117	8	specific	specific	ADJ
ajlm-2688	117	9	fluorochromes	fluorochrome	NOUN
ajlm-2688	117	10	according	accord	VERB
ajlm-2688	117	11	to	to	ADP
ajlm-2688	117	12	the	the	DET
ajlm-2688	117	13	euroflow	euroflow	NOUN
ajlm-2688	117	14	guidelines.7,22	guidelines.7,22	NOUN
ajlm-2688	117	15	these	these	DET
ajlm-2688	117	16	findings	finding	NOUN
ajlm-2688	117	17	may	may	AUX
ajlm-2688	117	18	not	not	PART
ajlm-2688	117	19	be	be	AUX
ajlm-2688	117	20	universally	universally	ADV
ajlm-2688	117	21	applicable	applicable	ADJ
ajlm-2688	117	22	to	to	ADP
ajlm-2688	117	23	products	product	NOUN
ajlm-2688	117	24	from	from	ADP
ajlm-2688	117	25	alternative	alternative	ADJ
ajlm-2688	117	26	manufacturers	manufacturer	NOUN
ajlm-2688	117	27	.	.	PUNCT
ajlm-2688	118	1	samples	sample	NOUN
ajlm-2688	118	2	were	be	AUX
ajlm-2688	118	3	collected	collect	VERB
ajlm-2688	118	4	in	in	ADP
ajlm-2688	118	5	edta	edta	NOUN
ajlm-2688	118	6	tubes	tube	NOUN
ajlm-2688	118	7	.	.	PUNCT
ajlm-2688	119	1	various	various	ADJ
ajlm-2688	119	2	studies	study	NOUN
ajlm-2688	119	3	have	have	AUX
ajlm-2688	119	4	indicated	indicate	VERB
ajlm-2688	119	5	that	that	SCONJ
ajlm-2688	119	6	the	the	DET
ajlm-2688	119	7	stability	stability	NOUN
ajlm-2688	119	8	of	of	ADP
ajlm-2688	119	9	cell	cell	NOUN
ajlm-2688	119	10	surface	surface	NOUN
ajlm-2688	119	11	marker	marker	NOUN
ajlm-2688	119	12	expression	expression	NOUN
ajlm-2688	119	13	and	and	CCONJ
ajlm-2688	119	14	population	population	NOUN
ajlm-2688	119	15	distribution	distribution	NOUN
ajlm-2688	119	16	is	be	AUX
ajlm-2688	119	17	greater	great	ADJ
ajlm-2688	119	18	in	in	ADP
ajlm-2688	119	19	sodium	sodium	NOUN
ajlm-2688	119	20	-	-	PUNCT
ajlm-2688	119	21	heparin	heparin	NOUN
ajlm-2688	119	22	blood	blood	NOUN
ajlm-2688	119	23	compared	compare	VERB
ajlm-2688	119	24	to	to	ADP
ajlm-2688	119	25	edta	edta	NOUN
ajlm-2688	119	26	blood.19,20	blood.19,20	NOUN
ajlm-2688	119	27	however	however	ADV
ajlm-2688	119	28	,	,	PUNCT
ajlm-2688	119	29	it	it	PRON
ajlm-2688	119	30	should	should	AUX
ajlm-2688	119	31	be	be	AUX
ajlm-2688	119	32	noted	note	VERB
ajlm-2688	119	33	that	that	SCONJ
ajlm-2688	119	34	storing	store	VERB
ajlm-2688	119	35	sodium	sodium	NOUN
ajlm-2688	119	36	-	-	PUNCT
ajlm-2688	119	37	heparin	heparin	NOUN
ajlm-2688	119	38	samples	sample	NOUN
ajlm-2688	119	39	is	be	AUX
ajlm-2688	119	40	associated	associate	VERB
ajlm-2688	119	41	with	with	ADP
ajlm-2688	119	42	a	a	DET
ajlm-2688	119	43	more	more	ADV
ajlm-2688	119	44	rapid	rapid	ADJ
ajlm-2688	119	45	decline	decline	NOUN
ajlm-2688	119	46	in	in	ADP
ajlm-2688	119	47	leukocyte	leukocyte	NOUN
ajlm-2688	119	48	counts	count	NOUN
ajlm-2688	119	49	over	over	ADP
ajlm-2688	119	50	time	time	NOUN
ajlm-2688	119	51	.	.	PUNCT
ajlm-2688	120	1	the	the	DET
ajlm-2688	120	2	use	use	NOUN
ajlm-2688	120	3	of	of	ADP
ajlm-2688	120	4	whole	whole	ADJ
ajlm-2688	120	5	blood	blood	NOUN
ajlm-2688	120	6	fixation	fixation	NOUN
ajlm-2688	120	7	strategies	strategy	NOUN
ajlm-2688	120	8	(	(	PUNCT
ajlm-2688	120	9	cyto	cyto	PROPN
ajlm-2688	120	10	-	-	PUNCT
ajlm-2688	120	11	chex	chex	PROPN
ajlm-2688	120	12	®	®	PROPN
ajlm-2688	120	13	,	,	PUNCT
ajlm-2688	120	14	transfix	transfix	VERB
ajlm-2688	120	15	®	®	NOUN
ajlm-2688	120	16	)	)	PUNCT
ajlm-2688	120	17	to	to	PART
ajlm-2688	120	18	preserve	preserve	VERB
ajlm-2688	120	19	cell	cell	NOUN
ajlm-2688	120	20	populations	population	NOUN
ajlm-2688	120	21	in	in	ADP
ajlm-2688	120	22	stored	store	VERB
ajlm-2688	120	23	samples	sample	NOUN
ajlm-2688	120	24	intended	intend	VERB
ajlm-2688	120	25	for	for	ADP
ajlm-2688	120	26	flow	flow	NOUN
ajlm-2688	120	27	cytometric	cytometric	ADJ
ajlm-2688	120	28	analysis	analysis	NOUN
ajlm-2688	120	29	was	be	AUX
ajlm-2688	120	30	beyond	beyond	ADP
ajlm-2688	120	31	the	the	DET
ajlm-2688	120	32	scope	scope	NOUN
ajlm-2688	120	33	of	of	ADP
ajlm-2688	120	34	this	this	DET
ajlm-2688	120	35	study	study	NOUN
ajlm-2688	120	36	.	.	PUNCT
ajlm-2688	121	1	yet	yet	ADV
ajlm-2688	121	2	,	,	PUNCT
ajlm-2688	121	3	these	these	DET
ajlm-2688	121	4	reagents	reagent	NOUN
ajlm-2688	121	5	have	have	AUX
ajlm-2688	121	6	been	be	AUX
ajlm-2688	121	7	shown	show	VERB
ajlm-2688	121	8	to	to	PART
ajlm-2688	121	9	reduce	reduce	VERB
ajlm-2688	121	10	signal	signal	PROPN
ajlm-2688	121	11	intensity.19,20	intensity.19,20	ADJ
ajlm-2688	121	12	future	future	ADJ
ajlm-2688	121	13	studies	study	NOUN
ajlm-2688	121	14	could	could	AUX
ajlm-2688	121	15	involve	involve	VERB
ajlm-2688	121	16	larger	large	ADJ
ajlm-2688	121	17	cohorts	cohort	NOUN
ajlm-2688	121	18	,	,	PUNCT
ajlm-2688	121	19	encompassing	encompass	VERB
ajlm-2688	121	20	diverse	diverse	ADJ
ajlm-2688	121	21	haematological	haematological	ADJ
ajlm-2688	121	22	malignancies	malignancy	NOUN
ajlm-2688	121	23	.	.	PUNCT
ajlm-2688	122	1	in	in	ADP
ajlm-2688	122	2	addition	addition	NOUN
ajlm-2688	122	3	,	,	PUNCT
ajlm-2688	122	4	correlations	correlation	NOUN
ajlm-2688	122	5	between	between	ADP
ajlm-2688	122	6	disease	disease	NOUN
ajlm-2688	122	7	progression	progression	NOUN
ajlm-2688	122	8	,	,	PUNCT
ajlm-2688	122	9	molecular	molecular	ADJ
ajlm-2688	122	10	abnormalities	abnormality	NOUN
ajlm-2688	122	11	,	,	PUNCT
ajlm-2688	122	12	or	or	CCONJ
ajlm-2688	122	13	treatment	treatment	NOUN
ajlm-2688	122	14	interventions	intervention	NOUN
ajlm-2688	122	15	and	and	CCONJ
ajlm-2688	122	16	alterations	alteration	NOUN
ajlm-2688	122	17	in	in	ADP
ajlm-2688	122	18	antigen	antigen	ADJ
ajlm-2688	122	19	expression	expression	NOUN
ajlm-2688	122	20	of	of	ADP
ajlm-2688	122	21	cells	cell	NOUN
ajlm-2688	122	22	could	could	AUX
ajlm-2688	122	23	be	be	AUX
ajlm-2688	122	24	investigated	investigate	VERB
ajlm-2688	122	25	.	.	PUNCT
ajlm-2688	123	1	conclusion	conclusion	NOUN
ajlm-2688	123	2	in	in	ADP
ajlm-2688	123	3	conclusion	conclusion	NOUN
ajlm-2688	123	4	,	,	PUNCT
ajlm-2688	123	5	this	this	DET
ajlm-2688	123	6	study	study	NOUN
ajlm-2688	123	7	showed	show	VERB
ajlm-2688	123	8	that	that	SCONJ
ajlm-2688	123	9	storage	storage	NOUN
ajlm-2688	123	10	time	time	NOUN
ajlm-2688	123	11	and	and	CCONJ
ajlm-2688	123	12	storage	storage	NOUN
ajlm-2688	123	13	temperature	temperature	NOUN
ajlm-2688	123	14	impact	impact	NOUN
ajlm-2688	123	15	the	the	DET
ajlm-2688	123	16	stability	stability	NOUN
ajlm-2688	123	17	of	of	ADP
ajlm-2688	123	18	surface	surface	NOUN
ajlm-2688	123	19	markers	marker	NOUN
ajlm-2688	123	20	required	require	VERB
ajlm-2688	123	21	for	for	ADP
ajlm-2688	123	22	the	the	DET
ajlm-2688	123	23	diagnosis	diagnosis	NOUN
ajlm-2688	123	24	of	of	ADP
ajlm-2688	123	25	cll	cll	PROPN
ajlm-2688	123	26	,	,	PUNCT
ajlm-2688	123	27	which	which	PRON
ajlm-2688	123	28	we	we	PRON
ajlm-2688	123	29	can	can	AUX
ajlm-2688	123	30	translate	translate	VERB
ajlm-2688	123	31	to	to	ADP
ajlm-2688	123	32	our	our	PRON
ajlm-2688	123	33	clinical	clinical	ADJ
ajlm-2688	123	34	setting	setting	NOUN
ajlm-2688	123	35	.	.	PUNCT
ajlm-2688	124	1	to	to	PART
ajlm-2688	124	2	ensure	ensure	VERB
ajlm-2688	124	3	reliable	reliable	ADJ
ajlm-2688	124	4	results	result	NOUN
ajlm-2688	124	5	,	,	PUNCT
ajlm-2688	124	6	referral	referral	ADJ
ajlm-2688	124	7	samples	sample	NOUN
ajlm-2688	124	8	expected	expect	VERB
ajlm-2688	124	9	to	to	PART
ajlm-2688	124	10	reach	reach	VERB
ajlm-2688	124	11	the	the	DET
ajlm-2688	124	12	laboratory	laboratory	NOUN
ajlm-2688	124	13	more	more	ADJ
ajlm-2688	124	14	than	than	ADP
ajlm-2688	124	15	48	48	NUM
ajlm-2688	124	16	h	h	NOUN
ajlm-2688	124	17	after	after	ADP
ajlm-2688	124	18	collection	collection	NOUN
ajlm-2688	124	19	must	must	AUX
ajlm-2688	124	20	be	be	AUX
ajlm-2688	124	21	maintained	maintain	VERB
ajlm-2688	124	22	at	at	ADP
ajlm-2688	124	23	refrigerator	refrigerator	NOUN
ajlm-2688	124	24	temperatures	temperature	NOUN
ajlm-2688	124	25	during	during	ADP
ajlm-2688	124	26	storage	storage	NOUN
ajlm-2688	124	27	and	and	CCONJ
ajlm-2688	124	28	transportation	transportation	NOUN
ajlm-2688	124	29	.	.	PUNCT
ajlm-2688	125	1	while	while	SCONJ
ajlm-2688	125	2	our	our	PRON
ajlm-2688	125	3	study	study	NOUN
ajlm-2688	125	4	specifically	specifically	ADV
ajlm-2688	125	5	focused	focus	VERB
ajlm-2688	125	6	on	on	ADP
ajlm-2688	125	7	cll	cll	PROPN
ajlm-2688	125	8	as	as	ADP
ajlm-2688	125	9	a	a	DET
ajlm-2688	125	10	proof	proof	NOUN
ajlm-2688	125	11	of	of	ADP
ajlm-2688	125	12	concept	concept	NOUN
ajlm-2688	125	13	,	,	PUNCT
ajlm-2688	125	14	the	the	DET
ajlm-2688	125	15	implications	implication	NOUN
ajlm-2688	125	16	of	of	ADP
ajlm-2688	125	17	our	our	PRON
ajlm-2688	125	18	findings	finding	NOUN
ajlm-2688	125	19	likely	likely	ADV
ajlm-2688	125	20	extend	extend	VERB
ajlm-2688	125	21	beyond	beyond	ADP
ajlm-2688	125	22	the	the	DET
ajlm-2688	125	23	markers	marker	NOUN
ajlm-2688	125	24	employed	employ	VERB
ajlm-2688	125	25	in	in	ADP
ajlm-2688	125	26	cll	cll	PROPN
ajlm-2688	125	27	diagnosis	diagnosis	NOUN
ajlm-2688	125	28	and	and	CCONJ
ajlm-2688	125	29	the	the	DET
ajlm-2688	125	30	pre	pre	ADJ
ajlm-2688	125	31	-	-	ADJ
ajlm-2688	125	32	analytical	analytical	ADJ
ajlm-2688	125	33	phase	phase	NOUN
ajlm-2688	125	34	may	may	AUX
ajlm-2688	125	35	need	need	VERB
ajlm-2688	125	36	to	to	PART
ajlm-2688	125	37	be	be	AUX
ajlm-2688	125	38	customised	customise	VERB
ajlm-2688	125	39	to	to	ADP
ajlm-2688	125	40	the	the	DET
ajlm-2688	125	41	clinical	clinical	ADJ
ajlm-2688	125	42	application	application	NOUN
ajlm-2688	125	43	.	.	PUNCT
ajlm-2688	126	1	acknowledgements	acknowledgement	NOUN
ajlm-2688	126	2	competing	compete	VERB
ajlm-2688	126	3	interests	interest	NOUN
ajlm-2688	126	4	the	the	DET
ajlm-2688	126	5	authors	author	NOUN
ajlm-2688	126	6	declare	declare	VERB
ajlm-2688	126	7	that	that	SCONJ
ajlm-2688	126	8	they	they	PRON
ajlm-2688	126	9	have	have	VERB
ajlm-2688	126	10	no	no	DET
ajlm-2688	126	11	financial	financial	ADJ
ajlm-2688	126	12	or	or	CCONJ
ajlm-2688	126	13	personal	personal	ADJ
ajlm-2688	126	14	relationships	relationship	NOUN
ajlm-2688	126	15	that	that	PRON
ajlm-2688	126	16	may	may	AUX
ajlm-2688	126	17	have	have	AUX
ajlm-2688	126	18	inappropriately	inappropriately	ADV
ajlm-2688	126	19	influenced	influence	VERB
ajlm-2688	126	20	them	they	PRON
ajlm-2688	126	21	in	in	ADP
ajlm-2688	126	22	writing	write	VERB
ajlm-2688	126	23	this	this	DET
ajlm-2688	126	24	article	article	NOUN
ajlm-2688	126	25	.	.	PUNCT
ajlm-2688	127	1	authors	author	NOUN
ajlm-2688	127	2	’	’	PART
ajlm-2688	127	3	contributions	contribution	NOUN
ajlm-2688	127	4	s.m.g	s.m.g	VERB
ajlm-2688	127	5	.	.	PUNCT
ajlm-2688	128	1	and	and	CCONJ
ajlm-2688	128	2	a.-c.v.m	a.-c.v.m	NOUN
ajlm-2688	128	3	.	.	PROPN
ajlm-2688	128	4	conceptualised	conceptualise	VERB
ajlm-2688	128	5	and	and	CCONJ
ajlm-2688	128	6	designed	design	VERB
ajlm-2688	128	7	the	the	DET
ajlm-2688	128	8	study	study	NOUN
ajlm-2688	128	9	.	.	PUNCT
ajlm-2688	129	1	s.m.g	s.m.g	PROPN
ajlm-2688	129	2	.	.	PUNCT
ajlm-2688	130	1	wrote	write	VERB
ajlm-2688	130	2	the	the	DET
ajlm-2688	130	3	draft	draft	NOUN
ajlm-2688	130	4	protocol	protocol	NOUN
ajlm-2688	130	5	,	,	PUNCT
ajlm-2688	130	6	wrote	write	VERB
ajlm-2688	130	7	the	the	DET
ajlm-2688	130	8	draft	draft	NOUN
ajlm-2688	130	9	manuscript	manuscript	NOUN
ajlm-2688	130	10	,	,	PUNCT
ajlm-2688	130	11	and	and	CCONJ
ajlm-2688	130	12	carried	carry	VERB
ajlm-2688	130	13	out	out	ADP
ajlm-2688	130	14	the	the	DET
ajlm-2688	130	15	flow	flow	NOUN
ajlm-2688	130	16	cytometric	cytometric	ADJ
ajlm-2688	130	17	analysis	analysis	NOUN
ajlm-2688	130	18	of	of	ADP
ajlm-2688	130	19	the	the	DET
ajlm-2688	130	20	samples	sample	NOUN
ajlm-2688	130	21	.	.	PUNCT
ajlm-2688	131	1	s.m.g	s.m.g	VERB
ajlm-2688	131	2	.	.	PUNCT
ajlm-2688	132	1	and	and	CCONJ
ajlm-2688	132	2	a.-c.v.m	a.-c.v.m	NOUN
ajlm-2688	132	3	.	.	PUNCT
ajlm-2688	132	4	coordinated	coordinate	VERB
ajlm-2688	132	5	all	all	DET
ajlm-2688	132	6	aspects	aspect	NOUN
ajlm-2688	132	7	of	of	ADP
ajlm-2688	132	8	the	the	DET
ajlm-2688	132	9	implementation	implementation	NOUN
ajlm-2688	132	10	of	of	ADP
ajlm-2688	132	11	the	the	DET
ajlm-2688	132	12	study	study	NOUN
ajlm-2688	132	13	and	and	CCONJ
ajlm-2688	132	14	participated	participate	VERB
ajlm-2688	132	15	in	in	ADP
ajlm-2688	132	16	the	the	DET
ajlm-2688	132	17	experimental	experimental	ADJ
ajlm-2688	132	18	phase	phase	NOUN
ajlm-2688	132	19	of	of	ADP
ajlm-2688	132	20	the	the	DET
ajlm-2688	132	21	study	study	NOUN
ajlm-2688	132	22	and	and	CCONJ
ajlm-2688	132	23	contributed	contribute	VERB
ajlm-2688	132	24	to	to	ADP
ajlm-2688	132	25	the	the	DET
ajlm-2688	132	26	writing	writing	NOUN
ajlm-2688	132	27	of	of	ADP
ajlm-2688	132	28	the	the	DET
ajlm-2688	132	29	article	article	NOUN
ajlm-2688	132	30	and	and	CCONJ
ajlm-2688	132	31	approval	approval	NOUN
ajlm-2688	132	32	of	of	ADP
ajlm-2688	132	33	the	the	DET
ajlm-2688	132	34	final	final	ADJ
ajlm-2688	132	35	version	version	NOUN
ajlm-2688	132	36	.	.	PUNCT
ajlm-2688	133	1	sources	source	NOUN
ajlm-2688	133	2	of	of	ADP
ajlm-2688	133	3	support	support	NOUN
ajlm-2688	133	4	this	this	DET
ajlm-2688	133	5	research	research	NOUN
ajlm-2688	133	6	received	receive	VERB
ajlm-2688	133	7	no	no	DET
ajlm-2688	133	8	specific	specific	ADJ
ajlm-2688	133	9	grant	grant	NOUN
ajlm-2688	133	10	from	from	ADP
ajlm-2688	133	11	any	any	DET
ajlm-2688	133	12	funding	funding	NOUN
ajlm-2688	133	13	agency	agency	NOUN
ajlm-2688	133	14	in	in	ADP
ajlm-2688	133	15	the	the	DET
ajlm-2688	133	16	public	public	ADJ
ajlm-2688	133	17	,	,	PUNCT
ajlm-2688	133	18	commercial	commercial	ADJ
ajlm-2688	133	19	,	,	PUNCT
ajlm-2688	133	20	or	or	CCONJ
ajlm-2688	133	21	not	not	PART
ajlm-2688	133	22	-	-	PUNCT
ajlm-2688	133	23	for	for	ADP
ajlm-2688	133	24	-	-	PUNCT
ajlm-2688	133	25	profit	profit	NOUN
ajlm-2688	133	26	sectors	sector	NOUN
ajlm-2688	133	27	.	.	PUNCT
ajlm-2688	134	1	data	datum	NOUN
ajlm-2688	134	2	availability	availability	NOUN
ajlm-2688	134	3	the	the	DET
ajlm-2688	134	4	data	datum	NOUN
ajlm-2688	134	5	that	that	PRON
ajlm-2688	134	6	support	support	VERB
ajlm-2688	134	7	the	the	DET
ajlm-2688	134	8	findings	finding	NOUN
ajlm-2688	134	9	of	of	ADP
ajlm-2688	134	10	this	this	DET
ajlm-2688	134	11	study	study	NOUN
ajlm-2688	134	12	are	be	AUX
ajlm-2688	134	13	available	available	ADJ
ajlm-2688	134	14	from	from	ADP
ajlm-2688	134	15	the	the	DET
ajlm-2688	134	16	corresponding	corresponding	ADJ
ajlm-2688	134	17	author	author	NOUN
ajlm-2688	134	18	,	,	PUNCT
ajlm-2688	134	19	a.-c.v.m	a.-c.v.m	NOUN
ajlm-2688	134	20	.	.	PUNCT
ajlm-2688	134	21	,	,	PUNCT
ajlm-2688	134	22	upon	upon	SCONJ
ajlm-2688	134	23	reasonable	reasonable	ADJ
ajlm-2688	134	24	request	request	NOUN
ajlm-2688	134	25	.	.	PUNCT
ajlm-2688	135	1	disclaimer	disclaimer	VERB
ajlm-2688	135	2	the	the	DET
ajlm-2688	135	3	views	view	NOUN
ajlm-2688	135	4	and	and	CCONJ
ajlm-2688	135	5	opinions	opinion	NOUN
ajlm-2688	135	6	expressed	express	VERB
ajlm-2688	135	7	in	in	ADP
ajlm-2688	135	8	this	this	DET
ajlm-2688	135	9	article	article	NOUN
ajlm-2688	135	10	are	be	AUX
ajlm-2688	135	11	those	those	PRON
ajlm-2688	135	12	of	of	ADP
ajlm-2688	135	13	the	the	DET
ajlm-2688	135	14	authors	author	NOUN
ajlm-2688	135	15	and	and	CCONJ
ajlm-2688	135	16	are	be	AUX
ajlm-2688	135	17	the	the	DET
ajlm-2688	135	18	product	product	NOUN
ajlm-2688	135	19	of	of	ADP
ajlm-2688	135	20	professional	professional	ADJ
ajlm-2688	135	21	research	research	NOUN
ajlm-2688	135	22	.	.	PUNCT
ajlm-2688	136	1	the	the	DET
ajlm-2688	136	2	article	article	NOUN
ajlm-2688	136	3	does	do	AUX
ajlm-2688	136	4	not	not	PART
ajlm-2688	136	5	necessarily	necessarily	ADV
ajlm-2688	136	6	reflect	reflect	VERB
ajlm-2688	136	7	the	the	DET
ajlm-2688	136	8	official	official	ADJ
ajlm-2688	136	9	policy	policy	NOUN
ajlm-2688	136	10	or	or	CCONJ
ajlm-2688	136	11	position	position	NOUN
ajlm-2688	136	12	of	of	ADP
ajlm-2688	136	13	any	any	DET
ajlm-2688	136	14	affiliated	affiliated	ADJ
ajlm-2688	136	15	institution	institution	NOUN
ajlm-2688	136	16	,	,	PUNCT
ajlm-2688	136	17	funder	funder	NOUN
ajlm-2688	136	18	,	,	PUNCT
ajlm-2688	136	19	agency	agency	NOUN
ajlm-2688	136	20	,	,	PUNCT
ajlm-2688	136	21	or	or	CCONJ
ajlm-2688	136	22	that	that	PRON
ajlm-2688	136	23	of	of	ADP
ajlm-2688	136	24	the	the	DET
ajlm-2688	136	25	publisher	publisher	NOUN
ajlm-2688	136	26	.	.	PUNCT
ajlm-2688	137	1	the	the	DET
ajlm-2688	137	2	authors	author	NOUN
ajlm-2688	137	3	are	be	AUX
ajlm-2688	137	4	responsible	responsible	ADJ
ajlm-2688	137	5	for	for	ADP
ajlm-2688	137	6	this	this	DET
ajlm-2688	137	7	article	article	NOUN
ajlm-2688	137	8	’s	’s	PART
ajlm-2688	137	9	results	result	NOUN
ajlm-2688	137	10	,	,	PUNCT
ajlm-2688	137	11	findings	finding	NOUN
ajlm-2688	137	12	,	,	PUNCT
ajlm-2688	137	13	and	and	CCONJ
ajlm-2688	137	14	content	content	NOUN
ajlm-2688	137	15	.	.	PUNCT
ajlm-2688	138	1	references	reference	NOUN
ajlm-2688	138	2	köhnke	köhnke	PROPN
ajlm-2688	138	3	t	t	PROPN
ajlm-2688	138	4	,	,	PUNCT
ajlm-2688	138	5	wittmann	wittmann	PROPN
ajlm-2688	138	6	vk	vk	PROPN
ajlm-2688	138	7	,	,	PUNCT
ajlm-2688	138	8	bücklein	bücklein	VERB
ajlm-2688	138	9	vl	vl	PROPN
ajlm-2688	138	10	,	,	PUNCT
ajlm-2688	138	11	et	et	PROPN
ajlm-2688	138	12	al	al	PROPN
ajlm-2688	138	13	.	.	PUNCT
ajlm-2688	139	1	diagnosis	diagnosis	NOUN
ajlm-2688	139	2	of	of	ADP
ajlm-2688	139	3	cll	cll	PROPN
ajlm-2688	139	4	revisited	revisit	VERB
ajlm-2688	139	5	:	:	PUNCT
ajlm-2688	139	6	increased	increase	VERB
ajlm-2688	139	7	specificity	specificity	NOUN
ajlm-2688	139	8	by	by	ADP
ajlm-2688	139	9	a	a	DET
ajlm-2688	139	10	modified	modify	VERB
ajlm-2688	139	11	five	five	NUM
ajlm-2688	139	12	-	-	PUNCT
ajlm-2688	139	13	marker	marker	NOUN
ajlm-2688	139	14	scoring	scoring	NOUN
ajlm-2688	139	15	system	system	NOUN
ajlm-2688	139	16	including	include	VERB
ajlm-2688	139	17	cd200	cd200	PROPN
ajlm-2688	139	18	.	.	PUNCT
ajlm-2688	140	1	br	br	PROPN
ajlm-2688	140	2	j	j	PROPN
ajlm-2688	140	3	haematol	haematol	NOUN
ajlm-2688	140	4	.	.	PUNCT
ajlm-2688	141	1	2017;179(3):480–487	2017;179(3):480–487	NUM
ajlm-2688	141	2	.	.	PUNCT
ajlm-2688	141	3	https://doi.org/10.1111/bjh.14901	https://doi.org/10.1111/bjh.14901	PROPN
ajlm-2688	141	4	hallek	hallek	NOUN
ajlm-2688	141	5	m.	m.	NOUN
ajlm-2688	141	6	chronic	chronic	ADJ
ajlm-2688	141	7	lymphocytic	lymphocytic	ADJ
ajlm-2688	141	8	leukemia	leukemia	NOUN
ajlm-2688	141	9	:	:	PUNCT
ajlm-2688	141	10	2020	2020	NUM
ajlm-2688	141	11	update	update	NOUN
ajlm-2688	141	12	on	on	ADP
ajlm-2688	141	13	diagnosis	diagnosis	NOUN
ajlm-2688	141	14	,	,	PUNCT
ajlm-2688	141	15	risk	risk	NOUN
ajlm-2688	141	16	stratification	stratification	NOUN
ajlm-2688	141	17	and	and	CCONJ
ajlm-2688	141	18	treatment	treatment	NOUN
ajlm-2688	141	19	.	.	PUNCT
ajlm-2688	141	20	am	be	AUX
ajlm-2688	141	21	j	j	PROPN
ajlm-2688	141	22	hematol	hematol	NOUN
ajlm-2688	141	23	.	.	PUNCT
ajlm-2688	142	1	2019;94(11):1266–1287	2019;94(11):1266–1287	NOUN
ajlm-2688	142	2	.	.	PUNCT
ajlm-2688	143	1	https://doi.org/10.1002/ajh.25595	https://doi.org/10.1002/ajh.25595	PROPN
ajlm-2688	143	2	alaggio	alaggio	PROPN
ajlm-2688	143	3	r	r	PROPN
ajlm-2688	143	4	,	,	PUNCT
ajlm-2688	143	5	amador	amador	PROPN
ajlm-2688	143	6	c	c	PROPN
ajlm-2688	143	7	,	,	PUNCT
ajlm-2688	143	8	anagnostopoulos	anagnostopoulos	PROPN
ajlm-2688	143	9	i	i	PROPN
ajlm-2688	143	10	,	,	PUNCT
ajlm-2688	143	11	et	et	PROPN
ajlm-2688	143	12	al	al	PROPN
ajlm-2688	143	13	.	.	PUNCT
ajlm-2688	144	1	the	the	DET
ajlm-2688	144	2	5th	5th	ADJ
ajlm-2688	144	3	edition	edition	NOUN
ajlm-2688	144	4	of	of	ADP
ajlm-2688	144	5	the	the	DET
ajlm-2688	144	6	world	world	PROPN
ajlm-2688	144	7	health	health	PROPN
ajlm-2688	144	8	organization	organization	NOUN
ajlm-2688	144	9	classification	classification	NOUN
ajlm-2688	144	10	of	of	ADP
ajlm-2688	144	11	haematolymphoid	haematolymphoid	ADJ
ajlm-2688	144	12	tumours	tumours	NOUN
ajlm-2688	144	13	:	:	PUNCT
ajlm-2688	144	14	lymphoid	lymphoid	ADJ
ajlm-2688	144	15	neoplasms	neoplasm	NOUN
ajlm-2688	144	16	.	.	PUNCT
ajlm-2688	145	1	leukemia	leukemia	NOUN
ajlm-2688	145	2	.	.	PUNCT
ajlm-2688	146	1	2022;36(7):1720–1748	2022;36(7):1720–1748	X
ajlm-2688	146	2	.	.	PUNCT
ajlm-2688	146	3	https://doi.org/10.1038/s41375-022-01620-2	https://doi.org/10.1038/s41375-022-01620-2	NUM
ajlm-2688	146	4	matutes	matute	NOUN
ajlm-2688	146	5	e	e	NOUN
ajlm-2688	146	6	,	,	PUNCT
ajlm-2688	146	7	owusu	owusu	PROPN
ajlm-2688	146	8	-	-	NOUN
ajlm-2688	146	9	ankomah	ankomah	NOUN
ajlm-2688	146	10	k	k	NOUN
ajlm-2688	146	11	,	,	PUNCT
ajlm-2688	146	12	morilla	morilla	NOUN
ajlm-2688	146	13	r	r	NOUN
ajlm-2688	146	14	,	,	PUNCT
ajlm-2688	146	15	et	et	PROPN
ajlm-2688	146	16	al	al	PROPN
ajlm-2688	146	17	.	.	PUNCT
ajlm-2688	147	1	the	the	DET
ajlm-2688	147	2	immunological	immunological	ADJ
ajlm-2688	147	3	profile	profile	NOUN
ajlm-2688	147	4	of	of	ADP
ajlm-2688	147	5	b	b	NOUN
ajlm-2688	147	6	-	-	PUNCT
ajlm-2688	147	7	cell	cell	NOUN
ajlm-2688	147	8	disorders	disorder	NOUN
ajlm-2688	147	9	and	and	CCONJ
ajlm-2688	147	10	proposal	proposal	NOUN
ajlm-2688	147	11	of	of	ADP
ajlm-2688	147	12	a	a	DET
ajlm-2688	147	13	scoring	scoring	NOUN
ajlm-2688	147	14	system	system	NOUN
ajlm-2688	147	15	for	for	ADP
ajlm-2688	147	16	the	the	DET
ajlm-2688	147	17	diagnosis	diagnosis	NOUN
ajlm-2688	147	18	of	of	ADP
ajlm-2688	147	19	cll	cll	PROPN
ajlm-2688	147	20	.	.	PUNCT
ajlm-2688	148	1	leukemia	leukemia	PROPN
ajlm-2688	148	2	.	.	PUNCT
ajlm-2688	149	1	1994;8(10):1640–1645	1994;8(10):1640–1645	PROPN
ajlm-2688	149	2	.	.	PUNCT
ajlm-2688	150	1	zhu	zhu	PROPN
ajlm-2688	150	2	j	j	PROPN
ajlm-2688	150	3	,	,	PUNCT
ajlm-2688	150	4	raimbault	raimbault	VERB
ajlm-2688	150	5	a	a	DET
ajlm-2688	150	6	,	,	PUNCT
ajlm-2688	150	7	sourdeau	sourdeau	NOUN
ajlm-2688	150	8	e	e	PROPN
ajlm-2688	150	9	,	,	PUNCT
ajlm-2688	150	10	et	et	PROPN
ajlm-2688	150	11	al	al	PROPN
ajlm-2688	150	12	.	.	PUNCT
ajlm-2688	151	1	holding	hold	VERB
ajlm-2688	151	2	on	on	ADP
ajlm-2688	151	3	to	to	ADP
ajlm-2688	151	4	the	the	DET
ajlm-2688	151	5	matutes	matute	NOUN
ajlm-2688	151	6	score	score	NOUN
ajlm-2688	151	7	while	while	SCONJ
ajlm-2688	151	8	dropping	drop	VERB
ajlm-2688	151	9	fmc7	fmc7	PROPN
ajlm-2688	151	10	:	:	PUNCT
ajlm-2688	151	11	new	new	ADJ
ajlm-2688	151	12	opportunity	opportunity	NOUN
ajlm-2688	151	13	from	from	ADP
ajlm-2688	151	14	standardised	standardised	ADJ
ajlm-2688	151	15	approaches	approach	NOUN
ajlm-2688	151	16	in	in	ADP
ajlm-2688	151	17	multiparameter	multiparameter	NOUN
ajlm-2688	151	18	flow	flow	NOUN
ajlm-2688	151	19	cytometry	cytometry	NOUN
ajlm-2688	151	20	.	.	PUNCT
ajlm-2688	152	1	br	br	PROPN
ajlm-2688	152	2	j	j	PROPN
ajlm-2688	152	3	haematol	haematol	NOUN
ajlm-2688	152	4	.	.	PUNCT
ajlm-2688	153	1	2020;190(4):e255	2020;190(4):e255	NUM
ajlm-2688	153	2	–	–	PUNCT
ajlm-2688	153	3	e258	e258	PROPN
ajlm-2688	153	4	.	.	PUNCT
ajlm-2688	154	1	https://doi.org/10.1111/bjh.16870	https://doi.org/10.1111/bjh.16870	PROPN
ajlm-2688	154	2	moreau	moreau	PROPN
ajlm-2688	154	3	ej	ej	PROPN
ajlm-2688	154	4	,	,	PUNCT
ajlm-2688	154	5	matutes	matute	VERB
ajlm-2688	154	6	e	e	NOUN
ajlm-2688	154	7	,	,	PUNCT
ajlm-2688	154	8	a’hern	a’hern	ADJ
ajlm-2688	154	9	rp	rp	NOUN
ajlm-2688	154	10	,	,	PUNCT
ajlm-2688	154	11	et	et	PROPN
ajlm-2688	154	12	al	al	PROPN
ajlm-2688	154	13	.	.	PUNCT
ajlm-2688	154	14	improvement	improvement	NOUN
ajlm-2688	154	15	of	of	ADP
ajlm-2688	154	16	the	the	DET
ajlm-2688	154	17	chronic	chronic	ADJ
ajlm-2688	154	18	lymphocytic	lymphocytic	ADJ
ajlm-2688	154	19	leukemia	leukemia	NOUN
ajlm-2688	154	20	scoring	scoring	NOUN
ajlm-2688	154	21	system	system	NOUN
ajlm-2688	154	22	with	with	ADP
ajlm-2688	154	23	the	the	DET
ajlm-2688	154	24	monoclonal	monoclonal	NOUN
ajlm-2688	154	25	antibody	antibody	NOUN
ajlm-2688	154	26	sn8	sn8	ADV
ajlm-2688	154	27	(	(	PUNCT
ajlm-2688	154	28	cd79b	cd79b	ADJ
ajlm-2688	154	29	)	)	PUNCT
ajlm-2688	154	30	.	.	PUNCT
ajlm-2688	155	1	am	be	AUX
ajlm-2688	155	2	j	j	PROPN
ajlm-2688	155	3	clin	clin	PROPN
ajlm-2688	155	4	pathol	pathol	NOUN
ajlm-2688	155	5	.	.	PUNCT
ajlm-2688	156	1	1997;108(4):378–382	1997;108(4):378–382	X
ajlm-2688	156	2	.	.	PUNCT
ajlm-2688	156	3	https://doi.org/10.1093/ajcp/108.4.378	https://doi.org/10.1093/ajcp/108.4.378	PROPN
ajlm-2688	156	4	van	van	PROPN
ajlm-2688	156	5	dongen	dongen	PROPN
ajlm-2688	156	6	jjm	jjm	PROPN
ajlm-2688	156	7	,	,	PUNCT
ajlm-2688	156	8	lhermitte	lhermitte	PROPN
ajlm-2688	156	9	l	l	PROPN
ajlm-2688	156	10	,	,	PUNCT
ajlm-2688	156	11	böttcher	böttcher	PROPN
ajlm-2688	156	12	s	s	PROPN
ajlm-2688	156	13	,	,	PUNCT
ajlm-2688	156	14	et	et	PROPN
ajlm-2688	156	15	al	al	PROPN
ajlm-2688	156	16	.	.	PROPN
ajlm-2688	156	17	euroflow	euroflow	PROPN
ajlm-2688	156	18	consortium	consortium	PROPN
ajlm-2688	156	19	(	(	PUNCT
ajlm-2688	156	20	eu	eu	NOUN
ajlm-2688	156	21	-	-	ADJ
ajlm-2688	156	22	fp6	fp6	ADJ
ajlm-2688	156	23	,	,	PUNCT
ajlm-2688	156	24	lshb	lshb	NOUN
ajlm-2688	156	25	-	-	PUNCT
ajlm-2688	156	26	ct-2006	ct-2006	NOUN
ajlm-2688	156	27	-	-	PUNCT
ajlm-2688	156	28	018708	018708	NUM
ajlm-2688	156	29	)	)	PUNCT
ajlm-2688	156	30	.	.	PUNCT
ajlm-2688	157	1	euroflow	euroflow	ADJ
ajlm-2688	157	2	antibody	antibody	NOUN
ajlm-2688	157	3	panels	panel	NOUN
ajlm-2688	157	4	for	for	ADP
ajlm-2688	157	5	standardized	standardized	ADJ
ajlm-2688	157	6	n	n	CCONJ
ajlm-2688	157	7	-	-	PUNCT
ajlm-2688	157	8	dimensional	dimensional	ADJ
ajlm-2688	157	9	flow	flow	NOUN
ajlm-2688	157	10	cytometric	cytometric	ADJ
ajlm-2688	157	11	immunophenotyping	immunophenotyping	NOUN
ajlm-2688	157	12	of	of	ADP
ajlm-2688	157	13	normal	normal	ADJ
ajlm-2688	157	14	,	,	PUNCT
ajlm-2688	157	15	reactive	reactive	ADJ
ajlm-2688	157	16	and	and	CCONJ
ajlm-2688	157	17	malignant	malignant	ADJ
ajlm-2688	157	18	leukocytes	leukocyte	NOUN
ajlm-2688	157	19	.	.	PUNCT
ajlm-2688	158	1	leukemia	leukemia	NOUN
ajlm-2688	158	2	.	.	PUNCT
ajlm-2688	159	1	2012;26(9):1908–1975	2012;26(9):1908–1975	NUM
ajlm-2688	159	2	.	.	PUNCT
ajlm-2688	160	1	https://doi.org/10.1038/leu.2012.120	https://doi.org/10.1038/leu.2012.120	PROPN
ajlm-2688	160	2	rawstron	rawstron	PROPN
ajlm-2688	160	3	ac	ac	PROPN
ajlm-2688	160	4	,	,	PUNCT
ajlm-2688	160	5	kreuzer	kreuzer	PROPN
ajlm-2688	160	6	ka	ka	PROPN
ajlm-2688	160	7	,	,	PUNCT
ajlm-2688	160	8	soosapilla	soosapilla	PROPN
ajlm-2688	160	9	a	a	NOUN
ajlm-2688	160	10	,	,	PUNCT
ajlm-2688	160	11	et	et	PROPN
ajlm-2688	160	12	al	al	PROPN
ajlm-2688	160	13	.	.	PROPN
ajlm-2688	160	14	reproducible	reproducible	VERB
ajlm-2688	160	15	diagnosis	diagnosis	NOUN
ajlm-2688	160	16	of	of	ADP
ajlm-2688	160	17	chronic	chronic	ADJ
ajlm-2688	160	18	lymphocytic	lymphocytic	ADJ
ajlm-2688	160	19	leukemia	leukemia	NOUN
ajlm-2688	160	20	by	by	ADP
ajlm-2688	160	21	flow	flow	NOUN
ajlm-2688	160	22	cytometry	cytometry	NOUN
ajlm-2688	160	23	:	:	PUNCT
ajlm-2688	160	24	an	an	DET
ajlm-2688	160	25	european	european	ADJ
ajlm-2688	160	26	research	research	PROPN
ajlm-2688	160	27	initiative	initiative	NOUN
ajlm-2688	160	28	on	on	ADP
ajlm-2688	160	29	cll	cll	PROPN
ajlm-2688	160	30	(	(	PUNCT
ajlm-2688	160	31	eric	eric	PROPN
ajlm-2688	160	32	)	)	PUNCT
ajlm-2688	160	33	&	&	CCONJ
ajlm-2688	160	34	european	european	ADJ
ajlm-2688	160	35	society	society	PROPN
ajlm-2688	160	36	for	for	ADP
ajlm-2688	160	37	clinical	clinical	ADJ
ajlm-2688	160	38	cell	cell	NOUN
ajlm-2688	160	39	analysis	analysis	NOUN
ajlm-2688	160	40	(	(	PUNCT
ajlm-2688	160	41	escca	escca	NOUN
ajlm-2688	160	42	)	)	PUNCT
ajlm-2688	160	43	harmonisation	harmonisation	NOUN
ajlm-2688	160	44	project	project	NOUN
ajlm-2688	160	45	.	.	PUNCT
ajlm-2688	161	1	cytometry	cytometry	PROPN
ajlm-2688	161	2	b	b	PROPN
ajlm-2688	161	3	clin	clin	PROPN
ajlm-2688	161	4	cytom	cytom	PROPN
ajlm-2688	161	5	.	.	PUNCT
ajlm-2688	162	1	2018;94(1):121–128	2018;94(1):121–128	X
ajlm-2688	162	2	.	.	PUNCT
ajlm-2688	163	1	https://doi.org/10.1002/cyto.b.21595	https://doi.org/10.1002/cyto.b.21595	NOUN
ajlm-2688	163	2	ting	te	VERB
ajlm-2688	163	3	ys	ys	PROPN
ajlm-2688	163	4	,	,	PUNCT
ajlm-2688	163	5	smith	smith	PROPN
ajlm-2688	163	6	sabc	sabc	PROPN
ajlm-2688	163	7	,	,	PUNCT
ajlm-2688	163	8	brown	brown	PROPN
ajlm-2688	163	9	da	da	PROPN
ajlm-2688	163	10	,	,	PUNCT
ajlm-2688	163	11	et	et	PROPN
ajlm-2688	163	12	al	al	PROPN
ajlm-2688	163	13	.	.	PUNCT
ajlm-2688	164	1	cd200	cd200	PROPN
ajlm-2688	164	2	is	be	AUX
ajlm-2688	164	3	a	a	DET
ajlm-2688	164	4	useful	useful	ADJ
ajlm-2688	164	5	diagnostic	diagnostic	ADJ
ajlm-2688	164	6	marker	marker	NOUN
ajlm-2688	164	7	for	for	ADP
ajlm-2688	164	8	identifying	identify	VERB
ajlm-2688	164	9	atypical	atypical	ADJ
ajlm-2688	164	10	chronic	chronic	ADJ
ajlm-2688	164	11	lymphocytic	lymphocytic	ADJ
ajlm-2688	164	12	leukemia	leukemia	NOUN
ajlm-2688	164	13	by	by	ADP
ajlm-2688	164	14	flow	flow	NOUN
ajlm-2688	164	15	cytometry	cytometry	NOUN
ajlm-2688	164	16	.	.	PUNCT
ajlm-2688	165	1	int	int	PROPN
ajlm-2688	165	2	j	j	PROPN
ajlm-2688	165	3	lab	lab	NOUN
ajlm-2688	165	4	hematol	hematol	NOUN
ajlm-2688	165	5	.	.	PUNCT
ajlm-2688	166	1	2018;40(5):533–539	2018;40(5):533–539	NUM
ajlm-2688	166	2	.	.	PUNCT
ajlm-2688	166	3	https://doi.org/10.1111/ijlh.12857	https://doi.org/10.1111/ijlh.12857	PROPN
ajlm-2688	166	4	jalal	jalal	PROPN
ajlm-2688	166	5	sd	sd	PROPN
ajlm-2688	166	6	.	.	PUNCT
ajlm-2688	167	1	the	the	DET
ajlm-2688	167	2	contribution	contribution	NOUN
ajlm-2688	167	3	of	of	ADP
ajlm-2688	167	4	cd200	cd200	PROPN
ajlm-2688	167	5	to	to	ADP
ajlm-2688	167	6	the	the	DET
ajlm-2688	167	7	diagnostic	diagnostic	ADJ
ajlm-2688	167	8	accuracy	accuracy	NOUN
ajlm-2688	167	9	of	of	ADP
ajlm-2688	167	10	matutes	matute	NOUN
ajlm-2688	167	11	score	score	VERB
ajlm-2688	167	12	in	in	ADP
ajlm-2688	167	13	the	the	DET
ajlm-2688	167	14	diagnosis	diagnosis	NOUN
ajlm-2688	167	15	of	of	ADP
ajlm-2688	167	16	chronic	chronic	ADJ
ajlm-2688	167	17	lymphocytic	lymphocytic	ADJ
ajlm-2688	167	18	leukemia	leukemia	NOUN
ajlm-2688	167	19	in	in	ADP
ajlm-2688	167	20	limited	limited	ADJ
ajlm-2688	167	21	resources	resource	NOUN
ajlm-2688	167	22	laboratories	laboratory	NOUN
ajlm-2688	167	23	.	.	PUNCT
ajlm-2688	168	1	plos	plos	PROPN
ajlm-2688	168	2	one	one	NUM
ajlm-2688	168	3	.	.	PUNCT
ajlm-2688	169	1	2021;16	2021;16	NUM
ajlm-2688	169	2	:	:	PUNCT
ajlm-2688	169	3	e0247491	e0247491	NOUN
ajlm-2688	169	4	.	.	PUNCT
ajlm-2688	170	1	https://doi.org/10.1371/journal.pone.0247491	https://doi.org/10.1371/journal.pone.0247491	PROPN
ajlm-2688	170	2	criel	criel	VERB
ajlm-2688	170	3	a	a	PRON
ajlm-2688	170	4	,	,	PUNCT
ajlm-2688	170	5	verhoef	verhoef	NOUN
ajlm-2688	170	6	g	g	NOUN
ajlm-2688	170	7	,	,	PUNCT
ajlm-2688	170	8	vlietinck	vlietinck	ADJ
ajlm-2688	170	9	r	r	NOUN
ajlm-2688	170	10	,	,	PUNCT
ajlm-2688	170	11	et	et	PROPN
ajlm-2688	170	12	al	al	PROPN
ajlm-2688	170	13	.	.	PUNCT
ajlm-2688	171	1	further	further	ADJ
ajlm-2688	171	2	characterization	characterization	NOUN
ajlm-2688	171	3	of	of	ADP
ajlm-2688	171	4	morphologically	morphologically	ADV
ajlm-2688	171	5	defined	define	VERB
ajlm-2688	171	6	typical	typical	ADJ
ajlm-2688	171	7	and	and	CCONJ
ajlm-2688	171	8	atypical	atypical	ADJ
ajlm-2688	171	9	cll	cll	PROPN
ajlm-2688	171	10	:	:	PUNCT
ajlm-2688	171	11	a	a	DET
ajlm-2688	171	12	clinical	clinical	ADJ
ajlm-2688	171	13	,	,	PUNCT
ajlm-2688	171	14	immunophenotypic	immunophenotypic	ADJ
ajlm-2688	171	15	,	,	PUNCT
ajlm-2688	171	16	cytogenetic	cytogenetic	ADJ
ajlm-2688	171	17	and	and	CCONJ
ajlm-2688	171	18	prognostic	prognostic	ADJ
ajlm-2688	171	19	study	study	NOUN
ajlm-2688	171	20	on	on	ADP
ajlm-2688	171	21	390	390	NUM
ajlm-2688	171	22	cases	case	NOUN
ajlm-2688	171	23	.	.	PUNCT
ajlm-2688	172	1	br	br	X
ajlm-2688	172	2	j	j	PROPN
ajlm-2688	172	3	haematol	haematol	NOUN
ajlm-2688	172	4	.	.	PUNCT
ajlm-2688	173	1	1997;97(2):383–391	1997;97(2):383–391	NUM
ajlm-2688	173	2	.	.	PUNCT
ajlm-2688	173	3	https://doi.org/10.1046/j.1365-2141.1997.402686.x	https://doi.org/10.1046/j.1365-2141.1997.402686.x	ADJ
ajlm-2688	173	4	swerdlow	swerdlow	PROPN
ajlm-2688	173	5	s	s	PROPN
ajlm-2688	173	6	,	,	PUNCT
ajlm-2688	173	7	campo	campo	PROPN
ajlm-2688	173	8	e	e	PROPN
ajlm-2688	173	9	,	,	PUNCT
ajlm-2688	173	10	harris	harris	PROPN
ajlm-2688	173	11	nl	nl	PROPN
ajlm-2688	173	12	,	,	PUNCT
ajlm-2688	173	13	et	et	PROPN
ajlm-2688	173	14	al	al	PROPN
ajlm-2688	173	15	.	.	PUNCT
ajlm-2688	174	1	who	who	PRON
ajlm-2688	174	2	classification	classification	NOUN
ajlm-2688	174	3	of	of	ADP
ajlm-2688	174	4	tumours	tumour	NOUN
ajlm-2688	174	5	of	of	ADP
ajlm-2688	174	6	haematopoietic	haematopoietic	ADJ
ajlm-2688	174	7	and	and	CCONJ
ajlm-2688	174	8	lymphoid	lymphoid	ADJ
ajlm-2688	174	9	tissues	tissue	NOUN
ajlm-2688	174	10	.	.	PUNCT
ajlm-2688	175	1	rev	rev	PROPN
ajlm-2688	175	2	.	.	PUNCT
ajlm-2688	175	3	4th	4th	ADJ
ajlm-2688	175	4	ed	ed	NOUN
ajlm-2688	175	5	.	.	PROPN
ajlm-2688	175	6	,	,	PUNCT
ajlm-2688	175	7	volume	volume	NOUN
ajlm-2688	175	8	.	.	PUNCT
ajlm-2688	176	1	2	2	X
ajlm-2688	176	2	.	.	X
ajlm-2688	176	3	geneva	geneva	NOUN
ajlm-2688	176	4	:	:	PUNCT
ajlm-2688	176	5	who	who	PRON
ajlm-2688	176	6	;	;	PUNCT
ajlm-2688	176	7	2017	2017	NUM
ajlm-2688	176	8	.	.	PUNCT
ajlm-2688	177	1	cornet	cornet	PROPN
ajlm-2688	177	2	e	e	PROPN
ajlm-2688	177	3	,	,	PUNCT
ajlm-2688	177	4	boucher	boucher	PROPN
ajlm-2688	177	5	a	a	PROPN
ajlm-2688	177	6	-	-	PUNCT
ajlm-2688	177	7	s	s	NOUN
ajlm-2688	177	8	,	,	PUNCT
ajlm-2688	177	9	salaun	salaun	PROPN
ajlm-2688	177	10	v	v	NOUN
ajlm-2688	177	11	,	,	PUNCT
ajlm-2688	177	12	et	et	PROPN
ajlm-2688	177	13	al	al	PROPN
ajlm-2688	177	14	.	.	PROPN
ajlm-2688	177	15	incidence	incidence	NOUN
ajlm-2688	177	16	of	of	ADP
ajlm-2688	177	17	atypical	atypical	ADJ
ajlm-2688	177	18	chronic	chronic	ADJ
ajlm-2688	177	19	lymphocytic	lymphocytic	ADJ
ajlm-2688	177	20	leukemia	leukemia	NOUN
ajlm-2688	177	21	in	in	ADP
ajlm-2688	177	22	1819	1819	NUM
ajlm-2688	177	23	patients	patient	NOUN
ajlm-2688	177	24	with	with	ADP
ajlm-2688	177	25	b	b	PROPN
ajlm-2688	177	26	chronic	chronic	ADJ
ajlm-2688	177	27	lymphoproliferative	lymphoproliferative	ADJ
ajlm-2688	177	28	disorder	disorder	NOUN
ajlm-2688	177	29	.	.	PUNCT
ajlm-2688	178	1	blood	blood	NOUN
ajlm-2688	178	2	.	.	PUNCT
ajlm-2688	179	1	2013;122(21):1770	2013;122(21):1770	NUM
ajlm-2688	179	2	.	.	NOUN
ajlm-2688	179	3	https://doi.org/10.1182/blood.v122.21.1770.1770	https://doi.org/10.1182/blood.v122.21.1770.1770	PROPN
ajlm-2688	179	4	oscier	oscier	X
ajlm-2688	179	5	dg	dg	PROPN
ajlm-2688	179	6	,	,	PUNCT
ajlm-2688	179	7	matutes	matute	NOUN
ajlm-2688	179	8	e	e	NOUN
ajlm-2688	179	9	,	,	PUNCT
ajlm-2688	179	10	copplestone	copplestone	NOUN
ajlm-2688	179	11	a	a	PRON
ajlm-2688	179	12	,	,	PUNCT
ajlm-2688	179	13	et	et	PROPN
ajlm-2688	179	14	al	al	PROPN
ajlm-2688	179	15	.	.	PROPN
ajlm-2688	179	16	atypical	atypical	ADJ
ajlm-2688	179	17	lymphocyte	lymphocyte	ADJ
ajlm-2688	179	18	morphology	morphology	NOUN
ajlm-2688	179	19	:	:	PUNCT
ajlm-2688	179	20	an	an	DET
ajlm-2688	179	21	adverse	adverse	ADJ
ajlm-2688	179	22	prognostic	prognostic	ADJ
ajlm-2688	179	23	factor	factor	NOUN
ajlm-2688	179	24	for	for	ADP
ajlm-2688	179	25	disease	disease	NOUN
ajlm-2688	179	26	progression	progression	NOUN
ajlm-2688	179	27	in	in	ADP
ajlm-2688	179	28	stage	stage	NOUN
ajlm-2688	179	29	a	a	DET
ajlm-2688	179	30	cll	cll	PROPN
ajlm-2688	179	31	independent	independent	NOUN
ajlm-2688	179	32	of	of	ADP
ajlm-2688	179	33	trisomy	trisomy	NOUN
ajlm-2688	179	34	12	12	NUM
ajlm-2688	179	35	.	.	PUNCT
ajlm-2688	180	1	br	br	PROPN
ajlm-2688	180	2	j	j	PROPN
ajlm-2688	180	3	haematol	haematol	NOUN
ajlm-2688	180	4	.	.	PUNCT
ajlm-2688	181	1	1997;98(4):934–939	1997;98(4):934–939	X
ajlm-2688	181	2	.	.	PUNCT
ajlm-2688	182	1	https://doi.org/10.1046/j.1365-2141.1997.3263141.x	https://doi.org/10.1046/j.1365-2141.1997.3263141.x	PROPN
ajlm-2688	182	2	frater	frater	PROPN
ajlm-2688	182	3	jl	jl	PROPN
ajlm-2688	182	4	,	,	PUNCT
ajlm-2688	182	5	mccarron	mccarron	PROPN
ajlm-2688	182	6	kf	kf	PROPN
ajlm-2688	182	7	,	,	PUNCT
ajlm-2688	182	8	hammel	hammel	PROPN
ajlm-2688	182	9	jp	jp	PROPN
ajlm-2688	182	10	,	,	PUNCT
ajlm-2688	182	11	et	et	PROPN
ajlm-2688	182	12	al	al	PROPN
ajlm-2688	182	13	.	.	PROPN
ajlm-2688	182	14	typical	typical	ADJ
ajlm-2688	182	15	and	and	CCONJ
ajlm-2688	182	16	atypical	atypical	ADJ
ajlm-2688	182	17	chronic	chronic	ADJ
ajlm-2688	182	18	lymphocytic	lymphocytic	ADJ
ajlm-2688	182	19	leukaemia	leukaemia	NOUN
ajlm-2688	182	20	differ	differ	VERB
ajlm-2688	182	21	clinically	clinically	ADV
ajlm-2688	182	22	and	and	CCONJ
ajlm-2688	182	23	immunophenotypically	immunophenotypically	ADV
ajlm-2688	182	24	.	.	PUNCT
ajlm-2688	183	1	am	be	AUX
ajlm-2688	183	2	j	j	PROPN
ajlm-2688	183	3	clin	clin	PROPN
ajlm-2688	183	4	pathol	pathol	NOUN
ajlm-2688	183	5	.	.	PUNCT
ajlm-2688	184	1	2001;116(5):655–664	2001;116(5):655–664	NUM
ajlm-2688	184	2	.	.	X
ajlm-2688	184	3	https://doi.org/10.1309/7q1j-1aa8-du4q-pvlq	https://doi.org/10.1309/7q1j-1aa8-du4q-pvlq	PROPN
ajlm-2688	184	4	sorigue	sorigue	PROPN
ajlm-2688	184	5	m	m	PROPN
ajlm-2688	184	6	,	,	PUNCT
ajlm-2688	184	7	junca	junca	PROPN
ajlm-2688	184	8	j.	j.	PROPN
ajlm-2688	184	9	atypical	atypical	PROPN
ajlm-2688	184	10	chronic	chronic	ADJ
ajlm-2688	184	11	lymphocytic	lymphocytic	ADJ
ajlm-2688	184	12	leukemia	leukemia	NOUN
ajlm-2688	184	13	:	:	PUNCT
ajlm-2688	184	14	brief	brief	ADJ
ajlm-2688	184	15	historical	historical	ADJ
ajlm-2688	184	16	overview	overview	NOUN
ajlm-2688	184	17	and	and	CCONJ
ajlm-2688	184	18	current	current	ADJ
ajlm-2688	184	19	usage	usage	NOUN
ajlm-2688	184	20	of	of	ADP
ajlm-2688	184	21	an	an	DET
ajlm-2688	184	22	equivocal	equivocal	ADJ
ajlm-2688	184	23	concept	concept	NOUN
ajlm-2688	184	24	.	.	PUNCT
ajlm-2688	185	1	int	int	NOUN
ajlm-2688	185	2	j	j	PROPN
ajlm-2688	185	3	lab	lab	NOUN
ajlm-2688	185	4	hematol	hematol	NOUN
ajlm-2688	185	5	.	.	PUNCT
ajlm-2688	186	1	2019;41(1):e17	2019;41(1):e17	NUM
ajlm-2688	186	2	–	–	PUNCT
ajlm-2688	186	3	e19	e19	NOUN
ajlm-2688	186	4	.	.	PUNCT
ajlm-2688	187	1	https://doi.org/10.1111/ijlh.12930	https://doi.org/10.1111/ijlh.12930	ADJ
ajlm-2688	187	2	ekong	ekong	PROPN
ajlm-2688	187	3	t	t	PROPN
ajlm-2688	187	4	,	,	PUNCT
ajlm-2688	187	5	hill	hill	PROPN
ajlm-2688	187	6	am	am	PROPN
ajlm-2688	187	7	,	,	PUNCT
ajlm-2688	187	8	gompels	gompel	NOUN
ajlm-2688	187	9	m	m	PRON
ajlm-2688	187	10	,	,	PUNCT
ajlm-2688	187	11	brown	brown	ADJ
ajlm-2688	187	12	a	a	PRON
ajlm-2688	187	13	,	,	PUNCT
ajlm-2688	187	14	pinching	pinch	VERB
ajlm-2688	187	15	aj	aj	PROPN
ajlm-2688	187	16	.	.	PUNCT
ajlm-2688	188	1	the	the	DET
ajlm-2688	188	2	effect	effect	NOUN
ajlm-2688	188	3	of	of	ADP
ajlm-2688	188	4	the	the	DET
ajlm-2688	188	5	temperature	temperature	NOUN
ajlm-2688	188	6	and	and	CCONJ
ajlm-2688	188	7	duration	duration	NOUN
ajlm-2688	188	8	of	of	ADP
ajlm-2688	188	9	sample	sample	NOUN
ajlm-2688	188	10	storage	storage	NOUN
ajlm-2688	188	11	on	on	ADP
ajlm-2688	188	12	the	the	DET
ajlm-2688	188	13	measurement	measurement	NOUN
ajlm-2688	188	14	of	of	ADP
ajlm-2688	188	15	lymphocyte	lymphocyte	ADJ
ajlm-2688	188	16	subpopulations	subpopulation	NOUN
ajlm-2688	188	17	from	from	ADP
ajlm-2688	188	18	hiv-1	hiv-1	ADJ
ajlm-2688	188	19	-	-	PUNCT
ajlm-2688	188	20	positive	positive	ADJ
ajlm-2688	188	21	and	and	CCONJ
ajlm-2688	188	22	control	control	NOUN
ajlm-2688	188	23	subjects	subject	NOUN
ajlm-2688	188	24	.	.	PUNCT
ajlm-2688	189	1	j	j	PROPN
ajlm-2688	189	2	immunol	immunol	NOUN
ajlm-2688	189	3	methods	method	NOUN
ajlm-2688	189	4	.	.	PUNCT
ajlm-2688	190	1	1992;151(1–2):217–225	1992;151(1–2):217–225	NUM
ajlm-2688	190	2	.	.	PUNCT
ajlm-2688	191	1	https://doi.org/10.1016/0022-1759(92)90120-i	https://doi.org/10.1016/0022-1759(92)90120-i	PROPN
ajlm-2688	191	2	correia	correia	PROPN
ajlm-2688	191	3	rp	rp	PROPN
ajlm-2688	191	4	,	,	PUNCT
ajlm-2688	191	5	bortolucci	bortolucci	PROPN
ajlm-2688	191	6	aca	aca	PROPN
ajlm-2688	191	7	,	,	PUNCT
ajlm-2688	191	8	lopes	lopes	PROPN
ajlm-2688	191	9	acw	acw	PROPN
ajlm-2688	191	10	,	,	PUNCT
ajlm-2688	191	11	et	et	PROPN
ajlm-2688	191	12	al	al	PROPN
ajlm-2688	191	13	.	.	PUNCT
ajlm-2688	192	1	recommendations	recommendation	NOUN
ajlm-2688	192	2	for	for	ADP
ajlm-2688	192	3	quality	quality	NOUN
ajlm-2688	192	4	assurance	assurance	NOUN
ajlm-2688	192	5	in	in	ADP
ajlm-2688	192	6	multiparametric	multiparametric	ADJ
ajlm-2688	192	7	flow	flow	NOUN
ajlm-2688	192	8	cytometry	cytometry	NOUN
ajlm-2688	192	9	:	:	PUNCT
ajlm-2688	192	10	first	first	ADJ
ajlm-2688	192	11	consensus	consensus	NOUN
ajlm-2688	192	12	of	of	ADP
ajlm-2688	192	13	the	the	DET
ajlm-2688	192	14	brazilian	brazilian	ADJ
ajlm-2688	192	15	group	group	NOUN
ajlm-2688	192	16	of	of	ADP
ajlm-2688	192	17	flow	flow	NOUN
ajlm-2688	192	18	cytometry	cytometry	NOUN
ajlm-2688	192	19	(	(	PUNCT
ajlm-2688	192	20	gbcflux	gbcflux	PROPN
ajlm-2688	192	21	)	)	PUNCT
ajlm-2688	192	22	.	.	PUNCT
ajlm-2688	193	1	j	j	PROPN
ajlm-2688	193	2	bras	bras	PROPN
ajlm-2688	193	3	patol	patol	VERB
ajlm-2688	193	4	med	med	ADJ
ajlm-2688	193	5	lab	lab	NOUN
ajlm-2688	193	6	.	.	PUNCT
ajlm-2688	194	1	2015;51(6):389–396	2015;51(6):389–396	X
ajlm-2688	194	2	.	.	PUNCT
ajlm-2688	195	1	https://doi.org/10.5935/1676-2444.20150061	https://doi.org/10.5935/1676-2444.20150061	PROPN
ajlm-2688	195	2	diks	diks	PROPN
ajlm-2688	195	3	am	be	AUX
ajlm-2688	195	4	,	,	PUNCT
ajlm-2688	195	5	bonroy	bonroy	ADP
ajlm-2688	195	6	c	c	NOUN
ajlm-2688	195	7	,	,	PUNCT
ajlm-2688	195	8	teodosio	teodosio	NOUN
ajlm-2688	195	9	c	c	NOUN
ajlm-2688	195	10	,	,	PUNCT
ajlm-2688	195	11	et	et	PROPN
ajlm-2688	195	12	al	al	PROPN
ajlm-2688	195	13	.	.	PROPN
ajlm-2688	195	14	impact	impact	NOUN
ajlm-2688	195	15	of	of	ADP
ajlm-2688	195	16	blood	blood	NOUN
ajlm-2688	195	17	storage	storage	NOUN
ajlm-2688	195	18	and	and	CCONJ
ajlm-2688	195	19	sample	sample	NOUN
ajlm-2688	195	20	handling	handling	NOUN
ajlm-2688	195	21	on	on	ADP
ajlm-2688	195	22	quality	quality	NOUN
ajlm-2688	195	23	of	of	ADP
ajlm-2688	195	24	high	high	ADJ
ajlm-2688	195	25	dimensional	dimensional	ADJ
ajlm-2688	195	26	flow	flow	NOUN
ajlm-2688	195	27	cytometric	cytometric	ADJ
ajlm-2688	195	28	data	datum	NOUN
ajlm-2688	195	29	in	in	ADP
ajlm-2688	195	30	multicenter	multicenter	ADJ
ajlm-2688	195	31	clinical	clinical	ADJ
ajlm-2688	195	32	research	research	NOUN
ajlm-2688	195	33	.	.	PUNCT
ajlm-2688	196	1	j	j	PROPN
ajlm-2688	196	2	immunol	immunol	NOUN
ajlm-2688	196	3	methods	method	NOUN
ajlm-2688	196	4	.	.	PUNCT
ajlm-2688	197	1	2019;475:112616	2019;475:112616	X
ajlm-2688	197	2	.	.	PUNCT
ajlm-2688	198	1	https://doi.org/10.1016/j.jim.2019.06.007	https://doi.org/10.1016/j.jim.2019.06.007	PROPN
ajlm-2688	198	2	davis	davis	PROPN
ajlm-2688	198	3	bh	bh	PROPN
ajlm-2688	198	4	,	,	PUNCT
ajlm-2688	198	5	dasgupta	dasgupta	PROPN
ajlm-2688	198	6	a	a	PRON
ajlm-2688	198	7	,	,	PUNCT
ajlm-2688	198	8	kussick	kussick	PROPN
ajlm-2688	198	9	s	s	PROPN
ajlm-2688	198	10	,	,	PUNCT
ajlm-2688	198	11	han	han	PROPN
ajlm-2688	198	12	jy	jy	PROPN
ajlm-2688	198	13	,	,	PUNCT
ajlm-2688	198	14	estrellado	estrellado	PROPN
ajlm-2688	198	15	a.	a.	NOUN
ajlm-2688	198	16	validation	validation	NOUN
ajlm-2688	198	17	of	of	ADP
ajlm-2688	198	18	cell	cell	NOUN
ajlm-2688	198	19	-	-	PUNCT
ajlm-2688	198	20	based	base	VERB
ajlm-2688	198	21	fluorescence	fluorescence	NOUN
ajlm-2688	198	22	assays	assay	NOUN
ajlm-2688	198	23	:	:	PUNCT
ajlm-2688	198	24	practice	practice	NOUN
ajlm-2688	198	25	guidelines	guideline	NOUN
ajlm-2688	198	26	from	from	ADP
ajlm-2688	198	27	the	the	DET
ajlm-2688	198	28	icsh	icsh	NOUN
ajlm-2688	198	29	and	and	CCONJ
ajlm-2688	198	30	iccs	iccs	ADJ
ajlm-2688	198	31	–	–	PUNCT
ajlm-2688	198	32	part	part	NOUN
ajlm-2688	198	33	ii	ii	PROPN
ajlm-2688	198	34	–	–	PUNCT
ajlm-2688	198	35	preanalytical	preanalytical	ADJ
ajlm-2688	198	36	issues	issue	NOUN
ajlm-2688	198	37	.	.	PUNCT
ajlm-2688	199	1	cytometry	cytometry	PROPN
ajlm-2688	199	2	b	b	PROPN
ajlm-2688	199	3	clin	clin	PROPN
ajlm-2688	199	4	cytom	cytom	PROPN
ajlm-2688	199	5	.	.	PUNCT
ajlm-2688	200	1	2013;84(5):286–290	2013;84(5):286–290	NUM
ajlm-2688	200	2	.	.	PUNCT
ajlm-2688	200	3	https://doi.org/10.1002/cyto.b.21105	https://doi.org/10.1002/cyto.b.21105	VERB
ajlm-2688	201	1	government	government	NOUN
ajlm-2688	201	2	communications	communication	NOUN
ajlm-2688	201	3	(	(	PUNCT
ajlm-2688	201	4	gcis	gcis	PROPN
ajlm-2688	201	5	)	)	PUNCT
ajlm-2688	201	6	.	.	PUNCT
ajlm-2688	202	1	south	south	PROPN
ajlm-2688	202	2	africa	africa	PROPN
ajlm-2688	202	3	yearbook	yearbook	PROPN
ajlm-2688	202	4	(	(	PUNCT
ajlm-2688	202	5	sayb	sayb	NOUN
ajlm-2688	202	6	)	)	PUNCT
ajlm-2688	202	7	2021/22	2021/22	NUM
ajlm-2688	203	1	[	[	X
ajlm-2688	203	2	homepage	homepage	NOUN
ajlm-2688	203	3	on	on	ADP
ajlm-2688	203	4	the	the	DET
ajlm-2688	203	5	internet	internet	NOUN
ajlm-2688	203	6	]	]	PUNCT
ajlm-2688	203	7	.	.	PUNCT
ajlm-2688	203	8	2021	2021	NUM
ajlm-2688	204	1	[	[	X
ajlm-2688	204	2	cited	cite	VERB
ajlm-2688	204	3	may	may	PROPN
ajlm-2688	204	4	04	04	NUM
ajlm-2688	204	5	]	]	PUNCT
ajlm-2688	204	6	.	.	PUNCT
ajlm-2688	205	1	available	available	ADJ
ajlm-2688	205	2	from	from	ADP
ajlm-2688	205	3	:	:	PUNCT
ajlm-2688	205	4	https://www.gcis.gov.za/sites/default/files/docs/gcis/sayb2021_2022onlineversion.pdf	https://www.gcis.gov.za/sites/default/files/docs/gcis/sayb2021_2022onlineversion.pdf	PROPN
ajlm-2688	205	5	.	.	PUNCT
ajlm-2688	206	1	van	van	PROPN
ajlm-2688	206	2	der	der	PROPN
ajlm-2688	206	3	westhuizen	westhuizen	PROPN
ajlm-2688	206	4	m	m	PROPN
ajlm-2688	206	5	,	,	PUNCT
ajlm-2688	206	6	van	van	PROPN
ajlm-2688	206	7	marle	marle	PROPN
ajlm-2688	206	8	a	a	PROPN
ajlm-2688	206	9	-	-	PUNCT
ajlm-2688	206	10	c.	c.	NOUN
ajlm-2688	206	11	standard	standard	ADJ
ajlm-2688	206	12	operating	operating	NOUN
ajlm-2688	206	13	procedure	procedure	NOUN
ajlm-2688	206	14	:	:	PUNCT
ajlm-2688	206	15	immunophenotyping	immunophenotype	VERB
ajlm-2688	206	16	of	of	ADP
ajlm-2688	206	17	haematological	haematological	ADJ
ajlm-2688	206	18	malignancies	malignancy	NOUN
ajlm-2688	206	19	.	.	PUNCT
ajlm-2688	207	1	bloemfontein	bloemfontein	PROPN
ajlm-2688	207	2	:	:	PUNCT
ajlm-2688	207	3	national	national	PROPN
ajlm-2688	207	4	health	health	PROPN
ajlm-2688	207	5	laboratory	laboratory	PROPN
ajlm-2688	207	6	service	service	NOUN
ajlm-2688	207	7	(	(	PUNCT
ajlm-2688	207	8	nhls	nhls	PROPN
ajlm-2688	207	9	)	)	PUNCT
ajlm-2688	207	10	;	;	PUNCT
ajlm-2688	207	11	2020	2020	NUM
ajlm-2688	207	12	.	.	PUNCT
ajlm-2688	208	1	nhls	nhls	PROPN
ajlm-2688	208	2	handbook	handbook	PROPN
ajlm-2688	208	3	technical	technical	PROPN
ajlm-2688	208	4	working	working	PROPN
ajlm-2688	208	5	group	group	NOUN
ajlm-2688	208	6	(	(	PUNCT
ajlm-2688	208	7	twg	twg	PROPN
ajlm-2688	208	8	)	)	PUNCT
ajlm-2688	208	9	.	.	PUNCT
ajlm-2688	209	1	national	national	PROPN
ajlm-2688	209	2	health	health	PROPN
ajlm-2688	209	3	laboratory	laboratory	PROPN
ajlm-2688	209	4	services	service	NOUN
ajlm-2688	209	5	standard	standard	ADJ
ajlm-2688	209	6	operating	operating	NOUN
ajlm-2688	209	7	procedure	procedure	NOUN
ajlm-2688	209	8	:	:	PUNCT
ajlm-2688	209	9	document	document	NOUN
ajlm-2688	209	10	number	number	NOUN
ajlm-2688	209	11	gpq0064v1	gpq0064v1	PROPN
ajlm-2688	209	12	.	.	PUNCT
ajlm-2688	210	1	johannesburg	johannesburg	PROPN
ajlm-2688	210	2	:	:	PUNCT
ajlm-2688	210	3	national	national	PROPN
ajlm-2688	210	4	health	health	PROPN
ajlm-2688	210	5	laboratory	laboratory	PROPN
ajlm-2688	210	6	service	service	NOUN
ajlm-2688	210	7	;	;	PUNCT
ajlm-2688	210	8	2018	2018	NUM
ajlm-2688	210	9	.	.	PUNCT
ajlm-2688	211	1	kalina	kalina	PROPN
ajlm-2688	211	2	t	t	PROPN
ajlm-2688	211	3	,	,	PUNCT
ajlm-2688	211	4	flores	flores	PROPN
ajlm-2688	211	5	-	-	PUNCT
ajlm-2688	211	6	montero	montero	PROPN
ajlm-2688	211	7	j	j	PROPN
ajlm-2688	211	8	,	,	PUNCT
ajlm-2688	211	9	van	van	PROPN
ajlm-2688	211	10	der	der	PROPN
ajlm-2688	211	11	velden	velden	PROPN
ajlm-2688	211	12	vhj	vhj	PROPN
ajlm-2688	211	13	,	,	PUNCT
ajlm-2688	211	14	et	et	PROPN
ajlm-2688	211	15	al	al	PROPN
ajlm-2688	211	16	.	.	PROPN
ajlm-2688	211	17	euroflow	euroflow	PROPN
ajlm-2688	211	18	consortium	consortium	PROPN
ajlm-2688	211	19	(	(	PUNCT
ajlm-2688	211	20	eu	eu	NOUN
ajlm-2688	211	21	-	-	ADJ
ajlm-2688	211	22	fp6	fp6	ADJ
ajlm-2688	211	23	,	,	PUNCT
ajlm-2688	211	24	lshb	lshb	NOUN
ajlm-2688	211	25	-	-	PUNCT
ajlm-2688	211	26	ct-2006	ct-2006	NOUN
ajlm-2688	211	27	-	-	PUNCT
ajlm-2688	211	28	018708	018708	NUM
ajlm-2688	211	29	)	)	PUNCT
ajlm-2688	211	30	.	.	PUNCT
ajlm-2688	212	1	euroflow	euroflow	ADJ
ajlm-2688	212	2	standardization	standardization	NOUN
ajlm-2688	212	3	of	of	ADP
ajlm-2688	212	4	flow	flow	NOUN
ajlm-2688	212	5	cytometer	cytometer	NOUN
ajlm-2688	212	6	instrument	instrument	NOUN
ajlm-2688	212	7	settings	setting	NOUN
ajlm-2688	212	8	and	and	CCONJ
ajlm-2688	212	9	immunophenotyping	immunophenotype	VERB
ajlm-2688	212	10	protocols	protocol	NOUN
ajlm-2688	212	11	.	.	PUNCT
ajlm-2688	213	1	leukemia	leukemia	NOUN
ajlm-2688	213	2	.	.	PUNCT
ajlm-2688	214	1	2012;26(9):1986–2010	2012;26(9):1986–2010	NUM
ajlm-2688	214	2	.	.	PUNCT
ajlm-2688	215	1	https://doi.org/10.1038/leu.2012.122	https://doi.org/10.1038/leu.2012.122	PROPN
ajlm-2688	215	2	sorigue	sorigue	NOUN
ajlm-2688	215	3	m	m	PROPN
ajlm-2688	215	4	,	,	PUNCT
ajlm-2688	215	5	raya	raya	PROPN
ajlm-2688	215	6	m	m	PROPN
ajlm-2688	215	7	,	,	PUNCT
ajlm-2688	215	8	vergara	vergara	PROPN
ajlm-2688	215	9	s	s	PROPN
ajlm-2688	215	10	,	,	PUNCT
ajlm-2688	215	11	junca	junca	PROPN
ajlm-2688	215	12	j.	j.	PROPN
ajlm-2688	215	13	concordance	concordance	NOUN
ajlm-2688	215	14	between	between	ADP
ajlm-2688	215	15	flow	flow	NOUN
ajlm-2688	215	16	cytometry	cytometry	PROPN
ajlm-2688	215	17	cll	cll	PROPN
ajlm-2688	215	18	scores	score	NOUN
ajlm-2688	215	19	.	.	PUNCT
ajlm-2688	216	1	int	int	NOUN
ajlm-2688	216	2	j	j	PROPN
ajlm-2688	216	3	lab	lab	NOUN
ajlm-2688	216	4	hematol	hematol	NOUN
ajlm-2688	216	5	.	.	PUNCT
ajlm-2688	217	1	2021;43(4):743–751	2021;43(4):743–751	NUM
ajlm-2688	217	2	.	.	PUNCT
ajlm-2688	218	1	https://doi.org/10.1111/ijlh.13567	https://doi.org/10.1111/ijlh.13567	VERB
ajlm-2688	218	2	clinical	clinical	ADJ
ajlm-2688	218	3	flow	flow	NOUN
ajlm-2688	218	4	wiki	wiki	NOUN
ajlm-2688	218	5	.	.	PUNCT
ajlm-2688	219	1	introduction	introduction	NOUN
ajlm-2688	219	2	to	to	PART
ajlm-2688	219	3	flow	flow	VERB
ajlm-2688	219	4	cytometric	cytometric	ADJ
ajlm-2688	219	5	analysis	analysis	NOUN
ajlm-2688	219	6	flow	flow	NOUN
ajlm-2688	219	7	cytometry	cytometry	NOUN
ajlm-2688	220	1	[	[	X
ajlm-2688	220	2	homepage	homepage	NOUN
ajlm-2688	220	3	on	on	ADP
ajlm-2688	220	4	the	the	DET
ajlm-2688	220	5	internet	internet	NOUN
ajlm-2688	220	6	]	]	PUNCT
ajlm-2688	220	7	.	.	PUNCT
ajlm-2688	221	1	pasadena	pasadena	PROPN
ajlm-2688	221	2	,	,	PUNCT
ajlm-2688	221	3	ca	can	AUX
ajlm-2688	221	4	:	:	PUNCT
ajlm-2688	221	5	de	de	ADJ
ajlm-2688	221	6	novo	novo	PROPN
ajlm-2688	221	7	software	software	PROPN
ajlm-2688	221	8	.	.	PUNCT
ajlm-2688	222	1	n.d	n.d	PROPN
ajlm-2688	222	2	.	.	PUNCT
ajlm-2688	223	1	[	[	X
ajlm-2688	223	2	cited	cite	VERB
ajlm-2688	223	3	2023	2023	NUM
ajlm-2688	223	4	oct	oct	NOUN
ajlm-2688	223	5	18	18	NUM
ajlm-2688	223	6	]	]	PUNCT
ajlm-2688	223	7	.	.	PUNCT
ajlm-2688	224	1	available	available	ADJ
ajlm-2688	224	2	from	from	ADP
ajlm-2688	224	3	:	:	PUNCT
ajlm-2688	224	4	https://wiki.clinicalflow.com/introduction-flow-cytometric-analysis	https://wiki.clinicalflow.com/introduction-flow-cytometric-analysis	NOUN
ajlm-2688	224	5	.	.	PUNCT
ajlm-2688	225	1	bain	bain	PROPN
ajlm-2688	225	2	bj	bj	PROPN
ajlm-2688	225	3	,	,	PUNCT
ajlm-2688	225	4	barnett	barnett	PROPN
ajlm-2688	225	5	d	d	PROPN
ajlm-2688	225	6	,	,	PUNCT
ajlm-2688	225	7	linch	linch	NOUN
ajlm-2688	225	8	d	d	NOUN
ajlm-2688	225	9	,	,	PUNCT
ajlm-2688	225	10	matutes	matute	NOUN
ajlm-2688	225	11	e	e	NOUN
ajlm-2688	225	12	,	,	PUNCT
ajlm-2688	225	13	reilly	reilly	PROPN
ajlm-2688	225	14	jt	jt	PROPN
ajlm-2688	225	15	.	.	PROPN
ajlm-2688	225	16	revised	revise	VERB
ajlm-2688	225	17	guideline	guideline	NOUN
ajlm-2688	225	18	on	on	ADP
ajlm-2688	225	19	immunophenotyping	immunophenotype	VERB
ajlm-2688	225	20	in	in	ADP
ajlm-2688	225	21	acute	acute	PROPN
ajlm-2688	225	22	leukaemias	leukaemia	NOUN
ajlm-2688	225	23	and	and	CCONJ
ajlm-2688	225	24	chronic	chronic	ADJ
ajlm-2688	225	25	lymphoproliferative	lymphoproliferative	ADJ
ajlm-2688	225	26	disorders	disorder	NOUN
ajlm-2688	225	27	.	.	PUNCT
ajlm-2688	226	1	clin	clin	PROPN
ajlm-2688	226	2	lab	lab	NOUN
ajlm-2688	226	3	haematol	haematol	NOUN
ajlm-2688	226	4	.	.	PUNCT
ajlm-2688	227	1	2002;24(1):1–13	2002;24(1):1–13	NUM
ajlm-2688	227	2	.	.	PUNCT
ajlm-2688	228	1	https://doi.org/10.1046/j.1365-2257.2002.00135.x	https://doi.org/10.1046/j.1365-2257.2002.00135.x	PROPN
ajlm-2688	228	2	sędek	sędek	PROPN
ajlm-2688	228	3	ł	ł	PROPN
ajlm-2688	228	4	,	,	PUNCT
ajlm-2688	228	5	flores	flores	PROPN
ajlm-2688	228	6	-	-	PUNCT
ajlm-2688	228	7	montero	montero	PROPN
ajlm-2688	228	8	j	j	PROPN
ajlm-2688	228	9	,	,	PUNCT
ajlm-2688	228	10	van	van	PROPN
ajlm-2688	228	11	der	der	PROPN
ajlm-2688	228	12	sluijs	sluijs	VERB
ajlm-2688	228	13	a	a	PRON
ajlm-2688	228	14	,	,	PUNCT
ajlm-2688	228	15	et	et	PROPN
ajlm-2688	228	16	al	al	PROPN
ajlm-2688	228	17	.	.	PROPN
ajlm-2688	228	18	impact	impact	NOUN
ajlm-2688	228	19	of	of	ADP
ajlm-2688	228	20	pre	pre	ADJ
ajlm-2688	228	21	-	-	ADJ
ajlm-2688	228	22	analytical	analytical	ADJ
ajlm-2688	228	23	and	and	CCONJ
ajlm-2688	228	24	analytical	analytical	ADJ
ajlm-2688	228	25	variables	variable	NOUN
ajlm-2688	228	26	associated	associate	VERB
ajlm-2688	228	27	with	with	ADP
ajlm-2688	228	28	sample	sample	NOUN
ajlm-2688	228	29	preparation	preparation	NOUN
ajlm-2688	228	30	on	on	ADP
ajlm-2688	228	31	flow	flow	NOUN
ajlm-2688	228	32	cytometric	cytometric	ADJ
ajlm-2688	228	33	stainings	staining	NOUN
ajlm-2688	228	34	obtained	obtain	VERB
ajlm-2688	228	35	with	with	ADP
ajlm-2688	228	36	euroflow	euroflow	NOUN
ajlm-2688	228	37	panels	panel	NOUN
ajlm-2688	228	38	.	.	PUNCT
ajlm-2688	229	1	cancers	cancer	NOUN
ajlm-2688	229	2	(	(	PUNCT
ajlm-2688	229	3	basel	basel	PROPN
ajlm-2688	229	4	)	)	PUNCT
ajlm-2688	229	5	.	.	PUNCT
ajlm-2688	230	1	2022;14(3):473	2022;14(3):473	NUM
ajlm-2688	230	2	.	.	PUNCT
ajlm-2688	230	3	https://doi.org/10.3390/cancers14030473	https://doi.org/10.3390/cancers14030473	PROPN
ajlm-2688	230	4	european	european	PROPN
ajlm-2688	230	5	pharmacopoeia	pharmacopoeia	PROPN
ajlm-2688	230	6	commission	commission	PROPN
ajlm-2688	230	7	.	.	PUNCT
ajlm-2688	231	1	european	european	ADJ
ajlm-2688	231	2	pharmacopoeia	pharmacopoeia	PROPN
ajlm-2688	231	3	(	(	PUNCT
ajlm-2688	231	4	ph	ph	PROPN
ajlm-2688	231	5	.	.	PROPN
ajlm-2688	231	6	eu	eu	PROPN
ajlm-2688	231	7	.	.	PUNCT
ajlm-2688	231	8	)	)	PUNCT
ajlm-2688	232	1	[	[	X
ajlm-2688	232	2	homepage	homepage	NOUN
ajlm-2688	232	3	on	on	ADP
ajlm-2688	232	4	the	the	DET
ajlm-2688	232	5	internet	internet	NOUN
ajlm-2688	232	6	]	]	PUNCT
ajlm-2688	232	7	.	.	PUNCT
ajlm-2688	233	1	11th	11th	ADJ
ajlm-2688	233	2	ed	ed	NOUN
ajlm-2688	233	3	.	.	PUNCT
ajlm-2688	233	4	strasbourg	strasbourg	NOUN
ajlm-2688	233	5	:	:	PUNCT
ajlm-2688	233	6	european	european	ADJ
ajlm-2688	233	7	directorate	directorate	NOUN
ajlm-2688	233	8	for	for	ADP
ajlm-2688	233	9	the	the	DET
ajlm-2688	233	10	quality	quality	NOUN
ajlm-2688	233	11	of	of	ADP
ajlm-2688	233	12	medicines	medicine	NOUN
ajlm-2688	233	13	and	and	CCONJ
ajlm-2688	233	14	healthcare	healthcare	NOUN
ajlm-2688	233	15	;	;	PUNCT
ajlm-2688	233	16	2022	2022	NUM
ajlm-2688	234	1	[	[	X
ajlm-2688	234	2	cited	cite	VERB
ajlm-2688	234	3	2023	2023	NUM
ajlm-2688	234	4	nov	nov	NOUN
ajlm-2688	234	5	18	18	NUM
ajlm-2688	234	6	]	]	PUNCT
ajlm-2688	234	7	.	.	PUNCT
ajlm-2688	235	1	available	available	ADJ
ajlm-2688	235	2	from	from	ADP
ajlm-2688	235	3	:	:	PUNCT
ajlm-2688	235	4	https://www.edqm.eu/en/european-pharmacopoeia-ph.-eur.-11th-edition	https://www.edqm.eu/en/european-pharmacopoeia-ph.-eur.-11th-edition	NOUN
ajlm-2688	235	5	steedman	steedman	NOUN
ajlm-2688	235	6	m.	m.	NOUN
ajlm-2688	235	7	temperature	temperature	NOUN
ajlm-2688	235	8	standards	standard	NOUN
ajlm-2688	235	9	for	for	ADP
ajlm-2688	235	10	cold	cold	ADJ
ajlm-2688	235	11	chain	chain	NOUN
ajlm-2688	235	12	logistics	logistic	NOUN
ajlm-2688	236	1	[	[	X
ajlm-2688	236	2	homepage	homepage	NOUN
ajlm-2688	236	3	on	on	ADP
ajlm-2688	236	4	the	the	DET
ajlm-2688	236	5	internet	internet	NOUN
ajlm-2688	236	6	]	]	PUNCT
ajlm-2688	236	7	.	.	PUNCT
ajlm-2688	237	1	2022	2022	NUM
ajlm-2688	238	1	[	[	X
ajlm-2688	238	2	cited	cite	VERB
ajlm-2688	238	3	2023	2023	NUM
ajlm-2688	238	4	nov	nov	NOUN
ajlm-2688	238	5	01	01	NUM
ajlm-2688	238	6	]	]	PUNCT
ajlm-2688	238	7	.	.	PUNCT
ajlm-2688	239	1	available	available	ADJ
ajlm-2688	239	2	from	from	ADP
ajlm-2688	239	3	:	:	PUNCT
ajlm-2688	239	4	https://www.cargo-wise.co.uk/blog/temperature-standards-for-cold-chain-logistics#:~:text=ambient%20temperature	https://www.cargo-wise.co.uk/blog/temperature-standards-for-cold-chain-logistics#:~:text=ambient%20temperature	PROPN
ajlm-2688	239	5	.	.	PUNCT
ajlm-2688	240	1	boshoff	boshoff	PROPN
ajlm-2688	240	2	t.	t.	PROPN
ajlm-2688	240	3	managing	manage	VERB
ajlm-2688	240	4	office	office	NOUN
ajlm-2688	240	5	temperature	temperature	NOUN
ajlm-2688	240	6	.	.	PUNCT
ajlm-2688	241	1	labour	labour	PROPN
ajlm-2688	241	2	guide	guide	VERB
ajlm-2688	241	3	south	south	PROPN
ajlm-2688	241	4	africa	africa	PROPN
ajlm-2688	242	1	[	[	X
ajlm-2688	242	2	homepage	homepage	NOUN
ajlm-2688	242	3	on	on	ADP
ajlm-2688	242	4	the	the	DET
ajlm-2688	242	5	internet	internet	NOUN
ajlm-2688	242	6	]	]	PUNCT
ajlm-2688	242	7	.	.	PUNCT
ajlm-2688	243	1	2015	2015	NUM
ajlm-2688	244	1	[	[	X
ajlm-2688	244	2	cited	cite	VERB
ajlm-2688	244	3	2023	2023	NUM
ajlm-2688	244	4	sep	sep	NOUN
ajlm-2688	244	5	04	04	NUM
ajlm-2688	244	6	]	]	PUNCT
ajlm-2688	244	7	.	.	PUNCT
ajlm-2688	245	1	available	available	ADJ
ajlm-2688	245	2	from	from	ADP
ajlm-2688	245	3	:	:	PUNCT
ajlm-2688	245	4	https://labourguide.co.za/health-and-safety/managing-office-temperature	https://labourguide.co.za/health-and-safety/managing-office-temperature	NUM
ajlm-2688	245	5	hardwick	hardwick	PROPN
ajlm-2688	245	6	j.	j.	PROPN
ajlm-2688	245	7	blood	blood	PROPN
ajlm-2688	245	8	storage	storage	NOUN
ajlm-2688	245	9	and	and	CCONJ
ajlm-2688	245	10	transportation	transportation	NOUN
ajlm-2688	245	11	.	.	PUNCT
ajlm-2688	246	1	isbt	isbt	NOUN
ajlm-2688	246	2	sci	sci	PROPN
ajlm-2688	246	3	ser	ser	PROPN
ajlm-2688	246	4	.	.	PUNCT
ajlm-2688	247	1	2020;15(s1):232–254	2020;15(s1):232–254	NUM
ajlm-2688	247	2	.	.	PUNCT
ajlm-2688	248	1	https://doi.org/10.1111/voxs.12599	https://doi.org/10.1111/voxs.12599	VERB
ajlm-2688	248	2	hatherley	hatherley	NOUN
ajlm-2688	248	3	d	d	PROPN
ajlm-2688	248	4	,	,	PUNCT
ajlm-2688	248	5	barclay	barclay	PROPN
ajlm-2688	248	6	an	an	PROPN
ajlm-2688	248	7	.	.	PUNCT
ajlm-2688	249	1	the	the	DET
ajlm-2688	249	2	cd200	cd200	PROPN
ajlm-2688	249	3	and	and	CCONJ
ajlm-2688	249	4	cd200	cd200	PROPN
ajlm-2688	249	5	receptor	receptor	NOUN
ajlm-2688	249	6	cell	cell	NOUN
ajlm-2688	249	7	surface	surface	NOUN
ajlm-2688	249	8	proteins	protein	NOUN
ajlm-2688	249	9	interact	interact	VERB
ajlm-2688	249	10	through	through	ADP
ajlm-2688	249	11	their	their	PRON
ajlm-2688	249	12	n	n	CCONJ
ajlm-2688	249	13	-	-	PUNCT
ajlm-2688	249	14	terminal	terminal	ADJ
ajlm-2688	249	15	immunoglobulin	immunoglobulin	NOUN
ajlm-2688	249	16	-	-	PUNCT
ajlm-2688	249	17	like	like	ADJ
ajlm-2688	249	18	domains	domain	NOUN
ajlm-2688	249	19	.	.	PUNCT
ajlm-2688	250	1	eur	eur	PROPN
ajlm-2688	250	2	j	j	PROPN
ajlm-2688	250	3	immunol	immunol	NOUN
ajlm-2688	250	4	.	.	PUNCT
ajlm-2688	251	1	2004;34(6):1688–1694	2004;34(6):1688–1694	PROPN
ajlm-2688	251	2	.	.	PUNCT
ajlm-2688	252	1	https://doi.org/10.1002/eji.200425080	https://doi.org/10.1002/eji.200425080	PROPN
ajlm-2688	252	2	acharya	acharya	PROPN
ajlm-2688	252	3	m	m	PROPN
ajlm-2688	252	4	,	,	PUNCT
ajlm-2688	252	5	borland	borland	PROPN
ajlm-2688	252	6	g	g	PROPN
ajlm-2688	252	7	,	,	PUNCT
ajlm-2688	252	8	edkins	edkin	VERB
ajlm-2688	252	9	al	al	PROPN
ajlm-2688	252	10	,	,	PUNCT
ajlm-2688	252	11	et	et	PROPN
ajlm-2688	252	12	al	al	PROPN
ajlm-2688	252	13	.	.	PUNCT
ajlm-2688	253	1	cd23	cd23	PROPN
ajlm-2688	253	2	/	/	SYM
ajlm-2688	253	3	fcεrii	fcεrii	PROPN
ajlm-2688	253	4	:	:	PUNCT
ajlm-2688	253	5	molecular	molecular	ADJ
ajlm-2688	253	6	multi	multi	ADJ
ajlm-2688	253	7	-	-	ADJ
ajlm-2688	253	8	tasking	tasking	ADJ
ajlm-2688	253	9	.	.	PUNCT
ajlm-2688	254	1	clin	clin	PROPN
ajlm-2688	254	2	exp	exp	NOUN
ajlm-2688	254	3	immunol	immunol	NOUN
ajlm-2688	254	4	.	.	PUNCT
ajlm-2688	255	1	2010;162(1):12–23	2010;162(1):12–23	X
ajlm-2688	255	2	.	.	PUNCT
ajlm-2688	255	3	https://doi.org/10.1111/j.1365-2249.2010.04210.x	https://doi.org/10.1111/j.1365-2249.2010.04210.x	PROPN
ajlm-2688	255	4	kaur	kaur	PROPN
ajlm-2688	256	1	a	a	PROPN
ajlm-2688	256	2	,	,	PUNCT
ajlm-2688	256	3	lee	lee	PROPN
ajlm-2688	256	4	h	h	PROPN
ajlm-2688	256	5	-	-	PUNCT
ajlm-2688	256	6	k	k	PROPN
ajlm-2688	256	7	,	,	PUNCT
ajlm-2688	256	8	del	del	PROPN
ajlm-2688	256	9	giudice	giudice	PROPN
ajlm-2688	256	10	d	d	PROPN
ajlm-2688	256	11	,	,	PUNCT
ajlm-2688	256	12	singh	singh	PROPN
ajlm-2688	256	13	i	i	PRON
ajlm-2688	256	14	,	,	PUNCT
ajlm-2688	256	15	eldibany	eldibany	NOUN
ajlm-2688	256	16	m.	m.	NOUN
ajlm-2688	256	17	effect	effect	NOUN
ajlm-2688	256	18	of	of	ADP
ajlm-2688	256	19	temperature	temperature	NOUN
ajlm-2688	256	20	fluctuation	fluctuation	NOUN
ajlm-2688	256	21	and	and	CCONJ
ajlm-2688	256	22	transport	transport	NOUN
ajlm-2688	256	23	time	time	NOUN
ajlm-2688	256	24	on	on	ADP
ajlm-2688	256	25	complete	complete	ADJ
ajlm-2688	256	26	blood	blood	NOUN
ajlm-2688	256	27	count	count	NOUN
ajlm-2688	256	28	parameters	parameter	NOUN
ajlm-2688	256	29	.	.	PUNCT
ajlm-2688	257	1	am	be	AUX
ajlm-2688	257	2	j	j	PROPN
ajlm-2688	257	3	clin	clin	PROPN
ajlm-2688	257	4	pathol	pathol	NOUN
ajlm-2688	257	5	.	.	PUNCT
ajlm-2688	258	1	2019;152(suppl	2019;152(suppl	NUM
ajlm-2688	258	2	1):s112	1):s112	NUM
ajlm-2688	258	3	.	.	PUNCT
ajlm-2688	259	1	https://doi.org/10.1093/ajcp/aqz121.019	https://doi.org/10.1093/ajcp/aqz121.019	AUX
ajlm-2688	259	2	guo	guo	PROPN
ajlm-2688	259	3	b	b	PROPN
ajlm-2688	259	4	,	,	PUNCT
ajlm-2688	259	5	zhang	zhang	PROPN
ajlm-2688	259	6	l	l	PROPN
ajlm-2688	259	7	,	,	PUNCT
ajlm-2688	259	8	chiorazzi	chiorazzi	NOUN
ajlm-2688	259	9	n	n	CCONJ
ajlm-2688	259	10	,	,	PUNCT
ajlm-2688	259	11	rothstein	rothstein	PROPN
ajlm-2688	259	12	tl	tl	PROPN
ajlm-2688	259	13	.	.	PUNCT
ajlm-2688	259	14	il-4	il-4	PART
ajlm-2688	260	1	rescues	rescue	VERB
ajlm-2688	260	2	surface	surface	NOUN
ajlm-2688	260	3	igm	igm	NOUN
ajlm-2688	260	4	expression	expression	NOUN
ajlm-2688	260	5	in	in	ADP
ajlm-2688	260	6	chronic	chronic	ADJ
ajlm-2688	260	7	lymphocytic	lymphocytic	ADJ
ajlm-2688	260	8	leukemia	leukemia	NOUN
ajlm-2688	260	9	.	.	PUNCT
ajlm-2688	261	1	blood	blood	NOUN
ajlm-2688	261	2	.	.	PUNCT
ajlm-2688	262	1	2016;128(4):553–562	2016;128(4):553–562	NUM
ajlm-2688	262	2	.	.	PUNCT
ajlm-2688	262	3	https://doi.org/10.1182/blood-2015-11-682997	https://doi.org/10.1182/blood-2015-11-682997	PROPN
ajlm-2688	262	4	jackson	jackson	PROPN
ajlm-2688	262	5	cj	cj	PROPN
ajlm-2688	262	6	,	,	PUNCT
ajlm-2688	262	7	reppe	reppe	PROPN
ajlm-2688	262	8	s	s	PROPN
ajlm-2688	262	9	,	,	PUNCT
ajlm-2688	262	10	eidet	eidet	PROPN
ajlm-2688	262	11	jr	jr	PROPN
ajlm-2688	262	12	,	,	PUNCT
ajlm-2688	262	13	et	et	PROPN
ajlm-2688	262	14	al	al	PROPN
ajlm-2688	262	15	.	.	PUNCT
ajlm-2688	262	16	optimization	optimization	NOUN
ajlm-2688	262	17	of	of	ADP
ajlm-2688	262	18	storage	storage	NOUN
ajlm-2688	262	19	temperature	temperature	NOUN
ajlm-2688	262	20	for	for	ADP
ajlm-2688	262	21	retention	retention	NOUN
ajlm-2688	262	22	of	of	ADP
ajlm-2688	262	23	undifferentiated	undifferentiated	ADJ
ajlm-2688	262	24	cell	cell	NOUN
ajlm-2688	262	25	character	character	NOUN
ajlm-2688	262	26	of	of	ADP
ajlm-2688	262	27	cultured	cultured	ADJ
ajlm-2688	262	28	human	human	ADJ
ajlm-2688	262	29	epidermal	epidermal	ADJ
ajlm-2688	262	30	cell	cell	NOUN
ajlm-2688	262	31	sheets	sheet	NOUN
ajlm-2688	262	32	.	.	PUNCT
ajlm-2688	263	1	sci	sci	PROPN
ajlm-2688	263	2	rep	rep	PROPN
ajlm-2688	263	3	.	.	PROPN
ajlm-2688	263	4	2017;7(1):8206	2017;7(1):8206	X
ajlm-2688	263	5	.	.	PUNCT
ajlm-2688	264	1	https://doi.org/10.1038/s41598-017-08586-7	https://doi.org/10.1038/s41598-017-08586-7	PROPN
ajlm-2688	264	2	sandes	sande	NOUN
ajlm-2688	264	3	af	af	PROPN
ajlm-2688	264	4	,	,	PUNCT
ajlm-2688	264	5	de	de	PROPN
ajlm-2688	264	6	lourdes	lourdes	PROPN
ajlm-2688	264	7	chauffaille	chauffaille	PROPN
ajlm-2688	264	8	m	m	PROPN
ajlm-2688	264	9	,	,	PUNCT
ajlm-2688	264	10	oliveira	oliveira	PROPN
ajlm-2688	264	11	crmc	crmc	PROPN
ajlm-2688	264	12	,	,	PUNCT
ajlm-2688	264	13	et	et	PROPN
ajlm-2688	264	14	al	al	PROPN
ajlm-2688	264	15	.	.	PUNCT
ajlm-2688	265	1	cd200	cd200	PROPN
ajlm-2688	265	2	has	have	VERB
ajlm-2688	265	3	an	an	DET
ajlm-2688	265	4	important	important	ADJ
ajlm-2688	265	5	role	role	NOUN
ajlm-2688	265	6	in	in	ADP
ajlm-2688	265	7	the	the	DET
ajlm-2688	265	8	differential	differential	ADJ
ajlm-2688	265	9	diagnosis	diagnosis	NOUN
ajlm-2688	265	10	of	of	ADP
ajlm-2688	265	11	mature	mature	ADJ
ajlm-2688	265	12	b	b	NOUN
ajlm-2688	265	13	-	-	PUNCT
ajlm-2688	265	14	cell	cell	NOUN
ajlm-2688	265	15	neoplasms	neoplasm	NOUN
ajlm-2688	265	16	by	by	ADP
ajlm-2688	265	17	multiparameter	multiparameter	NOUN
ajlm-2688	265	18	flow	flow	NOUN
ajlm-2688	265	19	cytometry	cytometry	NOUN
ajlm-2688	265	20	.	.	PUNCT
ajlm-2688	266	1	cytometry	cytometry	PROPN
ajlm-2688	266	2	b	b	PROPN
ajlm-2688	266	3	clin	clin	PROPN
ajlm-2688	266	4	cytom	cytom	NOUN
ajlm-2688	266	5	.	.	PUNCT
ajlm-2688	267	1	2014;86(2):98–105	2014;86(2):98–105	NOUN
ajlm-2688	267	2	.	.	PUNCT
ajlm-2688	268	1	https://doi.org/10.1002/cytob.21128	https://doi.org/10.1002/cytob.21128	NOUN